archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,8.7323e-05,1.5121,1.2774,1,1
1,GO BLEB ASSEMBLY,7.889e-07,1.4154,1.2967,1,1
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,7.2111e-07,1.1931,1.0766,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00017186,1.1881,0.97101,1,1
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,3.9926e-07,1.1602,1.0594,1,1
1,GO MEMBRANE RAFT ASSEMBLY,9.7801e-06,1.1516,1.4723,1,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,2.0833e-05,1.1041,0.87048,1,1
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.00092958,1.0756,0.91874,1,1
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,7.5427e-07,1.054,0.88242,1,1
1,GO NEUTROPHIL HOMEOSTASIS,1.8521e-05,1.0288,0.89941,1,1
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,2.1831e-07,1.0287,0.87582,1,1
1,GO HYALURONAN CATABOLIC PROCESS,1.4044e-06,1.0272,0.99016,1,1
1,GO T HELPER 2 CELL DIFFERENTIATION,2.3975e-07,1.0272,1.025,1,1
1,GO RESPONSE TO INTERFERON ALPHA,5.7413e-06,1.0105,1.0296,1,1
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,1.0779e-06,1.006,0.9373,1,1
1,GO GLYCOPROTEIN CATABOLIC PROCESS,3.1888e-05,0.98795,0.76324,1,1
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00026903,0.96203,0.74567,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,8.2505e-07,0.93424,0.77973,1,1
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,3.6228e-06,0.93268,0.8887,1,1
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,5.8301e-05,0.93074,0.85933,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,4.0073e-05,0.9304,0.83103,1,1
1,GO INFLAMMATORY RESPONSE TO WOUNDING,6.8936e-07,0.92222,0.96416,1,1
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,1.1267e-06,0.91845,0.90223,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00020448,0.90973,0.73687,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,2.4346e-05,0.90403,0.82123,1,1
1,GO REGULATION OF METANEPHROS DEVELOPMENT,1.9873e-07,0.903,0.88563,1,1
1,GO REGULATION OF PLASMINOGEN ACTIVATION,0.00013917,0.8915,0.82544,1,1
1,GO NEGATIVE REGULATION OF CELL KILLING,0.00019079,0.8802,0.68253,1,1
1,GO T HELPER 1 CELL DIFFERENTIATION,4.3763e-07,0.87942,0.80176,1,1
1,GO MEMBRANE RAFT ORGANIZATION,3.8583e-05,0.87229,0.8721,1,1
1,GO ENDODERMAL CELL DIFFERENTIATION,5.0683e-06,0.83498,0.82186,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.4674e-06,0.83091,0.78046,1,1
1,GO CD40 SIGNALING PATHWAY,1.725e-07,0.82693,0.76011,1,1
1,GO RESPONSE TO INTERFERON BETA,8.3127e-06,0.81918,0.90214,1,1
1,GO COLLAGEN BIOSYNTHETIC PROCESS,2.8077e-06,0.81777,0.75506,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,4.6597e-05,0.81651,0.69178,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,7.2111e-07,0.80446,0.66319,1,1
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,1.1964e-05,0.80417,0.72165,1,1
1,GO ZYMOGEN INHIBITION,1.071e-07,0.80339,0.85053,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,7.2111e-07,0.80137,0.7,1,1
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00013433,0.79871,0.74509,1,1
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.00012074,0.79101,0.68983,1,1
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.8958e-07,0.79033,0.77634,1,1
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,1.2308e-06,0.78385,0.75693,1,1
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.00010092,0.76685,0.59985,1,1
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00016023,0.76678,0.62869,1,1
1,GO ENDODERM FORMATION,1.1964e-05,0.76072,0.70836,1,1
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.00037661,0.75905,0.58424,1,1
1,GO DNA DEAMINATION,2.9532e-05,0.75553,0.61416,1,1
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,1.4674e-06,0.75166,0.77794,1,1
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,1.4674e-06,0.74902,0.81395,1,1
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,5.4977e-07,0.74703,0.73549,1,1
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,3.6414e-07,0.74649,0.75446,1,1
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.2862e-06,0.74437,0.67726,1,1
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,3.3132e-05,0.74281,0.63718,1,1
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,4.3218e-05,0.72759,0.63625,1,1
1,GO MUCUS SECRETION,0.00040247,0.72579,0.60867,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.0784e-06,0.72061,0.64324,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.5759e-05,0.71514,0.58832,1,1
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,2.1663e-05,0.71419,0.91332,1,1
1,GO CHAPERONE MEDIATED AUTOPHAGY,0.00045924,0.71383,0.54104,1,1
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,1.0604e-05,0.71065,0.74473,1,1
1,GO RESPONSE TO MURAMYL DIPEPTIDE,0.00017186,0.70915,0.54064,1,1
1,GO DENDRITIC CELL APOPTOTIC PROCESS,1.1493e-05,0.70704,0.59162,1,1
1,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,4.5813e-07,0.70682,0.68871,1,1
1,GO TROPHOBLAST CELL MIGRATION,9.7801e-06,0.70407,0.77659,1,1
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,3.9926e-07,0.69817,0.60266,1,1
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,2.9301e-06,0.69595,0.67261,1,1
1,GO HEMIDESMOSOME ASSEMBLY,6.2786e-05,0.69294,0.72488,1,1
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,5.508e-06,0.69023,0.67938,1,1
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.0779e-06,0.68838,0.62379,1,1
1,GO LATERAL MESODERM DEVELOPMENT,2.1702e-06,0.67902,0.61586,1,1
1,GO XENOBIOTIC CATABOLIC PROCESS,0.00098941,0.67234,0.53411,1,1
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,3.9926e-07,0.67082,0.65571,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,1.0604e-05,0.66014,0.49041,1,1
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,8.7323e-05,0.65756,0.57068,1,1
1,GO BONE TRABECULA FORMATION,0.0028141,0.65454,0.6288,1,1
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,1.104e-05,0.65376,0.60852,1,1
1,GO CHRONIC INFLAMMATORY RESPONSE,4.8612e-06,0.65302,0.62531,1,1
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,2.0033e-05,0.64921,0.62016,1,1
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,7.2111e-07,0.6465,0.67909,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,6.5896e-07,0.64612,0.63657,1,1
1,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,1.6455e-05,0.64567,0.68469,1,1
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,9.389e-05,0.64536,0.60463,1,1
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.00010092,0.6445,0.51858,1,1
1,GO HIPPO SIGNALING,2.3418e-05,0.64208,0.54027,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,4.1617e-05,0.6418,0.73205,1,1
1,GO EPIBOLY,9.7801e-06,0.6395,0.69259,1,1
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,9.7801e-06,0.63677,0.61319,1,1
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,1.7806e-05,0.63569,0.57191,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,1.7118e-05,0.6355,0.53575,1,1
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,5.8301e-05,0.63484,0.5715,1,1
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,3.17e-07,0.63026,0.70817,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,3.17e-07,0.62907,0.58968,1,1
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,1.4039e-05,0.62864,0.52162,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,3.6228e-06,0.62853,0.59511,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,2.5774e-06,0.62295,0.56637,1,1
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.8084e-07,0.6183,0.65122,1,1
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,4.1802e-07,0.61556,0.58084,1,1
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.02166,0.61252,0.61273,1,1
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,7.6603e-06,0.61142,0.67184,1,1
1,GO GAP JUNCTION ASSEMBLY,4.3218e-05,0.61055,0.53712,1,1
1,GO PIGMENT GRANULE MATURATION,9.0179e-06,0.60856,0.50042,1,1
1,GO ENDODERM DEVELOPMENT,1.2454e-05,0.60721,0.56636,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00012512,0.6071,0.49628,1,1
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,3.8583e-05,0.6059,0.63161,1,1
1,GO BIOLOGICAL PHASE,0.00031859,0.60413,0.56618,1,1
1,GO VASCULOGENESIS,4.7955e-07,0.60346,0.57724,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,4.8612e-06,0.60153,0.53939,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.00014935,0.60118,0.59684,1,1
1,GO REGULATION OF VIRAL GENOME REPLICATION,2.2524e-05,0.60018,0.47611,1,1
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,1.349e-05,0.59943,0.6373,1,1
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,1.0311e-06,0.59784,0.73939,1,1
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,3.9926e-07,0.59627,0.54906,1,1
1,GO CYTOLYSIS,3.5759e-05,0.59555,0.45524,1,1
1,GO LIVER REGENERATION,3.6228e-06,0.59534,0.53234,1,1
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,1.4039e-05,0.5935,0.55081,1,1
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.00024286,0.59333,0.63591,1,1
1,GO REGULATION OF PINOCYTOSIS,5.9841e-06,0.59209,0.64928,1,1
1,GO COLLAGEN METABOLIC PROCESS,2.2524e-05,0.58733,0.53184,1,1
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,5.2837e-06,0.58629,0.59452,1,1
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,3.6228e-06,0.58625,0.52284,1,1
1,GO CYSTEINE METABOLIC PROCESS,0.00022676,0.58608,0.48727,1,1
1,GO MUSCLE CELL FATE COMMITMENT,0.00010845,0.58552,0.50876,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00050664,0.58453,0.5176,1,1
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00012512,0.58437,0.50578,1,1
1,GO HEME METABOLIC PROCESS,6.0198e-07,0.58415,0.55693,1,1
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,5.0683e-06,0.58373,0.59064,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,2.2658e-06,0.58278,0.5419,1,1
1,GO NOTOCHORD DEVELOPMENT,7.3528e-06,0.58159,0.61194,1,1
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,2.5308e-05,0.57931,0.63549,1,1
1,GO NUCLEOSIDE CATABOLIC PROCESS,0.00081984,0.57908,0.46344,1,1
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,1.4039e-05,0.57699,0.58567,1,1
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,4.3218e-05,0.57696,0.46072,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.00012964,0.57539,0.59002,1,1
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,1.1267e-06,0.57534,0.4746,1,1
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,5.2139e-05,0.57087,0.60097,1,1
1,GO REGULATION OF ISOTYPE SWITCHING,0.00019753,0.57021,0.37795,1,1
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,5.8301e-05,0.56806,0.69538,1,1
1,GO APOPTOTIC CELL CLEARANCE,9.3916e-06,0.56783,0.61245,1,1
1,GO GLYCOLIPID CATABOLIC PROCESS,0.00012074,0.56622,0.5091,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,4.0073e-05,0.56455,0.55776,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,5.4121e-05,0.56287,0.49853,1,1
1,GO MULTI ORGANISM CELLULAR PROCESS,9.3916e-06,0.56236,0.77833,1,1
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,6.2367e-06,0.5601,0.53492,1,1
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,7.9801e-06,0.55959,0.49632,1,1
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.0012662,0.55846,0.34912,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00029782,0.55702,0.48569,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,1.349e-05,0.55675,0.47485,1,1
1,GO PLASMINOGEN ACTIVATION,0.00028792,0.55099,0.55501,1,1
1,GO CELLULAR RESPONSE TO X RAY,0.00052342,0.5507,0.43059,1,1
1,GO TYPE 2 IMMUNE RESPONSE,8.6584e-06,0.5506,0.55008,1,1
1,GO RESPONSE TO ANGIOTENSIN,2.0829e-07,0.55057,0.51393,1,1
1,GO BRANCH ELONGATION OF AN EPITHELIUM,0.00090094,0.55036,0.47567,1,1
1,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.00030804,0.54974,0.63041,1,1
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0018173,0.54808,0.39732,1,1
1,GO BASEMENT MEMBRANE ORGANIZATION,0.00013917,0.5478,0.54242,1,1
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.00019753,0.5469,0.43328,1,1
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,8.1192e-05,0.54627,0.5204,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,8.4205e-05,0.54509,0.51787,1,1
1,GO REGULATION OF GLOMERULAR FILTRATION,0.0014299,0.54251,0.43717,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00012512,0.54227,0.49257,1,1
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.00019079,0.54162,0.44737,1,1
1,GO NEGATIVE REGULATION OF COAGULATION,0.00040247,0.54015,0.51411,1,1
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,2.5308e-05,0.53991,0.50846,1,1
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,9.0179e-06,0.53793,0.50424,1,1
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,3.3132e-05,0.53723,0.5058,1,1
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,3.4421e-05,0.53714,0.4824,1,1
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,8.1192e-05,0.53489,0.47909,1,1
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.9904e-06,0.53474,0.51633,1,1
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,4.2876e-06,0.53405,0.6194,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,3.5759e-05,0.53245,0.39705,1,1
1,GO COLLAGEN CATABOLIC PROCESS,3.1888e-05,0.53243,0.53773,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00055855,0.53142,0.46256,1,1
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,3.8583e-05,0.53071,0.55837,1,1
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.00016595,0.53002,0.48161,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00012512,0.52934,0.62693,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,3.7791e-06,0.52924,0.47707,1,1
1,GO RESPONSE TO TYPE I INTERFERON,0.00017186,0.52911,0.58247,1,1
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,6.5149e-05,0.5289,0.56024,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,0.00029782,0.52766,0.4139,1,1
1,GO VAGINA DEVELOPMENT,4.3218e-05,0.5274,0.55374,1,1
1,GO AMYLOID BETA CLEARANCE,7.547e-05,0.52732,0.41108,1,1
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00049035,0.52599,0.36389,1,1
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.004408,0.52542,0.56802,1,1
1,GO REGULATION OF VIRAL LIFE CYCLE,1.5201e-05,0.52439,0.45816,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.027188,0.52405,0.31025,1,1
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,3.3132e-05,0.52259,0.46778,1,1
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,3.1904e-06,0.52137,0.47507,1,1
1,GO REGULATION OF AMYLOID BETA CLEARANCE,0.0042883,0.52061,0.36377,1,1
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,1.9904e-06,0.51976,0.59229,1,1
1,GO STORE OPERATED CALCIUM ENTRY,3.1888e-05,0.51969,0.39953,1,1
1,GO RESPONSE TO X RAY,2.7578e-07,0.51895,0.50807,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,3.9926e-07,0.51749,0.4636,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,3.0264e-07,0.51677,0.61463,1,1
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00029782,0.51364,0.50326,1,1
1,GO CELLULAR RESPONSE TO SALT STRESS,0.00022676,0.51359,0.48612,1,1
1,GO VIRAL GENOME REPLICATION,2.7343e-05,0.5126,0.40636,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0014738,0.5123,0.36545,1,1
1,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00045924,0.51214,0.4427,1,1
1,GO CELLULAR RESPONSE TO DSRNA,1.7118e-05,0.51143,0.50264,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.00044439,0.51112,0.48649,1,1
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,3.7791e-06,0.51085,0.47974,1,1
1,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.015574,0.51001,0.31739,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,1.8251e-06,0.50763,0.46321,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,4.1802e-07,0.50727,0.49925,1,1
1,GO TOLERANCE INDUCTION,0.0011199,0.50715,0.42034,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00038934,0.50603,0.40192,1,1
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0013457,0.50574,0.43951,1,1
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.00026903,0.50552,0.47625,1,1
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,3.1904e-06,0.50319,0.43335,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,9.4334e-07,0.5007,0.61605,1,1
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,2.4692e-06,0.49918,0.47136,1,1
1,GO POSITIVE REGULATION OF ERAD PATHWAY,1.2862e-06,0.49818,0.43976,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,9.3916e-06,0.49796,0.46015,1,1
1,GO LEUKOCYTE AGGREGATION,0.0012662,0.49735,0.48529,1,1
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00054072,0.49624,0.35161,1,1
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,1.4609e-05,0.49568,0.40283,1,1
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,1.6455e-05,0.49361,0.59041,1,1
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,4.1617e-05,0.49314,0.40101,1,1
1,GO MATURATION OF SSU RRNA,9.0551e-05,0.4915,0.36467,1,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,2.0833e-05,0.48967,0.42784,1,1
1,GO RETINAL METABOLIC PROCESS,0.0060989,0.48923,0.33401,1,1
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,3.4728e-06,0.48603,0.43018,1,1
1,GO SALIVARY GLAND DEVELOPMENT,0.00050664,0.48541,0.45904,1,1
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,3.6228e-06,0.48527,0.54284,1,1
1,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0032441,0.48516,0.39929,1,1
1,GO RRNA PSEUDOURIDINE SYNTHESIS,0.00034072,0.48473,0.36074,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00027832,0.48419,0.46919,1,1
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,4.1617e-05,0.48377,0.3915,1,1
1,GO PROGESTERONE METABOLIC PROCESS,0.0047853,0.483,0.27418,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,9.3916e-06,0.48235,0.40073,1,1
1,GO RECEPTOR CATABOLIC PROCESS,8.2505e-07,0.48233,0.45714,1,1
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00044439,0.48233,0.36066,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,7.6603e-06,0.47956,0.56525,1,1
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,9.7801e-06,0.47891,0.4414,1,1
1,GO ENTRY INTO HOST,2.9301e-06,0.47861,0.53104,1,1
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,8.628e-07,0.4783,0.49095,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,9.0221e-07,0.47824,0.54145,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.00090094,0.47813,0.40376,1,1
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0022332,0.47781,0.34788,1,1
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.00038934,0.47718,0.40778,1,1
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.00063551,0.47626,0.40032,1,1
1,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.019283,0.47608,0.3564,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00010092,0.47511,0.42865,1,1
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,5.9841e-06,0.47487,0.4688,1,1
1,GO HAIR FOLLICLE MATURATION,0.0011199,0.4746,0.33329,1,1
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.00013433,0.47445,0.56187,1,1
1,GO SKELETAL MUSCLE TISSUE REGENERATION,5.7413e-06,0.47436,0.43255,1,1
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,2.2524e-05,0.47395,0.35358,1,1
1,GO PINOCYTOSIS,4.3763e-07,0.47321,0.6138,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,3.6228e-06,0.47275,0.47175,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00092958,0.4724,0.34317,1,1
1,GO REGULATION OF TRANSPOSITION,0.00074557,0.47114,0.42421,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00017796,0.47112,0.38646,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,9.3916e-06,0.47109,0.48614,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,5.7413e-06,0.47004,0.41467,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,7.5427e-07,0.46997,0.44826,1,1
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.00084609,0.46959,0.5178,1,1
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00032948,0.46759,0.55347,1,1
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,6.7596e-05,0.46682,0.41295,1,1
1,GO REGULATION OF HORMONE METABOLIC PROCESS,2.8418e-05,0.46674,0.45041,1,1
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0031536,0.46592,0.3599,1,1
1,GO HYALURONAN METABOLIC PROCESS,0.00057693,0.4653,0.41293,1,1
1,GO MATURATION OF LSU RRNA,3.4421e-05,0.46526,0.43546,1,1
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,5.0226e-05,0.46466,0.45385,1,1
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.00023468,0.46432,0.40627,1,1
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00041602,0.46362,0.53531,1,1
1,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0033369,0.46336,0.3715,1,1
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,2.9301e-06,0.46315,0.40489,1,1
1,GO BLOOD VESSEL REMODELING,0.00038934,0.46169,0.38287,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,5.0226e-05,0.46006,0.3728,1,1
1,GO VASCULAR TRANSPORT,0.010773,0.45944,0.48247,1,1
1,GO MODULATION BY HOST OF VIRAL PROCESS,2.0784e-06,0.45851,0.53559,1,1
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,5.986e-08,0.45798,0.57621,1,1
1,GO VIRAL RNA GENOME REPLICATION,1.7806e-05,0.45743,0.39811,1,1
1,GO THYMOCYTE APOPTOTIC PROCESS,1.0184e-05,0.45741,0.42617,1,1
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,6.2786e-05,0.45732,0.49397,1,1
1,GO OSTEOBLAST DEVELOPMENT,0.0013872,0.45708,0.37524,1,1
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,6.8936e-07,0.45701,0.42799,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.00010462,0.45558,0.3937,1,1
1,GO MEMBRANE PROTEIN PROTEOLYSIS,5.0226e-05,0.45501,0.40837,1,1
1,GO PROTEASOME ASSEMBLY,9.7801e-06,0.45437,0.36929,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,3.9418e-06,0.45382,0.42082,1,1
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00035231,0.45355,0.36823,1,1
1,GO LYMPHANGIOGENESIS,2.6307e-05,0.45312,0.43197,1,1
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.00010845,0.45309,0.566,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0037331,0.45272,0.31321,1,1
1,GO MESODERMAL CELL DIFFERENTIATION,5.8301e-05,0.4525,0.3613,1,1
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,7.547e-05,0.45187,0.35253,1,1
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.02068,0.45146,0.27093,1,1
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.00013917,0.45014,0.44052,1,1
1,GO ZYMOGEN ACTIVATION,0.00013433,0.4498,0.46531,1,1
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,3.1888e-05,0.44959,0.41967,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,4.8379e-05,0.44939,0.37433,1,1
1,GO ENDOTHELIAL CELL CHEMOTAXIS,0.001662,0.4477,0.4105,1,1
1,GO REGULATION OF TRANSLATIONAL TERMINATION,2.4346e-05,0.44693,0.39313,1,1
1,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.0042883,0.44665,0.35545,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,1.2862e-06,0.44643,0.44712,1,1
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,1.8521e-05,0.44636,0.35093,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,7.0571e-06,0.44634,0.36313,1,1
1,GO MYELOID CELL APOPTOTIC PROCESS,5.2837e-06,0.44554,0.47337,1,1
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.0016129,0.44472,0.4285,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION,7.6603e-06,0.44429,0.35908,1,1
1,GO T CELL MEDIATED IMMUNITY,1.6455e-05,0.44399,0.44019,1,1
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,3.9418e-06,0.44195,0.44942,1,1
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,4.1112e-06,0.44187,0.36826,1,1
1,GO CYCLOOXYGENASE PATHWAY,0.0099891,0.44142,0.42713,1,1
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,8.3127e-06,0.44108,0.52002,1,1
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,3.4728e-06,0.43986,0.45943,1,1
1,GO CELLULAR RESPONSE TO IRON ION,0.00065623,0.43798,0.44836,1,1
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00069957,0.43773,0.3929,1,1
1,GO DEFENSE RESPONSE TO VIRUS,5.0226e-05,0.43748,0.38821,1,1
1,GO REGULATION OF MYOBLAST FUSION,2.8418e-05,0.43551,0.5295,1,1
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,3.1888e-05,0.4354,0.3623,1,1
1,GO CYTOKINE METABOLIC PROCESS,5.7413e-06,0.43528,0.38692,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00011241,0.43489,0.35804,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.7118e-05,0.43475,0.38092,1,1
1,GO TYPE I INTERFERON PRODUCTION,2.6307e-05,0.43431,0.32374,1,1
1,GO PROTEIN ACTIVATION CASCADE,6.0504e-05,0.43358,0.33842,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,4.6597e-05,0.43259,0.42029,1,1
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,2.5308e-05,0.43222,0.45964,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,3.0576e-06,0.43197,0.42723,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.00020448,0.43182,0.46406,1,1
1,GO RESPONSE TO FLUID SHEAR STRESS,8.4205e-05,0.43172,0.40175,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.00052342,0.4317,0.59067,1,1
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.00041602,0.43066,0.588,1,1
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,2.1702e-06,0.43063,0.41276,1,1
1,GO PLATELET AGGREGATION,3.9418e-06,0.42999,0.36779,1,1
1,GO RESPONSE TO HYPEROXIA,0.0010206,0.42895,0.3871,1,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.00029782,0.42878,0.35594,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,2.6307e-05,0.42834,0.46916,1,1
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,3.0689e-05,0.42819,0.38271,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.00072223,0.42792,0.3295,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,1.1267e-06,0.42778,0.48554,1,1
1,GO REGULATION OF NECROTIC CELL DEATH,3.3287e-06,0.42704,0.51867,1,1
1,GO BONE TRABECULA MORPHOGENESIS,0.022165,0.42704,0.34952,1,1
1,GO RIBOSOME ASSEMBLY,0.00024286,0.42689,0.3497,1,1
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00059588,0.42516,0.36825,1,1
1,GO LYMPH VESSEL MORPHOGENESIS,0.00017186,0.42445,0.37402,1,1
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00024286,0.42438,0.42738,1,1
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,3.1904e-06,0.42407,0.49715,1,1
1,GO MONONUCLEAR CELL DIFFERENTIATION,2.5308e-05,0.42354,0.39264,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,6.5896e-07,0.42324,0.39679,1,1
1,GO FORMATION OF PRIMARY GERM LAYER,2.9532e-05,0.42319,0.41115,1,1
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.00035231,0.42266,0.36727,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,5.6174e-05,0.42213,0.35591,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00034072,0.42118,0.48596,1,1
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,3.6228e-06,0.42029,0.47223,1,1
1,GO RIG I SIGNALING PATHWAY,1.2308e-06,0.42013,0.42217,1,1
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.0007696,0.41998,0.32896,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,3.17e-07,0.41976,0.37884,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,2.1702e-06,0.41965,0.3618,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00030804,0.41962,0.42806,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,9.0179e-06,0.41924,0.44085,1,1
1,GO RESPONSE TO INTERFERON GAMMA,6.7596e-05,0.41907,0.4504,1,1
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,7.013e-05,0.4188,0.37173,1,1
1,GO ENAMEL MINERALIZATION,0.0023671,0.4175,0.39553,1,1
1,GO PEPTIDYL PROLINE MODIFICATION,6.4994e-06,0.41743,0.35322,1,1
1,GO INTERLEUKIN 1 PRODUCTION,6.5149e-05,0.41731,0.42745,1,1
1,GO REGULATION OF MEMBRANE INVAGINATION,0.0029794,0.41636,0.35585,1,1
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,1.8521e-05,0.41634,0.37541,1,1
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,1.0604e-05,0.4163,0.49943,1,1
1,GO NIK NF KAPPAB SIGNALING,2.3975e-07,0.41583,0.41891,1,1
1,GO RESPONSE TO INTERLEUKIN 12,1.2862e-06,0.41524,0.40942,1,1
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,2.0033e-05,0.41479,0.39851,1,1
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,3.7145e-05,0.41397,0.43676,1,1
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,6.2786e-05,0.41374,0.32954,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00010462,0.41326,0.32554,1,1
1,GO REGULATION OF SYMBIOTIC PROCESS,6.4994e-06,0.41222,0.37462,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.4609e-05,0.41215,0.37737,1,1
1,GO VIRAL TRANSLATION,8.3127e-06,0.41209,0.40113,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.00017796,0.41167,0.38638,1,1
1,GO INTERFERON BETA PRODUCTION,0.00028792,0.41142,0.29094,1,1
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.00044439,0.41112,0.3662,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.00026903,0.41096,0.31868,1,1
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,2.5308e-05,0.41019,0.38181,1,1
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,2.1702e-06,0.40973,0.36644,1,1
1,GO PEPTIDE CROSS LINKING,0.00014418,0.40915,0.41479,1,1
1,GO RESPONSE TO SALT STRESS,5.8301e-05,0.40877,0.33836,1,1
1,GO REGULATION OF MRNA BINDING,3.5759e-05,0.40814,0.35005,1,1
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00014418,0.40814,0.42286,1,1
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,9.0179e-06,0.40786,0.36058,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00031859,0.40708,0.40465,1,1
1,GO MOVEMENT IN HOST ENVIRONMENT,2.3654e-06,0.40661,0.45676,1,1
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,7.3528e-06,0.40585,0.37122,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.017549,0.40564,0.25729,1,1
1,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.00074557,0.40549,0.38426,1,1
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.014138,0.40547,0.24713,1,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,2.8077e-06,0.40446,0.39325,1,1
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00012964,0.40416,0.39912,1,1
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0007696,0.40416,0.4134,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0060989,0.40414,0.38711,1,1
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0075304,0.4034,0.2807,1,1
1,GO PROGRAMMED NECROTIC CELL DEATH,2.3654e-06,0.40325,0.50001,1,1
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,8.1192e-05,0.40277,0.31562,1,1
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.00025131,0.40267,0.37434,1,1
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,5.7413e-06,0.40259,0.36302,1,1
1,GO INTERLEUKIN 2 PRODUCTION,5.0194e-07,0.40247,0.44664,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00049035,0.40197,0.37879,1,1
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00011241,0.4013,0.32563,1,1
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00012512,0.40103,0.32796,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,2.0829e-07,0.40024,0.37577,1,1
1,GO INTERLEUKIN 8 PRODUCTION,1.104e-05,0.40007,0.38686,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.0017641,0.39942,0.35823,1,1
1,GO COLLAGEN FIBRIL ORGANIZATION,0.00026903,0.39886,0.5765,1,1
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,6.2985e-07,0.39783,0.39293,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,5.9841e-06,0.39555,0.39463,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00050664,0.39517,0.37929,1,1
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,1.6455e-05,0.39374,0.33596,1,1
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00020448,0.39326,0.39399,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00353,0.39324,0.29497,1,1
1,GO POSITIVE REGULATION OF MITOPHAGY,0.00020448,0.39213,0.33452,1,1
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,3.5759e-05,0.39202,0.44151,1,1
1,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.00034072,0.39137,0.33879,1,1
1,GO CERAMIDE CATABOLIC PROCESS,0.00059588,0.38996,0.33874,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00017796,0.38981,0.41786,1,1
1,GO I KAPPAB PHOSPHORYLATION,0.00019079,0.38911,0.27387,1,1
1,GO REGULATION OF PROTEIN IMPORT,1.6455e-05,0.38812,0.35451,1,1
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,3.3287e-06,0.38802,0.38266,1,1
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00014418,0.38793,0.44647,1,1
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,2.3654e-06,0.38731,0.35839,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,9.7801e-06,0.38699,0.38555,1,1
1,GO ARGININE METABOLIC PROCESS,0.0006154,0.38692,0.35517,1,1
1,GO ANIMAL ORGAN REGENERATION,4.0073e-05,0.38657,0.41983,1,1
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,1.3441e-06,0.38657,0.36958,1,1
1,GO RESPONSE TO ESTROGEN,9.0221e-07,0.38605,0.38119,1,1
1,GO KERATAN SULFATE CATABOLIC PROCESS,0.00095906,0.38584,0.50672,1,1
1,GO REGULATION OF PROTEIN MATURATION,1.5331e-06,0.38382,0.37193,1,1
1,GO ERBB2 SIGNALING PATHWAY,3.5759e-05,0.38381,0.32344,1,1
1,GO IMMATURE T CELL PROLIFERATION,0.00010092,0.3835,0.43102,1,1
1,GO AMINOGLYCAN CATABOLIC PROCESS,9.389e-05,0.38349,0.43474,1,1
1,GO T CELL APOPTOTIC PROCESS,2.6902e-06,0.3831,0.35687,1,1
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,3.6228e-06,0.38288,0.35237,1,1
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,4.6597e-05,0.38263,0.32527,1,1
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.00019079,0.38245,0.35777,1,1
1,GO REGULATION OF STEM CELL DIFFERENTIATION,2.2879e-07,0.38216,0.36336,1,1
1,GO CYTOPLASMIC TRANSLATION,0.00035231,0.38197,0.31249,1,1
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,7.2754e-05,0.38189,0.33714,1,1
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0024367,0.38078,0.33635,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,2.4692e-06,0.38061,0.32855,1,1
1,GO MATURATION OF 5 8S RRNA,0.00013433,0.38036,0.3235,1,1
1,GO EMBRYO IMPLANTATION,1.349e-05,0.38029,0.45298,1,1
1,GO AORTIC VALVE DEVELOPMENT,0.00047456,0.38022,0.38993,1,1
1,GO VIRAL LIFE CYCLE,1.6015e-06,0.37964,0.38751,1,1
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,8.7323e-05,0.3792,0.38873,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,0.00026003,0.37907,0.37146,1,1
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,3.4772e-07,0.3785,0.49066,1,1
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,2.7343e-05,0.37758,0.40848,1,1
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,6.5149e-05,0.37717,0.37394,1,1
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,4.4712e-06,0.37702,0.35211,1,1
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.0081404,0.37698,0.29958,1,1
1,GO MAMMARY GLAND MORPHOGENESIS,0.00014935,0.37681,0.34428,1,1
1,GO TELOMERASE RNA LOCALIZATION,0.0010206,0.37609,0.29272,1,1
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0014299,0.37539,0.33708,1,1
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0025817,0.37515,0.39316,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,9.3916e-06,0.37484,0.35914,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,3.8583e-05,0.37424,0.32326,1,1
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.00010845,0.37407,0.34837,1,1
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00018427,0.37329,0.3228,1,1
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.4346e-05,0.37311,0.36972,1,1
1,GO MUSCLE FILAMENT SLIDING,0.00081984,0.37288,0.28691,1,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,2.7343e-05,0.3719,0.32281,1,1
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,8.4205e-05,0.37172,0.35973,1,1
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,1.5331e-06,0.37093,0.34489,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,3.5759e-05,0.37033,0.41627,1,1
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,2.5774e-06,0.37029,0.3434,1,1
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.7806e-05,0.36936,0.32184,1,1
1,GO LENS FIBER CELL DEVELOPMENT,0.0013457,0.36913,0.38082,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,8.7323e-05,0.36896,0.40233,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,2.1663e-05,0.36874,0.343,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,7.9801e-06,0.36865,0.31596,1,1
1,GO NECROTIC CELL DEATH,4.1112e-06,0.36814,0.44593,1,1
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00081984,0.36799,0.28299,1,1
1,GO PENTOSE METABOLIC PROCESS,0.00024286,0.36797,0.33323,1,1
1,GO COPPER ION HOMEOSTASIS,3.4728e-06,0.3673,0.48764,1,1
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0056288,0.36694,0.26514,1,1
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.00055855,0.36672,0.37102,1,1
1,GO SEMI LUNAR VALVE DEVELOPMENT,0.001191,0.36662,0.35455,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0015189,0.36644,0.36814,1,1
1,GO SNRNA PROCESSING,0.0022992,0.36635,0.54944,1,1
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.1888e-05,0.366,0.33115,1,1
1,GO MEMBRANE INVAGINATION,0.00012964,0.36568,0.2944,1,1
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.00025131,0.36564,0.37206,1,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,4.8612e-06,0.36556,0.37817,1,1
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,2.6307e-05,0.36524,0.36146,1,1
1,GO NCRNA PROCESSING,5.0226e-05,0.36512,0.27569,1,1
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00022676,0.36469,0.31645,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00041602,0.36445,0.33006,1,1
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00021909,0.36311,0.33094,1,1
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0033369,0.36296,0.36455,1,1
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,7.8282e-05,0.36261,0.31856,1,1
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0010206,0.36223,0.3005,1,1
1,GO CELLULAR COPPER ION HOMEOSTASIS,1.5816e-05,0.36166,0.52746,1,1
1,GO BEHAVIORAL RESPONSE TO PAIN,0.0017123,0.36132,0.29715,1,1
1,GO CRISTAE FORMATION,0.0029794,0.36054,0.24261,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,9.7801e-06,0.35955,0.32196,1,1
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.0040578,0.35893,0.25076,1,1
1,GO INTERACTION WITH HOST,2.0784e-06,0.3588,0.39129,1,1
1,GO NEGATIVE REGULATION OF CELL SIZE,2.1663e-05,0.35848,0.30594,1,1
1,GO TRANSLATIONAL TERMINATION,6.2786e-05,0.35841,0.28834,1,1
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.0001165,0.35821,0.26886,1,1
1,GO SKELETAL MUSCLE CELL PROLIFERATION,5.4121e-05,0.35803,0.35521,1,1
1,GO LEUKOCYTE APOPTOTIC PROCESS,2.8077e-06,0.35759,0.34389,1,1
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.0028141,0.35747,0.30386,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.4421e-05,0.3573,0.36868,1,1
1,GO BONE GROWTH,0.0022332,0.35588,0.32952,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0022332,0.35573,0.36319,1,1
1,GO RIBOSOME BIOGENESIS,0.00014935,0.35553,0.28966,1,1
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,4.5813e-07,0.35527,0.37973,1,1
1,GO REGULATION OF STEROL TRANSPORT,0.00010462,0.35505,0.30199,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,2.9301e-06,0.35458,0.30137,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00074557,0.35432,0.26522,1,1
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,4.0073e-05,0.35427,0.33647,1,1
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0001547,0.35415,0.29796,1,1
1,GO REGULATION OF GASTRULATION,1.4609e-05,0.35369,0.3503,1,1
1,GO SERTOLI CELL DEVELOPMENT,0.0027346,0.35364,0.27771,1,1
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.010773,0.35323,0.2807,1,1
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.036164,0.35251,0.22252,1,1
1,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.018836,0.35247,0.42294,1,1
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,7.013e-05,0.35211,0.41758,1,1
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.00014418,0.35194,0.40083,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00013433,0.35188,0.36577,1,1
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,4.1112e-06,0.35119,0.33568,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0046564,0.35108,0.28961,1,1
1,GO RESPONSE TO MANGANESE ION,1.349e-05,0.35094,0.35314,1,1
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00041602,0.35078,0.30303,1,1
1,GO IRON ION TRANSMEMBRANE TRANSPORT,3.4728e-06,0.35069,0.32548,1,1
1,GO MONONUCLEAR CELL MIGRATION,0.00017186,0.34928,0.33639,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,6.7728e-06,0.34904,0.31672,1,1
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00044439,0.34868,0.31277,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,7.0571e-06,0.348,0.3209,1,1
1,GO ERAD PATHWAY,2.6307e-05,0.348,0.26441,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00022676,0.3478,0.3283,1,1
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0013457,0.34769,0.37874,1,1
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.7343e-05,0.34748,0.33947,1,1
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00022676,0.34716,0.37858,1,1
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.00032948,0.34693,0.36141,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00057693,0.34661,0.28937,1,1
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0007696,0.34653,0.28703,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0007696,0.34483,0.29646,1,1
1,GO GOLGI TO VACUOLE TRANSPORT,3.4421e-05,0.34481,0.28857,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.0021689,0.34378,0.28291,1,1
1,GO NCRNA 3 END PROCESSING,0.0028957,0.34296,0.3773,1,1
1,GO INTERLEUKIN 1 BETA PRODUCTION,0.00012074,0.34295,0.38174,1,1
1,GO RRNA METABOLIC PROCESS,0.00019079,0.34139,0.26919,1,1
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.00020448,0.34056,0.45438,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00044439,0.34004,0.31269,1,1
1,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.02268,0.33993,0.25443,1,1
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.00353,0.33988,0.26277,1,1
1,GO VIRAL GENE EXPRESSION,2.3418e-05,0.33947,0.34981,1,1
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00052342,0.33933,0.31933,1,1
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.0226e-05,0.33897,0.29616,1,1
1,GO RESPONSE TO PROGESTERONE,0.0087944,0.33875,0.26684,1,1
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.00028792,0.3383,0.34277,1,1
1,GO TETRAPYRROLE METABOLIC PROCESS,2.1663e-05,0.33744,0.26722,1,1
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00010092,0.33723,0.26503,1,1
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,1.2962e-05,0.33704,0.37509,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.011904,0.33682,0.22492,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,0.00052342,0.33578,0.33275,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0013054,0.33571,0.34067,1,1
1,GO REGULATION OF HISTONE PHOSPHORYLATION,0.00042998,0.33543,0.3076,1,1
1,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.0049174,0.33518,0.36148,1,1
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,2.2524e-05,0.33491,0.29627,1,1
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00014418,0.33477,0.37042,1,1
1,GO REGULATION OF PHAGOCYTOSIS,8.7323e-05,0.33447,0.33081,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,2.2524e-05,0.33393,0.30867,1,1
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.0036303,0.33352,0.30341,1,1
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,5.4121e-05,0.33269,0.29134,1,1
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.038561,0.33189,0.32434,1,1
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00017796,0.33137,0.38507,1,1
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00026903,0.33127,0.30421,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0046564,0.33107,0.27857,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,6.7596e-05,0.33074,0.36454,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.014138,0.33058,0.24751,1,1
1,GO REGULATION OF FIBROBLAST MIGRATION,0.0021689,0.33052,0.33501,1,1
1,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.024288,0.33037,0.21746,1,1
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0014299,0.32954,0.31256,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.00019079,0.32929,0.30411,1,1
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.007729,0.32892,0.30623,1,1
1,GO RESPONSE TO VIRUS,4.1617e-05,0.32885,0.32696,1,1
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.0025083,0.32858,0.34465,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0029794,0.32832,0.29623,1,1
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00027832,0.32795,0.288,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,3.7145e-05,0.32793,0.46488,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00072223,0.32793,0.30609,1,1
1,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.038561,0.3275,0.27293,1,1
1,GO INTERLEUKIN 17 PRODUCTION,2.5308e-05,0.32749,0.43152,1,1
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,1.2454e-05,0.32743,0.44722,1,1
1,GO POSITIVE REGULATION OF TRANSLATION,5.2533e-07,0.32728,0.33682,1,1
1,GO PIGMENT ACCUMULATION,0.00047456,0.32724,0.27417,1,1
1,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.011326,0.32617,0.36068,1,1
1,GO PRIMARY MIRNA PROCESSING,0.00014418,0.32507,0.35988,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,1.5201e-05,0.32507,0.30294,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,1.2454e-05,0.3245,0.40936,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00035231,0.32398,0.39674,1,1
1,GO B CELL MEDIATED IMMUNITY,5.2139e-05,0.32382,0.29005,1,1
1,GO SNRNA METABOLIC PROCESS,0.00084609,0.32355,0.44013,1,1
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,3.8583e-05,0.32338,0.31049,1,1
1,GO MESODERM MORPHOGENESIS,2.0833e-05,0.32325,0.30431,1,1
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0018173,0.32281,0.281,1,1
1,GO RNA 5 END PROCESSING,0.00012074,0.3228,0.29727,1,1
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,2.8077e-06,0.32273,0.38344,1,1
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.00052342,0.32248,0.30335,1,1
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.4878e-05,0.32225,0.4387,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.4728e-06,0.32181,0.31898,1,1
1,GO TRANSLATIONAL INITIATION,0.00032948,0.32166,0.29504,1,1
1,GO PEPTIDE CATABOLIC PROCESS,0.00026003,0.32074,0.24963,1,1
1,GO LEFT RIGHT AXIS SPECIFICATION,0.0050528,0.31971,0.30666,1,1
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.0006154,0.31962,0.24848,1,1
1,GO CELL REDOX HOMEOSTASIS,1.5201e-05,0.31955,0.293,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.00012964,0.3194,0.33488,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.0010859,0.31924,0.21539,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0016129,0.3189,0.37544,1,1
1,GO MONOCYTE CHEMOTAXIS,0.00020448,0.31884,0.37135,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,8.2505e-07,0.31874,0.33074,1,1
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0064317,0.31867,0.54113,1,1
1,GO SPROUTING ANGIOGENESIS,2.4346e-05,0.31812,0.33445,1,1
1,GO CYTOKINETIC PROCESS,2.0833e-05,0.31726,0.2949,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.004408,0.31722,0.28121,1,1
1,GO GASTRULATION,3.7145e-05,0.31715,0.29991,1,1
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.00012074,0.31694,0.26127,1,1
1,GO PROTEIN TARGETING TO VACUOLE,0.0012662,0.31683,0.22138,1,1
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.004408,0.31647,0.28927,1,1
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,9.0551e-05,0.3159,0.27924,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00010462,0.31513,0.25221,1,1
1,GO RECEPTOR BIOSYNTHETIC PROCESS,1.5816e-05,0.31461,0.31204,1,1
1,GO NCRNA METABOLIC PROCESS,7.8282e-05,0.31443,0.24528,1,1
1,GO INNATE IMMUNE RESPONSE,7.013e-05,0.31441,0.24956,1,1
1,GO LIPOPROTEIN LOCALIZATION,0.00038934,0.31441,0.38643,1,1
1,GO KERATAN SULFATE METABOLIC PROCESS,0.00021167,0.31386,0.33291,1,1
1,GO VESICLE CARGO LOADING,2.2524e-05,0.31358,0.29499,1,1
1,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.0018173,0.31351,0.26164,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,7.547e-05,0.31346,0.25566,1,1
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0025083,0.31324,0.28291,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00050664,0.31311,0.29786,1,1
1,GO REGULATION OF VIRAL TRANSCRIPTION,4.6623e-06,0.31228,0.28167,1,1
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.00065623,0.3114,0.45373,1,1
1,GO LYMPH VESSEL DEVELOPMENT,0.001662,0.31045,0.32096,1,1
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.023205,0.30976,0.27112,1,1
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.0025083,0.30964,0.24157,1,1
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,3.8583e-05,0.3094,0.34669,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.011612,0.30928,0.23967,1,1
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.2524e-05,0.30918,0.27956,1,1
1,GO VIRAL RELEASE FROM HOST CELL,0.00014418,0.30892,0.25946,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.00010845,0.30888,0.25345,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00028792,0.30883,0.24502,1,1
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,5.2533e-07,0.30854,0.31614,1,1
1,GO MITOCHONDRIAL TRANSLATION,0.00026003,0.30834,0.24685,1,1
1,GO ACUTE PHASE RESPONSE,0.0046564,0.30828,0.27178,1,1
1,GO CELL CELL JUNCTION MAINTENANCE,0.0051916,0.30801,0.27816,1,1
1,GO KETONE BIOSYNTHETIC PROCESS,9.0551e-05,0.308,0.26331,1,1
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0018173,0.30708,0.28575,1,1
1,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.00014935,0.30708,0.26973,1,1
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00010845,0.30679,0.25632,1,1
1,GO TRNA 5 LEADER REMOVAL,3.8583e-05,0.30644,0.35312,1,1
1,GO LYMPHOCYTE MEDIATED IMMUNITY,6.5149e-05,0.30635,0.27563,1,1
1,GO ADAPTIVE IMMUNE RESPONSE,1.8521e-05,0.30552,0.29674,1,1
1,GO RESPONSE TO INTERLEUKIN 1,5.0683e-06,0.3052,0.32859,1,1
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.00042998,0.30503,0.26317,1,1
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00018427,0.30483,0.30812,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00050664,0.30448,0.30629,1,1
1,GO POSITIVE REGULATION OF LIPID STORAGE,9.7346e-05,0.30439,0.36198,1,1
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00012074,0.30412,0.25615,1,1
1,GO ACTIN FILAMENT SEVERING,0.001228,0.30394,0.40041,1,1
1,GO NUCLEAR PORE ORGANIZATION,0.00012074,0.30376,0.32865,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0094949,0.30363,0.27101,1,1
1,GO C21 STEROID HORMONE METABOLIC PROCESS,0.00050664,0.30351,0.27449,1,1
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.014486,0.30285,0.20609,1,1
1,GO MULTI ORGANISM LOCALIZATION,1.2971e-07,0.30285,0.39001,1,1
1,GO PIGMENT METABOLIC PROCESS,2.0033e-05,0.3028,0.26404,1,1
1,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.010506,0.3027,0.21381,1,1
1,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.0057817,0.30262,0.278,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.9532e-05,0.30225,0.32978,1,1
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,6.8936e-07,0.30217,0.35077,1,1
1,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0051916,0.30214,0.30739,1,1
1,GO CELLULAR RESPONSE TO ETHANOL,0.0014738,0.30213,0.31581,1,1
1,GO FOCAL ADHESION ASSEMBLY,0.0012662,0.30173,0.30657,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0028141,0.3015,0.25417,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.0047853,0.30123,0.17569,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.031059,0.30122,0.26901,1,1
1,GO MACROPHAGE MIGRATION,5.9841e-06,0.30081,0.35095,1,1
1,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.001662,0.30016,0.30508,1,1
1,GO T CELL CYTOKINE PRODUCTION,4.3218e-05,0.29996,0.38592,1,1
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0010859,0.29948,0.32924,1,1
1,GO RRNA MODIFICATION,0.0014738,0.2993,0.21884,1,1
1,GO OLIGOPEPTIDE TRANSPORT,0.0041716,0.2991,0.34759,1,1
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.00065623,0.29882,0.26223,1,1
1,GO NATURAL KILLER CELL PROLIFERATION,0.0040578,0.2987,0.34746,1,1
1,GO RESPONSE TO INTERLEUKIN 15,0.00024286,0.29837,0.36513,1,1
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,7.3528e-06,0.29831,0.29938,1,1
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.012203,0.29821,0.17609,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.0001547,0.29803,0.29255,1,1
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00072223,0.29798,0.17057,1,1
1,GO HISTONE PHOSPHORYLATION,8.4205e-05,0.29794,0.25743,1,1
1,GO NEGATIVE REGULATION OF GENE SILENCING,6.7596e-05,0.29777,0.28859,1,1
1,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0028141,0.29765,0.31681,1,1
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0029794,0.29761,0.28193,1,1
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,6.2367e-06,0.29746,0.33508,1,1
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,7.013e-05,0.29734,0.31639,1,1
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.001191,0.29678,0.2407,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,3.5759e-05,0.29675,0.34083,1,1
1,GO REGULATION OF KIDNEY DEVELOPMENT,6.2786e-05,0.29644,0.30952,1,1
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0010859,0.29638,0.23484,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00021167,0.29619,0.39117,1,1
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0024367,0.29589,0.29909,1,1
1,GO RESPONSE TO CADMIUM ION,0.045624,0.29579,0.18426,1,1
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.0025083,0.29549,0.53188,1,1
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,4.1112e-06,0.29518,0.42888,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.0022992,0.29502,0.32524,1,1
1,GO REGULATION OF MRNA CATABOLIC PROCESS,1.2862e-06,0.29489,0.25796,1,1
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.0066042,0.29484,0.25761,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,8.6584e-06,0.2948,0.26939,1,1
1,GO SELECTIVE AUTOPHAGY,1.5331e-06,0.29472,0.29246,1,1
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,1.1493e-05,0.2947,0.30103,1,1
1,GO REGULATION OF CELL AGING,2.8077e-06,0.29407,0.30189,1,1
1,GO SPERM EGG RECOGNITION,0.00029782,0.29368,0.22464,1,1
1,GO INTERACTION WITH SYMBIONT,2.8418e-05,0.29237,0.287,1,1
1,GO CORTICAL CYTOSKELETON ORGANIZATION,6.2367e-06,0.29192,0.31479,1,1
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00019079,0.29186,0.28694,1,1
1,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0013054,0.2918,0.28579,1,1
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00014418,0.29172,0.2407,1,1
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.036948,0.29156,0.31848,1,1
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0069616,0.29116,0.22936,1,1
1,GO MYOBLAST DIFFERENTIATION,1.0604e-05,0.29037,0.29841,1,1
1,GO REGENERATION,0.00012964,0.29036,0.24367,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,4.6623e-06,0.29035,0.29085,1,1
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00084609,0.29,0.22326,1,1
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.00010462,0.28993,0.29747,1,1
1,GO HYPOTONIC RESPONSE,0.011326,0.2899,0.24357,1,1
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.00011241,0.28949,0.28513,1,1
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.0028957,0.28943,0.22622,1,1
1,GO NATURAL KILLER CELL ACTIVATION,6.2786e-05,0.28942,0.29297,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.00010092,0.28934,0.40886,1,1
1,GO MYOBLAST MIGRATION,0.0025083,0.28919,0.43669,1,1
1,GO TRACHEA MORPHOGENESIS,0.0010206,0.28909,0.27175,1,1
1,GO PARAXIAL MESODERM DEVELOPMENT,0.00063551,0.28899,0.32352,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00052342,0.28892,0.22939,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.00017796,0.28882,0.24901,1,1
1,GO T CELL RECEPTOR SIGNALING PATHWAY,1.2308e-06,0.28881,0.27728,1,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.041967,0.28867,0.248,1,1
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.036164,0.28801,0.25868,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,5.2837e-06,0.28801,0.29963,1,1
1,GO PODOSOME ASSEMBLY,0.00011241,0.28791,0.36568,1,1
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.012508,0.2878,0.1751,1,1
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00045924,0.28773,0.32644,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00010462,0.28752,0.25008,1,1
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,1.7806e-05,0.2873,0.32018,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,2.1702e-06,0.28707,0.25932,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00020448,0.28706,0.26047,1,1
1,GO SYMBIOTIC PROCESS,6.5896e-07,0.28705,0.26923,1,1
1,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.046579,0.28694,0.2399,1,1
1,GO CELLULAR RESPONSE TO VIRUS,1.4039e-05,0.28692,0.28818,1,1
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00067758,0.2867,0.24568,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.00052342,0.28621,0.2522,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0027346,0.28592,0.23685,1,1
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.025414,0.28563,0.2444,1,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.030383,0.28545,0.19204,1,1
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,4.8612e-06,0.28518,0.26569,1,1
1,GO FIBROBLAST MIGRATION,0.0011549,0.28499,0.3211,1,1
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00049035,0.28496,0.23877,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00016595,0.28439,0.29912,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,4.6623e-06,0.28424,0.3219,1,1
1,GO RNA CATABOLIC PROCESS,1.6015e-06,0.28421,0.25595,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00034072,0.28389,0.28781,1,1
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0046564,0.28369,0.2214,1,1
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.00098941,0.28362,0.19606,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.010245,0.28353,0.18457,1,1
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,6.0504e-05,0.28284,0.2696,1,1
1,GO SEQUESTERING OF METAL ION,0.00022676,0.28268,0.2643,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0018173,0.28266,0.28321,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00018427,0.28262,0.25392,1,1
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00019079,0.28222,0.2125,1,1
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,7.013e-05,0.2822,0.251,1,1
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0019282,0.28217,0.31563,1,1
1,GO DECIDUALIZATION,0.02268,0.28206,0.2696,1,1
1,GO REGULATION OF SPROUTING ANGIOGENESIS,2.0833e-05,0.28176,0.34063,1,1
1,GO MITOCHONDRIAL GENE EXPRESSION,0.00052342,0.28086,0.22749,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,3.3132e-05,0.2806,0.34485,1,1
1,GO PHOSPHOLIPID CATABOLIC PROCESS,0.011326,0.28033,0.15719,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0001165,0.28031,0.21405,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00010462,0.2802,0.36064,1,1
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.004408,0.28009,0.27466,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00092958,0.28,0.22674,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,7.2754e-05,0.27984,0.335,1,1
1,GO AMINO SUGAR METABOLIC PROCESS,0.00014418,0.27967,0.24451,1,1
1,GO CELLULAR RESPONSE TO RETINOIC ACID,0.0013054,0.27944,0.25233,1,1
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,5.508e-06,0.27927,0.39524,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,6.2786e-05,0.27904,0.28622,1,1
1,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00074557,0.27893,0.29621,1,1
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00065623,0.27882,0.22822,1,1
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00045924,0.27864,0.28288,1,1
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.0021689,0.27844,0.21577,1,1
1,GO CELL CELL RECOGNITION,9.7801e-06,0.27838,0.26528,1,1
1,GO INTERFERON ALPHA PRODUCTION,0.0045306,0.27822,0.21205,1,1
1,GO TISSUE REGENERATION,0.00079435,0.2781,0.25002,1,1
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.007729,0.27803,0.27382,1,1
1,GO REGULATION OF PROTEIN FOLDING,0.00016595,0.27775,0.25053,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.016734,0.27773,0.23361,1,1
1,GO CHEMOKINE PRODUCTION,0.0026572,0.27751,0.23796,1,1
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.9263e-05,0.27713,0.26704,1,1
1,GO NEGATIVE REGULATION OF DNA REPAIR,9.0179e-06,0.27674,0.25307,1,1
1,GO OSTEOCLAST DEVELOPMENT,0.00040247,0.27659,0.34234,1,1
1,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.0087944,0.27632,0.21745,1,1
1,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.013139,0.27617,0.19782,1,1
1,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.0024367,0.27583,0.20836,1,1
1,GO CELL SUBSTRATE ADHESION,0.00013433,0.27574,0.32014,1,1
1,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.010245,0.27563,0.19721,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,1.5816e-05,0.27514,0.3028,1,1
1,GO TRABECULA FORMATION,0.0090226,0.27477,0.32916,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00021167,0.27467,0.24795,1,1
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0010528,0.27428,0.25829,1,1
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,6.2786e-05,0.27378,0.21379,1,1
1,GO REGULATION OF EXOSOMAL SECRETION,0.025994,0.27261,0.18775,1,1
1,GO TRANSLATIONAL ELONGATION,0.0001165,0.27257,0.2405,1,1
1,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00036427,0.27188,0.19954,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0013872,0.27176,0.26353,1,1
1,GO COPPER ION TRANSPORT,0.00012074,0.27168,0.27025,1,1
1,GO SULFUR COMPOUND CATABOLIC PROCESS,0.0012662,0.27146,0.31599,1,1
1,GO INTRACELLULAR MRNA LOCALIZATION,0.0001547,0.27126,0.31324,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION,1.0779e-06,0.27113,0.27373,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.00011241,0.27099,0.22309,1,1
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0019282,0.27078,0.31979,1,1
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.00074557,0.27069,0.35797,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00081984,0.27055,0.2151,1,1
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,1.5816e-05,0.27044,0.22588,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0057817,0.27001,0.22661,1,1
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,9.0551e-05,0.27,0.34114,1,1
1,GO PLATELET MORPHOGENESIS,7.013e-05,0.2699,0.25906,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0017123,0.26964,0.24138,1,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0064317,0.26942,0.21992,1,1
1,GO CYTOCHROME COMPLEX ASSEMBLY,0.0023671,0.26937,0.20747,1,1
1,GO STEROL IMPORT,0.00079435,0.26923,0.41577,1,1
1,GO HEMOGLOBIN METABOLIC PROCESS,0.0045306,0.26889,0.22862,1,1
1,GO REGULATION OF CELL SUBSTRATE ADHESION,0.00035231,0.2683,0.30615,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,3.4421e-05,0.26793,0.30464,1,1
1,GO RESPONSE TO IONIZING RADIATION,5.0683e-06,0.26769,0.22465,1,1
1,GO MEMBRANE LIPID CATABOLIC PROCESS,0.0079323,0.26768,0.17334,1,1
1,GO NEGATIVE REGULATION OF OSSIFICATION,0.00087311,0.26757,0.21686,1,1
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,1.4609e-05,0.26755,0.24747,1,1
1,GO RESPONSE TO MISFOLDED PROTEIN,0.00036427,0.26721,0.2327,1,1
1,GO POSITIVE REGULATION OF ORGAN GROWTH,6.7596e-05,0.26714,0.31185,1,1
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.0064317,0.26694,0.18668,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0025083,0.26675,0.23569,1,1
1,GO MATERNAL PLACENTA DEVELOPMENT,0.0028957,0.26641,0.26407,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00067758,0.26616,0.31827,1,1
1,GO REGULATION OF RNA BINDING,6.5149e-05,0.26612,0.25969,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0013457,0.26583,0.37106,1,1
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00022676,0.26537,0.24313,1,1
1,GO MITOCHONDRIAL DNA REPLICATION,9.7346e-05,0.26485,0.23966,1,1
1,GO HISTONE H4 DEACETYLATION,0.0045306,0.26479,0.23682,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00057693,0.26476,0.24249,1,1
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,1.0779e-06,0.26469,0.28323,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.00026003,0.26455,0.22406,1,1
1,GO IRON ION HOMEOSTASIS,1.9263e-05,0.26454,0.24204,1,1
1,GO MRNA TRANSCRIPTION,2.8418e-05,0.26419,0.346,1,1
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.016734,0.26414,0.20663,1,1
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.0018173,0.26363,0.34518,1,1
1,GO RESPONSE TO REDOX STATE,0.022165,0.2635,0.21226,1,1
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,2.5308e-05,0.26346,0.36826,1,1
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00081984,0.26343,0.22354,1,1
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.00095906,0.26309,0.22372,1,1
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,3.4421e-05,0.26308,0.32659,1,1
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00081984,0.26304,0.19504,1,1
1,GO EXOCRINE SYSTEM DEVELOPMENT,0.0094949,0.26303,0.2776,1,1
1,GO CELLULAR KETONE METABOLIC PROCESS,4.6597e-05,0.26289,0.19563,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00069957,0.2628,0.23501,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.00034072,0.26233,0.40224,1,1
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.00031859,0.26192,0.21101,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.004408,0.26141,0.28939,1,1
1,GO NADP METABOLIC PROCESS,0.010773,0.26127,0.20448,1,1
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.03245,0.2611,0.23159,1,1
1,GO AUTOPHAGOSOME MATURATION,0.00017796,0.26096,0.24687,1,1
1,GO REGULATION OF CELLULAR EXTRAVASATION,0.0013457,0.26095,0.27483,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00026003,0.26077,0.27893,1,1
1,GO MYELOID DENDRITIC CELL ACTIVATION,0.02068,0.26068,0.32553,1,1
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.00052342,0.25986,0.21344,1,1
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0013872,0.25984,0.25755,1,1
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.00045924,0.25943,0.3593,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.014841,0.25898,0.18167,1,1
1,GO RESPONSE TO PARATHYROID HORMONE,0.010773,0.25877,0.22113,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00067758,0.25865,0.21537,1,1
1,GO RESPONSE TO OXYGEN RADICAL,0.00040247,0.25864,0.18181,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.0085714,0.25832,0.22524,1,1
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.0062634,0.25817,0.25752,1,1
1,GO TRNA 5 END PROCESSING,8.1192e-05,0.25778,0.30413,1,1
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.014486,0.25728,0.38889,1,1
1,GO IMMUNOGLOBULIN PRODUCTION,0.00013917,0.25695,0.21925,1,1
1,GO SERTOLI CELL DIFFERENTIATION,0.0047853,0.25662,0.20962,1,1
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00069957,0.25642,0.2321,1,1
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.03245,0.25634,0.19199,1,1
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,5.0226e-05,0.2563,0.21597,1,1
1,GO ASTROCYTE DEVELOPMENT,0.00072223,0.25587,0.28085,1,1
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.00013917,0.25568,0.23287,1,1
1,GO HEPATOCYTE DIFFERENTIATION,0.03939,0.25513,0.26456,1,1
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.4421e-05,0.25504,0.25303,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,2.8418e-05,0.25431,0.23518,1,1
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0053338,0.25426,0.28137,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00040247,0.25369,0.1943,1,1
1,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.029068,0.25341,0.19035,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,1.0604e-05,0.25329,0.26672,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,4.2876e-06,0.25286,0.21214,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,3.9418e-06,0.25279,0.2203,1,1
1,GO PROTEIN FOLDING,0.0032441,0.25176,0.18179,1,1
1,GO RESPONSE TO HYDROGEN PEROXIDE,0.00029782,0.25165,0.23794,1,1
1,GO AUTOPHAGY OF NUCLEUS,0.0013054,0.2516,0.23534,1,1
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.9263e-05,0.25145,0.31643,1,1
1,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.036948,0.25089,0.16533,1,1
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0014738,0.25077,0.20898,1,1
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,4.3218e-05,0.25055,0.2701,1,1
1,GO RESPONSE TO CYTOKINE,4.3218e-05,0.25042,0.27147,1,1
1,GO MEMBRANE DISASSEMBLY,0.027803,0.25026,0.21685,1,1
1,GO PLATELET ACTIVATION,0.00049035,0.24983,0.22251,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00098941,0.24972,0.19934,1,1
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.0013054,0.2497,0.1754,1,1
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.00353,0.24942,0.19847,1,1
1,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.017969,0.24926,0.24529,1,1
1,GO NUCLEOSIDE METABOLIC PROCESS,3.5759e-05,0.24925,0.2426,1,1
1,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.011904,0.24921,0.25308,1,1
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.00079435,0.24901,0.30337,1,1
1,GO TRNA METHYLATION,0.00024286,0.24895,0.22438,1,1
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0087944,0.24872,0.21765,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,5.0683e-06,0.24866,0.25779,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00011241,0.24849,0.22507,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00028792,0.24835,0.23246,1,1
1,GO FATTY ACID BETA OXIDATION,0.0025083,0.24817,0.21023,1,1
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0029794,0.24791,0.29656,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,1.2454e-05,0.24791,0.29425,1,1
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.0079323,0.24761,0.24744,1,1
1,GO MITOPHAGY,9.7346e-05,0.24745,0.24782,1,1
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.0018173,0.24701,0.24113,1,1
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0007696,0.24698,0.20294,1,1
1,GO TRNA PROCESSING,0.00047456,0.2469,0.18144,1,1
1,GO CORONARY VASCULATURE DEVELOPMENT,0.001986,0.24682,0.25286,1,1
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,2.3418e-05,0.24665,0.33805,1,1
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.047551,0.2466,0.18179,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,6.5149e-05,0.24627,0.21123,1,1
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00026903,0.24621,0.40407,1,1
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0041716,0.2461,0.21005,1,1
1,GO MACROPHAGE CYTOKINE PRODUCTION,0.029068,0.24603,0.33736,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,1.349e-05,0.24559,0.21804,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,5.8301e-05,0.24548,0.23967,1,1
1,GO REGULATION OF PODOSOME ASSEMBLY,0.00049035,0.24505,0.38836,1,1
1,GO METANEPHROS DEVELOPMENT,0.00014935,0.245,0.22233,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00030804,0.24468,0.18995,1,1
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00022676,0.24459,0.25139,1,1
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.0010206,0.24457,0.2337,1,1
1,GO MUSCLE CELL PROLIFERATION,3.8583e-05,0.24455,0.26073,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.029719,0.24436,0.29815,1,1
1,GO MITOTIC CYTOKINETIC PROCESS,0.0001165,0.24436,0.2496,1,1
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,8.7323e-05,0.24432,0.22148,1,1
1,GO RNA DESTABILIZATION,8.1192e-05,0.24431,0.22225,1,1
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.029719,0.24429,0.15649,1,1
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.02166,0.24402,0.19259,1,1
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,2.9532e-05,0.24374,0.23223,1,1
1,GO VASCULATURE DEVELOPMENT,0.00010092,0.24367,0.25431,1,1
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.0001165,0.24349,0.21683,1,1
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0031536,0.24281,0.22708,1,1
1,GO ASTROCYTE ACTIVATION,0.0085714,0.24249,0.26238,1,1
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0032441,0.24249,0.20362,1,1
1,GO RESPONSE TO GAMMA RADIATION,4.4878e-05,0.24248,0.21214,1,1
1,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.0064317,0.24188,0.21611,1,1
1,GO RESPONSE TO TESTOSTERONE,0.00013917,0.24163,0.24703,1,1
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00049035,0.24144,0.18548,1,1
1,GO BLOOD VESSEL MORPHOGENESIS,0.00010462,0.24138,0.26014,1,1
1,GO DNA DEALKYLATION,0.0025083,0.24137,0.22803,1,1
1,GO LYMPHOCYTE CHEMOTAXIS,0.00021909,0.24136,0.24276,1,1
1,GO RESPONSE TO PEPTIDOGLYCAN,0.0017641,0.24102,0.32778,1,1
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.00018427,0.24102,0.28326,1,1
1,GO TONGUE MORPHOGENESIS,0.038561,0.24098,0.25813,1,1
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,3.7145e-05,0.2406,0.23154,1,1
1,GO REGULATION OF ORGAN GROWTH,1.104e-05,0.24039,0.25823,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.00028792,0.24,0.17836,1,1
1,GO SCHWANN CELL DIFFERENTIATION,0.00052342,0.23988,0.20023,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0022332,0.23979,0.23846,1,1
1,GO PHAGOCYTOSIS,2.2524e-05,0.23925,0.28826,1,1
1,GO POSITIVE REGULATION OF COAGULATION,0.0073363,0.23845,0.25654,1,1
1,GO NEPHRON TUBULE FORMATION,0.033166,0.23827,0.23854,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0007696,0.23763,0.22703,1,1
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.011047,0.23749,0.21386,1,1
1,GO RESPONSE TO INTERLEUKIN 7,0.01282,0.23741,0.1962,1,1
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.001662,0.23732,0.24924,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.00024286,0.23699,0.33959,1,1
1,GO CARDIOBLAST DIFFERENTIATION,0.018398,0.23667,0.27949,1,1
1,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.0011549,0.23658,0.24658,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,4.4712e-06,0.23637,0.20976,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00059588,0.23619,0.33256,1,1
1,GO RESPONSE TO DEXAMETHASONE,0.033894,0.23608,0.15266,1,1
1,GO NUCLEOSIDE SALVAGE,0.0075304,0.23576,0.39315,1,1
1,GO REGULATION OF CHOLESTEROL EFFLUX,0.00042998,0.23541,0.26977,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.00067758,0.2354,0.24148,1,1
1,GO CHOLESTEROL EFFLUX,0.0011199,0.23526,0.2219,1,1
1,GO RESPONSE TO LEPTIN,0.027803,0.23484,0.17814,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00049035,0.23423,0.36125,1,1
1,GO REGULATION OF GENE SILENCING,4.4712e-06,0.2341,0.2345,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.0087944,0.23395,0.25128,1,1
1,GO POSITIVE REGULATION OF HAIR CYCLE,0.02166,0.23377,0.23884,1,1
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0031536,0.23373,0.21367,1,1
1,GO MESODERM DEVELOPMENT,7.8282e-05,0.23369,0.18643,1,1
1,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0025083,0.23364,0.18281,1,1
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00021167,0.23303,0.23508,1,1
1,GO NCRNA EXPORT FROM NUCLEUS,0.0014738,0.23279,0.21005,1,1
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00021167,0.23262,0.29818,1,1
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,9.7346e-05,0.23253,0.19718,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,3.8583e-05,0.23227,0.28285,1,1
1,GO RESPONSE TO CORTICOSTEROID,0.0017641,0.23224,0.20195,1,1
1,GO PLASMA MEMBRANE TUBULATION,0.0024367,0.23217,0.22579,1,1
1,GO VIRION ASSEMBLY,4.0073e-05,0.23214,0.20991,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,6.2367e-06,0.232,0.19864,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0016129,0.23199,0.23835,1,1
1,GO AXIS ELONGATION,0.011612,0.23132,0.20925,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00067758,0.23077,0.19744,1,1
1,GO RNA MODIFICATION,0.00012964,0.23061,0.18902,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.0017641,0.23052,0.28332,1,1
1,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.0042883,0.23048,0.25386,1,1
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.029068,0.2297,0.19076,1,1
1,GO RNA 3 END PROCESSING,9.0551e-05,0.22955,0.19551,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.031059,0.22915,0.13324,1,1
1,GO INTERLEUKIN 4 PRODUCTION,0.02068,0.2291,0.14685,1,1
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.014841,0.22887,0.27572,1,1
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.0083534,0.22849,0.18279,1,1
1,GO ENDODERMAL CELL FATE COMMITMENT,0.00026903,0.22824,0.26694,1,1
1,GO CELLULAR IRON ION HOMEOSTASIS,7.8282e-05,0.22821,0.18525,1,1
1,GO REGULATION OF NUCLEASE ACTIVITY,0.011326,0.22807,0.22446,1,1
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,5.0226e-05,0.22807,0.22907,1,1
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0051916,0.22801,0.16725,1,1
1,GO PEPTIDE METABOLIC PROCESS,1.2962e-05,0.22794,0.19896,1,1
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.00069957,0.22792,0.23503,1,1
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.013465,0.22789,0.26544,1,1
1,GO CERAMIDE TRANSPORT,0.013798,0.22783,0.23329,1,1
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.017969,0.22769,0.22581,1,1
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,9.0179e-06,0.22761,0.23047,1,1
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.011904,0.22756,0.1948,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,0.0090226,0.22751,0.14636,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00098941,0.22751,0.19469,1,1
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,5.6174e-05,0.22728,0.26795,1,1
1,GO RNA POLYADENYLATION,0.00029782,0.22693,0.1778,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.011326,0.22693,0.15988,1,1
1,GO T CELL MIGRATION,0.0024367,0.22646,0.23275,1,1
1,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0014738,0.22612,0.24698,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0029794,0.22598,0.19315,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0022332,0.22594,0.24368,1,1
1,GO REGULATION OF MACROPHAGE MIGRATION,2.7343e-05,0.2257,0.28471,1,1
1,GO PULMONARY VALVE DEVELOPMENT,0.010506,0.2253,0.36154,1,1
1,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.03939,0.2252,0.18369,1,1
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.0010859,0.22506,0.29195,1,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00087311,0.22467,0.30764,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0025083,0.22425,0.19063,1,1
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,1.1964e-05,0.22392,0.24416,1,1
1,GO T CELL CHEMOTAXIS,0.00023468,0.22383,0.22772,1,1
1,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.045624,0.22366,0.17362,1,1
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.00095906,0.22362,0.19699,1,1
1,GO EXTRACELLULAR VESICLE BIOGENESIS,0.025994,0.22358,0.16946,1,1
1,GO CHONDROCYTE DIFFERENTIATION,0.00087311,0.22355,0.25535,1,1
1,GO TRANSITION METAL ION HOMEOSTASIS,5.2139e-05,0.22326,0.22816,1,1
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00081984,0.22294,0.21593,1,1
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00059588,0.22265,0.20145,1,1
1,GO POSITIVE REGULATION OF T CELL MIGRATION,0.001228,0.22263,0.24626,1,1
1,GO RESPONSE TO OSMOTIC STRESS,0.0025817,0.22208,0.17362,1,1
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.0010859,0.22159,0.17404,1,1
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00013433,0.22142,0.20376,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0071468,0.22126,0.16264,1,1
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,4.3218e-05,0.22106,0.19636,1,1
1,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.013798,0.22105,0.25566,1,1
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.001191,0.22105,0.25331,1,1
1,GO ACTIVATION OF IMMUNE RESPONSE,9.7346e-05,0.22078,0.17863,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.0079323,0.22044,0.21006,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00047456,0.21998,0.17923,1,1
1,GO OVULATION,0.029719,0.21987,0.24759,1,1
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0046564,0.21909,0.20043,1,1
1,GO POLYAMINE METABOLIC PROCESS,0.0041716,0.21901,0.2218,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,0.0031536,0.21805,0.24288,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.0042883,0.2177,0.23196,1,1
1,GO TRNA METABOLIC PROCESS,0.00092958,0.21758,0.1713,1,1
1,GO HISTONE H2B UBIQUITINATION,0.0010859,0.21753,0.18054,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,4.0073e-05,0.21731,0.2188,1,1
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.019739,0.21706,0.13987,1,1
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.016339,0.21699,0.23305,1,1
1,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.0021689,0.21655,0.18537,1,1
1,GO PLASMA MEMBRANE FUSION,0.038561,0.21637,0.18604,1,1
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00055855,0.21597,0.24373,1,1
1,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.031059,0.21595,0.2523,1,1
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00050664,0.21583,0.19415,1,1
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00013433,0.21578,0.2357,1,1
1,GO REGULATION OF CENTRIOLE REPLICATION,0.0085714,0.21565,0.14756,1,1
1,GO LYMPHOCYTE MIGRATION,0.0036303,0.21563,0.17783,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.0012662,0.21533,0.21485,1,1
1,GO VESICLE TARGETING,9.0551e-05,0.21491,0.21606,1,1
1,GO NUCLEOBASE METABOLIC PROCESS,0.0022992,0.21456,0.20341,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.0024367,0.21427,0.17936,1,1
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00012964,0.21391,0.23239,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0083534,0.21379,0.18787,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0025083,0.21352,0.16801,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.02268,0.21336,0.15972,1,1
1,GO RRNA METHYLATION,0.02068,0.213,0.13833,1,1
1,GO TRNA MODIFICATION,0.00087311,0.21222,0.17432,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.017969,0.21218,0.18157,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,8.4205e-05,0.21213,0.23321,1,1
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00084609,0.21196,0.17653,1,1
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0039469,0.21168,0.17946,1,1
1,GO RESPONSE TO RETINOIC ACID,0.0013872,0.21128,0.1883,1,1
1,GO POSITIVE REGULATION OF VIRAL PROCESS,6.2367e-06,0.21113,0.22291,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS,6.2786e-05,0.21094,0.17007,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.001872,0.21078,0.19515,1,1
1,GO CARDIAC MUSCLE CELL PROLIFERATION,0.0051916,0.21014,0.21399,1,1
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.03939,0.2101,0.1343,1,1
1,GO RUFFLE ORGANIZATION,0.00049035,0.21008,0.16896,1,1
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0036303,0.21008,0.18662,1,1
1,GO REGULATION OF MRNA 3 END PROCESSING,4.6597e-05,0.21002,0.20531,1,1
1,GO REGULATION OF IMMUNE RESPONSE,0.00012074,0.20963,0.1947,1,1
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00037661,0.20907,0.18054,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.00090094,0.20902,0.21061,1,1
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.043763,0.20859,0.17521,1,1
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.014138,0.20852,0.15867,1,1
1,GO STRIATED MUSCLE CELL PROLIFERATION,0.00050664,0.20838,0.2202,1,1
1,GO RESPONSE TO DSRNA,0.00020448,0.2082,0.30648,1,1
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.0028957,0.20736,0.2873,1,1
1,GO BODY FLUID SECRETION,0.00026003,0.20724,0.21223,1,1
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.044685,0.20707,0.14707,1,1
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.001872,0.2069,0.19399,1,1
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,3.4728e-06,0.20677,0.19052,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,3.7145e-05,0.20632,0.1972,1,1
1,GO OSTEOCLAST DIFFERENTIATION,0.00025131,0.20608,0.18491,1,1
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0097392,0.20588,0.17321,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0049174,0.20588,0.18847,1,1
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0062634,0.20582,0.22953,1,1
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,2.3418e-05,0.20553,0.21665,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0099891,0.20534,0.16932,1,1
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.011904,0.20495,0.22643,1,1
1,GO POSITIVE REGULATION OF HEART GROWTH,0.0016129,0.20472,0.25549,1,1
1,GO CELLULAR RESPONSE TO ATP,0.00017186,0.20426,0.21767,1,1
1,GO PROTEIN ADP RIBOSYLATION,0.0042883,0.20357,0.18547,1,1
1,GO MIDBODY ABSCISSION,0.0026572,0.2034,0.21377,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,1.349e-05,0.20279,0.17382,1,1
1,GO METANEPHRIC NEPHRON DEVELOPMENT,0.0012662,0.20275,0.23426,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0029794,0.20271,0.20361,1,1
1,GO STRESS FIBER ASSEMBLY,0.0028141,0.20259,0.19794,1,1
1,GO REGULATION OF LIPID LOCALIZATION,0.00079435,0.20228,0.15712,1,1
1,GO REGULATION OF MULTI ORGANISM PROCESS,0.011326,0.20215,0.19307,1,1
1,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.010773,0.20199,0.23598,1,1
1,GO NUCLEAR EXPORT,9.0179e-06,0.20099,0.18942,1,1
1,GO INTERFERON GAMMA PRODUCTION,0.00024286,0.20093,0.24628,1,1
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00014935,0.20073,0.19602,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0037331,0.20046,0.18697,1,1
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.00034072,0.20039,0.22491,1,1
1,GO GENITALIA MORPHOGENESIS,0.036164,0.20029,0.19198,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0039469,0.20028,0.2721,1,1
1,GO NUCLEAR ENVELOPE REASSEMBLY,0.0001165,0.20019,0.22614,1,1
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.00052342,0.20005,0.21182,1,1
1,GO PEPTIDYL TYROSINE MODIFICATION,5.0226e-05,0.19935,0.20845,1,1
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.00054072,0.19931,0.25376,1,1
1,GO RNA LOCALIZATION,0.00019753,0.19872,0.17885,1,1
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.001986,0.19867,0.19727,1,1
1,GO REGULATION OF HEMOPOIESIS,4.0073e-05,0.19814,0.18912,1,1
1,GO RESPONSE TO OXIDATIVE STRESS,4.3218e-05,0.19803,0.20469,1,1
1,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.00072223,0.19791,0.19223,1,1
1,GO REGULATION OF KERATINOCYTE MIGRATION,0.019739,0.19781,0.1865,1,1
1,GO RNA METHYLATION,0.00049035,0.19755,0.18085,1,1
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.014138,0.19748,0.15508,1,1
1,GO REGULATION OF URINE VOLUME,0.0030654,0.19708,0.19915,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,5.0226e-05,0.19683,0.1986,1,1
1,GO LACTATION,0.0034322,0.1965,0.19238,1,1
1,GO HISTONE MRNA METABOLIC PROCESS,0.0054795,0.19596,0.1396,1,1
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0067808,0.19587,0.17803,1,1
1,GO TONGUE DEVELOPMENT,0.018398,0.19584,0.20545,1,1
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.036948,0.19555,0.14824,1,1
1,GO POSITIVE REGULATION OF PROTEIN BINDING,0.00057693,0.19522,0.1701,1,1
1,GO AMIDE BIOSYNTHETIC PROCESS,7.8282e-05,0.19521,0.17127,1,1
1,GO MYELOID CELL HOMEOSTASIS,0.00014935,0.19516,0.18628,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,0.0013457,0.19504,0.14242,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,1.9263e-05,0.19501,0.18968,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,3.3132e-05,0.19492,0.20955,1,1
1,GO BASE EXCISION REPAIR AP SITE FORMATION,0.0045306,0.19429,0.21035,1,1
1,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.016734,0.19377,0.18143,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00063551,0.19376,0.21489,1,1
1,GO REGULATION OF RUFFLE ASSEMBLY,0.024288,0.1933,0.10685,1,1
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.0001165,0.19304,0.18022,1,1
1,GO RNA INTERFERENCE,0.025414,0.19302,0.17157,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.0045306,0.19291,0.13831,1,1
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00013433,0.19256,0.21236,1,1
1,GO MITOTIC CYTOKINESIS,0.007729,0.19225,0.15498,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.0011199,0.19181,0.22747,1,1
1,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0018173,0.19172,0.14958,1,1
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,8.3127e-06,0.19162,0.201,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.019739,0.19104,0.17425,1,1
1,GO ORGANELLE INHERITANCE,0.0010206,0.19036,0.17848,1,1
1,GO DENDRITIC CELL CHEMOTAXIS,0.0071468,0.19033,0.23091,1,1
1,GO CELL AGING,6.2367e-06,0.19015,0.2108,1,1
1,GO PROTEIN DENEDDYLATION,0.040234,0.18983,0.12338,1,1
1,GO KERATINOCYTE PROLIFERATION,0.0085714,0.18975,0.26929,1,1
1,GO ESTABLISHMENT OF RNA LOCALIZATION,0.00012074,0.18969,0.17852,1,1
1,GO ELECTRON TRANSPORT CHAIN,0.001662,0.18921,0.13859,1,1
1,GO PROTEIN KINASE A SIGNALING,0.00084609,0.18884,0.19295,1,1
1,GO HORMONE BIOSYNTHETIC PROCESS,0.012508,0.18873,0.16258,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.037747,0.18866,0.15735,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00016595,0.18833,0.17509,1,1
1,GO KIDNEY MESENCHYME DEVELOPMENT,0.041967,0.18741,0.16122,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.00027832,0.1872,0.17047,1,1
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0094949,0.18715,0.12199,1,1
1,GO VESICLE BUDDING FROM MEMBRANE,0.00019079,0.18695,0.20536,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.00028792,0.18678,0.1998,1,1
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00050664,0.18678,0.17459,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0011549,0.18676,0.17221,1,1
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0049174,0.1863,0.1686,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0047853,0.18623,0.16783,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.00081984,0.18622,0.24604,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.00025131,0.18551,0.17285,1,1
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0011199,0.18542,0.21398,1,1
1,GO PROTEIN HOMOTETRAMERIZATION,0.00092958,0.18497,0.15357,1,1
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.0042883,0.1849,0.19852,1,1
1,GO CELLULAR AMIDE METABOLIC PROCESS,4.8379e-05,0.18486,0.16195,1,1
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.00021909,0.18473,0.18114,1,1
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00067758,0.18427,0.22334,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,4.0073e-05,0.18418,0.20227,1,1
1,GO VACUOLAR ACIDIFICATION,0.017137,0.18411,0.1549,1,1
1,GO REGULATION OF HEART GROWTH,0.0011549,0.1837,0.19485,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0050528,0.18365,0.18106,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE I,0.0075304,0.18334,0.16621,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00092958,0.18319,0.14603,1,1
1,GO CARTILAGE DEVELOPMENT,0.0032441,0.18265,0.20508,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,6.0504e-05,0.18213,0.17467,1,1
1,GO GOLGI VESICLE BUDDING,0.0006154,0.18208,0.17306,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,2.5774e-06,0.18157,0.17648,1,1
1,GO CENTRIOLE ASSEMBLY,0.0045306,0.1811,0.12464,1,1
1,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.027188,0.18109,0.22431,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.03245,0.18075,0.18035,1,1
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0039469,0.18074,0.22662,1,1
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0062634,0.18033,0.22415,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0028957,0.18006,0.16001,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0014299,0.17994,0.25563,1,1
1,GO RNA CAPPING,9.7346e-05,0.17984,0.17231,1,1
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00026003,0.17948,0.15684,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0021689,0.1794,0.16625,1,1
1,GO FC RECEPTOR SIGNALING PATHWAY,0.00026003,0.17924,0.17391,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.00026903,0.17907,0.19117,1,1
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.0028141,0.17879,0.14699,1,1
1,GO POSITIVE REGULATION OF CELL AGING,0.03939,0.1785,0.21582,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00090094,0.1784,0.14403,1,1
1,GO PROTEIN TARGETING TO MEMBRANE,0.010245,0.17824,0.16189,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,3.4728e-06,0.1769,0.16851,1,1
1,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.012508,0.17678,0.15212,1,1
1,GO RNA PROCESSING,0.00026903,0.17656,0.1497,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,3.4421e-05,0.17626,0.19546,1,1
1,GO ATP BIOSYNTHETIC PROCESS,0.0042883,0.17615,0.18698,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.0075304,0.17593,0.21072,1,1
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0083534,0.17535,0.16581,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,2.9532e-05,0.17522,0.17455,1,1
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,5.8301e-05,0.17459,0.18435,1,1
1,GO PROTEIN TARGETING,0.00041602,0.17441,0.15855,1,1
1,GO MULTIVESICULAR BODY ORGANIZATION,0.0032441,0.17437,0.14872,1,1
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.001191,0.17413,0.16361,1,1
1,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.019739,0.17334,0.15364,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0022992,0.17318,0.12531,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.00067758,0.17275,0.15828,1,1
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.00024286,0.17203,0.15328,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,1.2454e-05,0.17177,0.20627,1,1
1,GO PROTEIN IMPORT,6.7596e-05,0.1717,0.15154,1,1
1,GO PROTEIN NEDDYLATION,0.0029794,0.1714,0.17124,1,1
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00018427,0.17104,0.16302,1,1
1,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.014138,0.17088,0.1261,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0026572,0.1707,0.13882,1,1
1,GO NEGATIVE REGULATION OF CELL DEATH,0.00019753,0.17062,0.14768,1,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0014738,0.17034,0.17843,1,1
1,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.037747,0.16977,0.11694,1,1
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.010773,0.1692,0.23229,1,1
1,GO DE NOVO PROTEIN FOLDING,0.036164,0.16867,0.13321,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.043763,0.16805,0.14453,1,1
1,GO IMPORT INTO NUCLEUS,0.00026903,0.16798,0.12344,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00032948,0.1677,0.19436,1,1
1,GO ACTIN CYTOSKELETON REORGANIZATION,0.004408,0.16705,0.17952,1,1
1,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.029719,0.16695,0.1382,1,1
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,1.5816e-05,0.16693,0.15452,1,1
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.0062634,0.1667,0.14116,1,1
1,GO REGULATION OF MITOPHAGY,0.012508,0.16635,0.1894,1,1
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00055855,0.16596,0.17218,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.019283,0.16565,0.15814,1,1
1,GO COPII COATED VESICLE BUDDING,0.001228,0.16531,0.17553,1,1
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00079435,0.16525,0.16786,1,1
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0030654,0.16511,0.19466,1,1
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0028141,0.16487,0.18409,1,1
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00065623,0.1648,0.16662,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.015203,0.16464,0.22004,1,1
1,GO LYMPHOCYTE COSTIMULATION,0.0057817,0.16395,0.13555,1,1
1,GO NUCLEAR TRANSPORT,3.8583e-05,0.16387,0.13606,1,1
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,6.7596e-05,0.1632,0.14,1,1
1,GO REGULATION OF DNA RECOMBINATION,0.0007696,0.16313,0.16151,1,1
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.00044439,0.16298,0.18409,1,1
1,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.03939,0.16267,0.10693,1,1
1,GO MYELOID CELL DIFFERENTIATION,0.00010845,0.16177,0.1584,1,1
1,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0075304,0.16174,0.098848,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0073363,0.16164,0.13595,1,1
1,GO SPINDLE LOCALIZATION,0.007729,0.16145,0.11819,1,1
1,GO RESPONSE TO STEROID HORMONE,0.0069616,0.16142,0.13181,1,1
1,GO MAINTENANCE OF LOCATION,8.1192e-05,0.16139,0.1647,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,3.3132e-05,0.16106,0.15159,1,1
1,GO TUBE MORPHOGENESIS,0.0010859,0.16096,0.17318,1,1
1,GO SULFUR COMPOUND TRANSPORT,0.0018173,0.16089,0.13617,1,1
1,GO THYROID HORMONE METABOLIC PROCESS,0.011904,0.16069,0.16482,1,1
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.013465,0.16029,0.14523,1,1
1,GO RESPONSE TO MINERALOCORTICOID,0.0053338,0.16028,0.24338,1,1
1,GO COPII COATED VESICLE CARGO LOADING,0.0011199,0.16017,0.18779,1,1
1,GO CIRCULATORY SYSTEM DEVELOPMENT,0.00087311,0.15974,0.16928,1,1
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0022992,0.15973,0.14286,1,1
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.0032441,0.15969,0.28425,1,1
1,GO GLOMERULUS DEVELOPMENT,0.0012662,0.15944,0.2842,1,1
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,2.4692e-06,0.15927,0.15215,1,1
1,GO REGULATION OF RESPONSE TO STRESS,0.00042998,0.15876,0.13656,1,1
1,GO RNA STABILIZATION,0.017549,0.15833,0.13386,1,1
1,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.040234,0.15787,0.12989,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.015203,0.15756,0.11938,1,1
1,GO PROTEIN POLYUBIQUITINATION,2.0833e-05,0.15752,0.14519,1,1
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0038387,0.15732,0.11847,1,1
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00069957,0.15728,0.17937,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,9.389e-05,0.15693,0.20487,1,1
1,GO MRNA TRANSPORT,0.00013433,0.15679,0.16946,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,0.00038934,0.15671,0.13118,1,1
1,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.027803,0.1565,0.092265,1,1
1,GO HISTONE DEACETYLATION,0.001191,0.15572,0.12142,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0020453,0.15561,0.12826,1,1
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0010528,0.15513,0.12676,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.0010206,0.15501,0.13526,1,1
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.035393,0.15481,0.10105,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00027832,0.15415,0.143,1,1
1,GO VACUOLE ORGANIZATION,0.0026572,0.15413,0.1182,1,1
1,GO MACROMOLECULE CATABOLIC PROCESS,2.4692e-06,0.15365,0.15978,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00012074,0.15364,0.15383,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0054795,0.1532,0.27496,1,1
1,GO AUTOPHAGOSOME ORGANIZATION,0.00047456,0.153,0.18694,1,1
1,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.013798,0.15291,0.14073,1,1
1,GO TELOMERE ORGANIZATION,0.00095906,0.15251,0.12157,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00035231,0.15213,0.16199,1,1
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0087944,0.1519,0.20736,1,1
1,GO RESPONSE TO ATP,0.0075304,0.1518,0.12078,1,1
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,2.5308e-05,0.15167,0.17907,1,1
1,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.036164,0.15088,0.13635,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.025994,0.15085,0.16364,1,1
1,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.033894,0.14962,0.1466,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE,0.011326,0.14962,0.10546,1,1
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0010859,0.14961,0.15806,1,1
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.0024367,0.14949,0.24871,1,1
1,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.031748,0.14937,0.14383,1,1
1,GO RESPONSE TO OXYGEN LEVELS,0.0038387,0.14935,0.15572,1,1
1,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.021165,0.14916,0.14433,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.0094949,0.14897,0.103,1,1
1,GO FACE DEVELOPMENT,0.0028141,0.14861,0.19622,1,1
1,GO INNER CELL MASS CELL PROLIFERATION,0.0071468,0.14778,0.29658,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY,3.3132e-05,0.14777,0.14059,1,1
1,GO PIGMENT GRANULE ORGANIZATION,0.033166,0.14705,0.16477,1,1
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00012964,0.14654,0.14161,1,1
1,GO REGULATION OF RECEPTOR RECYCLING,0.0060989,0.14597,0.18282,1,1
1,GO CONNECTIVE TISSUE DEVELOPMENT,0.010245,0.14558,0.15826,1,1
1,GO NEURAL TUBE FORMATION,0.02166,0.14497,0.12711,1,1
1,GO GOLGI VESICLE TRANSPORT,0.00012074,0.14457,0.14644,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0013457,0.1445,0.11899,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.0001165,0.14448,0.13449,1,1
1,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.025994,0.14396,0.17219,1,1
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.00029782,0.14395,0.12167,1,1
1,GO REGULATION OF SENSORY PERCEPTION,0.0087944,0.14379,0.14828,1,1
1,GO POSITIVE REGULATION OF BINDING,0.0025083,0.1436,0.12926,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,9.3916e-06,0.1434,0.15456,1,1
1,GO ERYTHROCYTE HOMEOSTASIS,0.00042998,0.1427,0.15572,1,1
1,GO RESPONSE TO UV,0.0028141,0.1427,0.10717,1,1
1,GO SCHWANN CELL DEVELOPMENT,0.020205,0.14254,0.13634,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,8.1192e-05,0.14231,0.18957,1,1
1,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.017137,0.14196,0.12604,1,1
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.013465,0.14195,0.24061,1,1
1,GO HEART VALVE DEVELOPMENT,0.03245,0.14185,0.16907,1,1
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,2.7343e-05,0.14162,0.13501,1,1
1,GO TRANSLESION SYNTHESIS,0.001228,0.14159,0.15343,1,1
1,GO REGULATION OF NUCLEAR DIVISION,0.014138,0.14151,0.087884,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0094949,0.14075,0.13829,1,1
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.013465,0.14069,0.14027,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.014486,0.14014,0.12113,1,1
1,GO GENE SILENCING,8.4205e-05,0.14012,0.12021,1,1
1,GO POSTREPLICATION REPAIR,0.0010206,0.13961,0.13073,1,1
1,GO NEURAL TUBE DEVELOPMENT,0.025414,0.13914,0.12163,1,1
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.024288,0.13903,0.093791,1,1
1,GO CELLULAR RESPONSE TO RADIATION,0.0021689,0.13765,0.10208,1,1
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.014841,0.13688,0.17062,1,1
1,GO REGULATION OF DNA CATABOLIC PROCESS,0.00012512,0.13681,0.23153,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0094949,0.13654,0.12757,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,1.7118e-05,0.13643,0.15162,1,1
1,GO ALPHA AMINO ACID METABOLIC PROCESS,0.017137,0.13643,0.088587,1,1
1,GO DNA BIOSYNTHETIC PROCESS,3.4728e-06,0.13617,0.1511,1,1
1,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.027188,0.13605,0.07987,1,1
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.012203,0.13541,0.17841,1,1
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0081404,0.13527,0.10817,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0073363,0.13511,0.11679,1,1
1,GO REGULATION OF ERAD PATHWAY,0.0020453,0.13483,0.13492,1,1
1,GO REGULATION OF CENTROSOME DUPLICATION,0.001872,0.13474,0.13465,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,5.4121e-05,0.13404,0.14249,1,1
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0010206,0.13378,0.12809,1,1
1,GO STEM CELL DIFFERENTIATION,0.00021909,0.13358,0.1436,1,1
1,GO REGULATION OF CATABOLIC PROCESS,1.8521e-05,0.13357,0.13861,1,1
1,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.024288,0.13319,0.10074,1,1
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0087944,0.13164,0.12679,1,1
1,GO REGULATION OF MRNA METABOLIC PROCESS,0.00020448,0.13088,0.12701,1,1
1,GO GENITALIA DEVELOPMENT,0.030383,0.13028,0.092207,1,1
1,GO SPHINGOID METABOLIC PROCESS,0.031059,0.1301,0.10135,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0007696,0.13002,0.12392,1,1
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0013872,0.12993,0.13188,1,1
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0021689,0.12979,0.1621,1,1
1,GO BONE DEVELOPMENT,0.0081404,0.12896,0.14562,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.001191,0.12876,0.12224,1,1
1,GO CELLULAR SENESCENCE,0.0013054,0.12839,0.1364,1,1
1,GO MITOTIC RECOMBINATION,0.012203,0.12789,0.16484,1,1
1,GO CELLULAR RESPIRATION,0.0053338,0.12788,0.12734,1,1
1,GO NON RECOMBINATIONAL REPAIR,0.00049035,0.12781,0.12545,1,1
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0040578,0.12706,0.16407,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.014486,0.1269,0.12813,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.0060989,0.12659,0.14078,1,1
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.0054795,0.12564,0.10969,1,1
1,GO BASE EXCISION REPAIR,0.0057817,0.1256,0.15406,1,1
1,GO ESTABLISHMENT OF TISSUE POLARITY,0.00074557,0.1253,0.16681,1,1
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0010528,0.12504,0.11799,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.037747,0.1249,0.17906,1,1
1,GO PROTEIN CATABOLIC PROCESS,0.00012512,0.12485,0.11987,1,1
1,GO MRNA CLEAVAGE,0.00040247,0.12428,0.1369,1,1
1,GO PROTEIN MONOUBIQUITINATION,0.0054795,0.12407,0.083867,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0094949,0.12393,0.16319,1,1
1,GO RECEPTOR RECYCLING,0.031748,0.12386,0.10932,1,1
1,GO MAINTENANCE OF LOCATION IN CELL,0.00036427,0.12359,0.14964,1,1
1,GO OXIDATIVE PHOSPHORYLATION,0.015203,0.12338,0.13094,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.001191,0.12304,0.10228,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.018836,0.12242,0.11521,1,1
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.027803,0.1221,0.10138,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.001662,0.12207,0.16185,1,1
1,GO CELL CYCLE G1 S PHASE TRANSITION,0.0064317,0.12098,0.083541,1,1
1,GO REGULATION OF HISTONE DEACETYLATION,0.045624,0.12055,0.12465,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.00012512,0.11984,0.12637,1,1
1,GO REGULATION OF HISTONE UBIQUITINATION,0.013139,0.11871,0.11116,1,1
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00037661,0.11775,0.11321,1,1
1,GO REGULATION OF FATTY ACID BETA OXIDATION,0.022165,0.11742,0.15597,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,6.0504e-05,0.11725,0.12535,1,1
1,GO AUTOPHAGY OF MITOCHONDRION,0.00092958,0.11502,0.13663,1,1
1,GO BLASTOCYST GROWTH,0.035393,0.11494,0.18576,1,1
1,GO RECEPTOR METABOLIC PROCESS,0.004408,0.11479,0.12264,1,1
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.035393,0.11471,0.13295,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.00032948,0.11401,0.1311,1,1
1,GO CELLULAR HORMONE METABOLIC PROCESS,0.020205,0.11368,0.10757,1,1
1,GO REGULATION OF ACTIN FILAMENT LENGTH,0.023741,0.11223,0.092723,1,1
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00057693,0.11155,0.10246,1,1
1,GO CELL CYCLE G2 M PHASE TRANSITION,0.00353,0.1108,0.095781,1,1
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.010506,0.11079,0.10361,1,1
1,GO APOPTOTIC DNA FRAGMENTATION,0.019283,0.11068,0.083958,1,1
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0059384,0.11053,0.11015,1,1
1,GO CARDIAC SEPTUM DEVELOPMENT,0.010245,0.11019,0.16814,1,1
1,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0030654,0.10974,0.092492,1,1
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0085714,0.10955,0.12456,1,1
1,GO MRNA 3 END PROCESSING,0.0059384,0.10938,0.11083,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0031536,0.1087,0.1543,1,1
1,GO CELLULAR RESPONSE TO UV,0.012508,0.10852,0.10064,1,1
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00010462,0.10835,0.13299,1,1
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.010245,0.10833,0.12553,1,1
1,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0056288,0.10832,0.087484,1,1
1,GO CELL CYCLE PHASE TRANSITION,0.0015189,0.10803,0.087313,1,1
1,GO REGULATION OF AUTOPHAGY,0.0021062,0.10667,0.10389,1,1
1,GO REGULATION OF BINDING,0.011047,0.10665,0.10249,1,1
1,GO MACROAUTOPHAGY,0.00014418,0.1055,0.12369,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.014841,0.10491,0.084573,1,1
1,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0079323,0.10475,0.093413,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,0.0050528,0.10466,0.0789,1,1
1,GO MEIOTIC SPINDLE ORGANIZATION,0.024846,0.10445,0.14516,1,1
1,GO REGULATION OF DNA REPAIR,0.015574,0.10232,0.076375,1,1
1,GO MITOTIC CELL CYCLE CHECKPOINT,0.0059384,0.10186,0.080179,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0099891,0.10141,0.16523,1,1
1,GO MITOTIC CELL CYCLE,0.010773,0.099976,0.072399,1,1
1,GO PEPTIDYL THREONINE MODIFICATION,0.03939,0.09936,0.07518,1,1
1,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.044685,0.098875,0.093699,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.037747,0.09817,0.078389,1,1
1,GO RUFFLE ASSEMBLY,0.027803,0.096832,0.09938,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,0.0024367,0.096372,0.087638,1,1
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0025817,0.094846,0.13206,1,1
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.007729,0.093582,0.060508,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.00017796,0.093352,0.11998,1,1
1,GO REGULATION OF DNA METABOLIC PROCESS,0.00050664,0.093265,0.086388,1,1
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.0018173,0.092091,0.11755,1,1
1,GO FEMALE GAMETE GENERATION,0.031059,0.092027,0.065696,1,1
1,GO PROTEIN LOCALIZATION TO ORGANELLE,0.00031859,0.091191,0.09351,1,1
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.00019753,0.090965,0.082361,1,1
1,GO REGULATION OF CELL CYCLE PROCESS,0.0049174,0.089026,0.071318,1,1
1,GO ORGANELLE DISASSEMBLY,0.0023671,0.08854,0.10581,1,1
1,GO CELL CYCLE PROCESS,0.029068,0.088378,0.053367,1,1
1,GO TUBE FORMATION,0.040234,0.08837,0.08933,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0010206,0.087704,0.074723,1,1
1,GO REGULATION OF ATPASE ACTIVITY,0.0075304,0.086614,0.093026,1,1
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0016129,0.085809,0.10819,1,1
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0062634,0.085464,0.082348,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,0.015574,0.083701,0.11785,1,1
1,GO REGULATION OF CENTROSOME CYCLE,0.014841,0.083249,0.09418,1,1
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0064317,0.083163,0.061761,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00059588,0.083088,0.076833,1,1
1,GO CELL DIVISION,0.03245,0.082775,0.06183,1,1
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00041602,0.082616,0.084617,1,1
1,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.026586,0.079624,0.062326,1,1
1,GO INTRACELLULAR PROTEIN TRANSPORT,0.0017123,0.079391,0.073978,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.036164,0.077628,0.081665,1,1
1,GO MITOCHONDRION ORGANIZATION,0.00084609,0.076636,0.084473,1,1
1,GO DOUBLE STRAND BREAK REPAIR,0.010773,0.074853,0.074688,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.015953,0.074327,0.063945,1,1
1,GO DNA MODIFICATION,0.024846,0.071979,0.081702,1,1
1,GO DNA METABOLIC PROCESS,0.0011549,0.071189,0.07488,1,1
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.00035231,0.068261,0.10134,1,1
1,GO CELL CYCLE,0.042857,0.065067,0.042154,1,1
1,GO HEART DEVELOPMENT,0.041967,0.063923,0.091431,1,1
1,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.047551,0.063781,0.063116,1,1
1,GO REGULATION OF CELL CYCLE,0.038561,0.06374,0.044157,1,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.029719,0.059605,0.057371,1,1
1,GO DNA RECOMBINATION,0.044685,0.051405,0.065609,1,1
2,GO OXYGEN TRANSPORT,7.547e-05,0.81539,0.747,1,1
2,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,3.1888e-05,0.78882,0.71035,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.5816e-05,0.72334,0.66453,1,1
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.1964e-05,0.71028,0.61784,1,1
2,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.0001547,0.67822,0.72094,1,1
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,5.2139e-05,0.64875,0.55119,1,1
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,3.3287e-06,0.63001,0.61814,1,1
2,GO RESPONSE TO HISTAMINE,2.0833e-05,0.61441,0.63341,1,1
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,9.7801e-06,0.60828,0.57979,1,1
2,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,2.9532e-05,0.59411,0.58126,1,1
2,GO SYNAPSE MATURATION,0.00042998,0.58389,0.55191,1,1
2,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,5.2139e-05,0.58202,0.58056,1,1
2,GO GAS TRANSPORT,0.00018427,0.57434,0.54092,1,1
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,5.2139e-05,0.56973,0.46119,1,1
2,GO RESPONSE TO L GLUTAMATE,1.7118e-05,0.5632,0.54731,1,1
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.00079435,0.55166,0.45742,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.00045924,0.54979,0.4128,1,1
2,GO OPIOID RECEPTOR SIGNALING PATHWAY,3.3287e-06,0.53768,0.54006,1,1
2,GO GLYCINE TRANSPORT,0.0013054,0.53755,0.45246,1,1
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,6.7728e-06,0.52581,0.51835,1,1
2,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,5.8301e-05,0.52235,0.52449,1,1
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,2.9532e-05,0.52075,0.4714,1,1
2,GO RIBOSOME ASSEMBLY,1.2454e-05,0.51965,0.52271,1,1
2,GO RRNA PSEUDOURIDINE SYNTHESIS,0.00057693,0.51373,0.47329,1,1
2,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.00063551,0.51371,0.55799,1,1
2,GO TRICARBOXYLIC ACID METABOLIC PROCESS,5.0226e-05,0.51244,0.43381,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,5.2139e-05,0.50845,0.43768,1,1
2,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,1.5201e-05,0.50695,0.52578,1,1
2,GO UV PROTECTION,9.4334e-07,0.50261,0.49723,1,1
2,GO CYTOPLASMIC TRANSLATION,3.0689e-05,0.50222,0.49325,1,1
2,GO MATURATION OF LSU RRNA,4.1112e-06,0.502,0.52582,1,1
2,GO IMP METABOLIC PROCESS,6.7728e-06,0.49745,0.52991,1,1
2,GO CYTOPLASMIC TRANSLATIONAL INITIATION,7.6603e-06,0.49722,0.46517,1,1
2,GO SYNAPTIC VESICLE MATURATION,0.00032948,0.49002,0.46862,1,1
2,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,4.8612e-06,0.48957,0.52222,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,2.1663e-05,0.48707,0.4741,1,1
2,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0016129,0.48064,0.3453,1,1
2,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.00023468,0.4804,0.55075,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,4.3218e-05,0.47808,0.45036,1,1
2,GO PLASMA MEMBRANE REPAIR,1.7118e-05,0.47515,0.43057,1,1
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00022676,0.47195,0.35921,1,1
2,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,9.7801e-06,0.46923,0.41322,1,1
2,GO AROMATIC AMINO ACID TRANSPORT,0.00055855,0.46866,0.47831,1,1
2,GO CORPUS CALLOSUM DEVELOPMENT,1.7474e-06,0.46223,0.46803,1,1
2,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,5.9841e-06,0.4566,0.47396,1,1
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.0010206,0.45403,0.33701,1,1
2,GO MODIFICATION OF SYNAPTIC STRUCTURE,4.6623e-06,0.45177,0.42629,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00090094,0.44779,0.4969,1,1
2,GO PSEUDOURIDINE SYNTHESIS,0.00090094,0.44589,0.36452,1,1
2,GO POSTSYNAPSE ASSEMBLY,0.00081984,0.4442,0.43576,1,1
2,GO MYOBLAST PROLIFERATION,2.2658e-06,0.44337,0.42829,1,1
2,GO REGULATION OF CYTOPLASMIC TRANSLATION,2.8077e-06,0.4422,0.38801,1,1
2,GO GLYCINE METABOLIC PROCESS,0.0028141,0.43581,0.3201,1,1
2,GO REGULATION OF GONAD DEVELOPMENT,0.0040578,0.43436,0.25227,1,1
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,3.7145e-05,0.43423,0.42594,1,1
2,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,2.8418e-05,0.43092,0.46841,1,1
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,7.9801e-06,0.4301,0.48694,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00010092,0.42967,0.42685,1,1
2,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,3.3132e-05,0.42733,0.37696,1,1
2,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.030383,0.42493,0.19913,1,1
2,GO RESPONSE TO ELECTRICAL STIMULUS,0.00026003,0.42415,0.32079,1,1
2,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00055855,0.42385,0.41074,1,1
2,GO TRANSLATIONAL INITIATION,7.547e-05,0.41916,0.42211,1,1
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,3.1888e-05,0.41789,0.46439,1,1
2,GO SUCKLING BEHAVIOR,0.00026903,0.4172,0.33519,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.00035231,0.41604,0.49831,1,1
2,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,5.0683e-06,0.41334,0.38134,1,1
2,GO SYNAPTIC MEMBRANE ADHESION,0.025414,0.4128,0.3198,1,1
2,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,1.9263e-05,0.40305,0.42321,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,2.5308e-05,0.40108,0.41323,1,1
2,GO POSITIVE REGULATION OF NEURON MIGRATION,0.010506,0.40104,0.28928,1,1
2,GO REGULATION OF TRANSLATIONAL FIDELITY,0.00012074,0.39933,0.39412,1,1
2,GO MATURATION OF SSU RRNA,6.2367e-06,0.39869,0.44019,1,1
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00042998,0.3971,0.41154,1,1
2,GO VIRAL TRANSLATION,7.2754e-05,0.3964,0.39111,1,1
2,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0001547,0.39577,0.46904,1,1
2,GO MITOCHONDRIAL TRANSCRIPTION,2.7343e-05,0.39541,0.37787,1,1
2,GO SNORNA METABOLIC PROCESS,0.00029782,0.39513,0.40738,1,1
2,GO EXCITATORY SYNAPSE ASSEMBLY,0.00092958,0.39423,0.35709,1,1
2,GO TELOMERASE RNA LOCALIZATION,4.8612e-06,0.39353,0.45365,1,1
2,GO CRISTAE FORMATION,0.00054072,0.39055,0.29118,1,1
2,GO ADULT HEART DEVELOPMENT,0.00037661,0.38782,0.35746,1,1
2,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.0027346,0.38363,0.34733,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,4.3218e-05,0.38243,0.41963,1,1
2,GO SNORNA 3 END PROCESSING,5.2139e-05,0.38121,0.44397,1,1
2,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.00050664,0.37775,0.38325,1,1
2,GO SHORT TERM MEMORY,0.00095906,0.37704,0.40963,1,1
2,GO L GLUTAMATE IMPORT,0.00029782,0.37583,0.3149,1,1
2,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.00098941,0.37401,0.34407,1,1
2,GO PURINE CONTAINING COMPOUND SALVAGE,0.00012964,0.3711,0.36059,1,1
2,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.00050664,0.37102,0.42067,1,1
2,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00037661,0.36981,0.37519,1,1
2,GO MATURATION OF 5 8S RRNA,3.8583e-05,0.36945,0.37424,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.00019753,0.36444,0.35376,1,1
2,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00054072,0.36443,0.38469,1,1
2,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,1.5201e-05,0.36311,0.41577,1,1
2,GO ARGININE METABOLIC PROCESS,0.0046564,0.36281,0.30972,1,1
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,4.6597e-05,0.36187,0.34182,1,1
2,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.00012964,0.36154,0.30061,1,1
2,GO REGULATION OF TRANSLATIONAL TERMINATION,0.00035231,0.36102,0.32193,1,1
2,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00010462,0.3597,0.34641,1,1
2,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.046579,0.35692,0.20046,1,1
2,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.0010859,0.35691,0.32071,1,1
2,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.0073363,0.3503,0.30711,1,1
2,GO INNERVATION,0.0039469,0.35026,0.33228,1,1
2,GO NEUROBLAST DIVISION,0.011612,0.34975,0.28156,1,1
2,GO PEPTIDYL ARGININE N METHYLATION,3.6228e-06,0.34889,0.39181,1,1
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.00042998,0.34806,0.28949,1,1
2,GO PENTOSE METABOLIC PROCESS,0.00014935,0.34481,0.31658,1,1
2,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0069616,0.34396,0.22937,1,1
2,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.00013433,0.34111,0.34542,1,1
2,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.00037661,0.34094,0.27564,1,1
2,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.0007696,0.3396,0.27294,1,1
2,GO TRNA WOBBLE URIDINE MODIFICATION,3.7145e-05,0.33157,0.30388,1,1
2,GO MITOCHONDRIAL RNA PROCESSING,0.0015653,0.33131,0.30878,1,1
2,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0026572,0.32997,0.31892,1,1
2,GO MITOCHONDRIAL TRNA PROCESSING,0.013465,0.32818,0.24099,1,1
2,GO REGULATION OF MRNA BINDING,1.8521e-05,0.32602,0.39788,1,1
2,GO NUCLEOTIDE SALVAGE,0.009256,0.3254,0.29083,1,1
2,GO VIRAL GENE EXPRESSION,0.00084609,0.324,0.33686,1,1
2,GO TRNA MODIFICATION,1.7474e-06,0.32353,0.31884,1,1
2,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.014138,0.32351,0.28252,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,9.0551e-05,0.3233,0.37047,1,1
2,GO TRNA WOBBLE BASE MODIFICATION,8.3127e-06,0.32282,0.32446,1,1
2,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0079323,0.32231,0.33252,1,1
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.00059588,0.31962,0.31253,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.00034072,0.31902,0.31313,1,1
2,GO PROTEIN TARGETING TO MEMBRANE,0.00038934,0.31485,0.30664,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00026003,0.31477,0.24803,1,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.017969,0.31376,0.23899,1,1
2,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,9.389e-05,0.31309,0.25901,1,1
2,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.011326,0.31244,0.21095,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00050664,0.31142,0.28401,1,1
2,GO VESICLE FUSION TO PLASMA MEMBRANE,0.00087311,0.30888,0.36835,1,1
2,GO ADAPTATION OF SIGNALING PATHWAY,0.0020453,0.30837,0.2676,1,1
2,GO RIBOSOME BIOGENESIS,1.5201e-05,0.30689,0.38255,1,1
2,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,3.0689e-05,0.30657,0.24294,1,1
2,GO NUCLEOBASE METABOLIC PROCESS,7.2754e-05,0.30498,0.28153,1,1
2,GO RRNA MODIFICATION,0.00019079,0.3047,0.35171,1,1
2,GO MITOCHONDRIAL RNA METABOLIC PROCESS,3.1888e-05,0.30322,0.37676,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.010506,0.30297,0.20661,1,1
2,GO REGULATION OF RIBOSOME BIOGENESIS,0.0020453,0.30247,0.24302,1,1
2,GO REGULATION OF METANEPHROS DEVELOPMENT,0.037747,0.30237,0.21763,1,1
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.018398,0.30166,0.21952,1,1
2,GO PEPTIDYL HISTIDINE MODIFICATION,9.7346e-05,0.30067,0.26078,1,1
2,GO SIALYLATION,0.014138,0.30053,0.27725,1,1
2,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00079435,0.30007,0.18658,1,1
2,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,6.7596e-05,0.29759,0.34957,1,1
2,GO DORSAL VENTRAL AXIS SPECIFICATION,0.010506,0.29461,0.26407,1,1
2,GO DIVALENT METAL ION EXPORT,0.0022332,0.2928,0.36634,1,1
2,GO MRNA MODIFICATION,4.8379e-05,0.29207,0.30818,1,1
2,GO TETRAHYDROFOLATE INTERCONVERSION,0.015574,0.29146,0.20846,1,1
2,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.00052342,0.29102,0.28985,1,1
2,GO TRNA PROCESSING,1.2962e-05,0.29098,0.2654,1,1
2,GO EMBRYONIC BRAIN DEVELOPMENT,8.7323e-05,0.29082,0.30253,1,1
2,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,8.6584e-06,0.2905,0.29277,1,1
2,GO NAD METABOLIC PROCESS,0.0023671,0.28961,0.22695,1,1
2,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.014138,0.28954,0.28542,1,1
2,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,6.5149e-05,0.28915,0.28619,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00028792,0.28897,0.30145,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,9.0179e-06,0.28815,0.27527,1,1
2,GO TRANSLATIONAL ELONGATION,1.1964e-05,0.28733,0.32113,1,1
2,GO SYNAPTIC VESICLE PRIMING,0.0028957,0.2873,0.30296,1,1
2,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.029719,0.28363,0.18988,1,1
2,GO RRNA METABOLIC PROCESS,2.3418e-05,0.28323,0.34974,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,9.3916e-06,0.27902,0.3275,1,1
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.00090094,0.27851,0.25073,1,1
2,GO RRNA METHYLATION,0.00026903,0.27841,0.29014,1,1
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.00030804,0.27816,0.28971,1,1
2,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.0016129,0.27614,0.26508,1,1
2,GO REGULATION OF RNA BINDING,1.1964e-05,0.27574,0.32944,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.00074557,0.27567,0.30316,1,1
2,GO MITOCHONDRIAL TRANSLATION,9.7346e-05,0.27364,0.32059,1,1
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,7.013e-05,0.27345,0.32831,1,1
2,GO TRNA METHYLATION,3.5759e-05,0.27313,0.26945,1,1
2,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00030804,0.27291,0.23048,1,1
2,GO ALANINE TRANSPORT,0.0087944,0.27138,0.26509,1,1
2,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.001662,0.27016,0.21343,1,1
2,GO AMINO ACID IMPORT,0.0012662,0.2701,0.22735,1,1
2,GO AORTA DEVELOPMENT,0.0085714,0.26865,0.15313,1,1
2,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0015189,0.26804,0.21471,1,1
2,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.017137,0.26785,0.23298,1,1
2,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.0001165,0.26645,0.3032,1,1
2,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.0040578,0.26605,0.17922,1,1
2,GO MITOCHONDRIAL GENE EXPRESSION,7.2754e-05,0.26601,0.31884,1,1
2,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0085714,0.26571,0.18409,1,1
2,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.031748,0.26536,0.17453,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00072223,0.26487,0.30639,1,1
2,GO FOLIC ACID METABOLIC PROCESS,0.0023671,0.26395,0.24744,1,1
2,GO RNA SURVEILLANCE,0.00047456,0.26387,0.23038,1,1
2,GO HISTONE ARGININE METHYLATION,0.00026003,0.26385,0.24286,1,1
2,GO TRNA METABOLIC PROCESS,7.547e-05,0.2631,0.22931,1,1
2,GO RRNA TRANSCRIPTION,2.1663e-05,0.26243,0.2901,1,1
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00026903,0.25989,0.18357,1,1
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0011199,0.2595,0.25663,1,1
2,GO OXIDATIVE PHOSPHORYLATION,0.00029782,0.25896,0.22688,1,1
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.041093,0.25782,0.22084,1,1
2,GO BONE GROWTH,0.018398,0.25539,0.2292,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,8.4205e-05,0.25489,0.25305,1,1
2,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.00067758,0.25404,0.22668,1,1
2,GO HEME METABOLIC PROCESS,0.0087944,0.25225,0.22885,1,1
2,GO PEPTIDYL ARGININE METHYLATION,2.9532e-05,0.25169,0.27082,1,1
2,GO GLUCOSE CATABOLIC PROCESS,0.009256,0.25137,0.19355,1,1
2,GO RNA 5 END PROCESSING,0.0012662,0.25107,0.26658,1,1
2,GO AMINO ACID ACTIVATION,0.0038387,0.25083,0.24203,1,1
2,GO MITOCHONDRION DISTRIBUTION,0.0041716,0.25013,0.19736,1,1
2,GO NCRNA PROCESSING,2.4346e-05,0.25012,0.28976,1,1
2,GO REGULATION OF LYASE ACTIVITY,0.00012512,0.25006,0.21597,1,1
2,GO MRNA METHYLATION,0.00047456,0.24908,0.26081,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,5.2139e-05,0.24816,0.30018,1,1
2,GO TRANSLATIONAL TERMINATION,9.389e-05,0.24753,0.30948,1,1
2,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.0001165,0.24642,0.25393,1,1
2,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.001986,0.24464,0.23949,1,1
2,GO REPRODUCTIVE BEHAVIOR,0.013139,0.24426,0.19899,1,1
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.026586,0.24392,0.20827,1,1
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,2.0033e-05,0.24352,0.25784,1,1
2,GO L SERINE METABOLIC PROCESS,0.029068,0.2424,0.26917,1,1
2,GO RELAXATION OF MUSCLE,0.024846,0.24158,0.16698,1,1
2,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.027188,0.24155,0.2339,1,1
2,GO AEROBIC RESPIRATION,0.00022676,0.24054,0.21892,1,1
2,GO STRESS GRANULE ASSEMBLY,8.7323e-05,0.24006,0.20617,1,1
2,GO HISTONE SERINE PHOSPHORYLATION,0.0029794,0.23994,0.18481,1,1
2,GO BASIC AMINO ACID TRANSPORT,0.014841,0.23992,0.23958,1,1
2,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0013054,0.23922,0.18418,1,1
2,GO NEURON REMODELING,0.0028957,0.23903,0.2714,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0057817,0.23891,0.21851,1,1
2,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00026003,0.23721,0.21392,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0030654,0.23662,0.19149,1,1
2,GO INHIBITORY SYNAPSE ASSEMBLY,0.0066042,0.23485,0.36675,1,1
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0094949,0.23455,0.2142,1,1
2,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0024367,0.23401,0.19118,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0087944,0.23216,0.185,1,1
2,GO AMINO ACID TRANSMEMBRANE TRANSPORT,2.0833e-05,0.23187,0.24768,1,1
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.00047456,0.23181,0.26376,1,1
2,GO CELLULAR RESPONSE TO PH,5.4121e-05,0.23124,0.2288,1,1
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.0033369,0.2308,0.20321,1,1
2,GO NCRNA METABOLIC PROCESS,6.0504e-05,0.23025,0.2474,1,1
2,GO REGULATION OF TRANSLATIONAL ELONGATION,0.00042998,0.22875,0.20767,1,1
2,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.045624,0.22828,0.27378,1,1
2,GO FIBROBLAST APOPTOTIC PROCESS,0.011326,0.22693,0.18548,1,1
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,1.7806e-05,0.22669,0.26374,1,1
2,GO AMP METABOLIC PROCESS,0.029719,0.2251,0.16922,1,1
2,GO POSITIVE REGULATION OF TRANSLATION,0.00084609,0.2226,0.17045,1,1
2,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00040247,0.22204,0.26714,1,1
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.001986,0.22115,0.21126,1,1
2,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.0018173,0.22081,0.17842,1,1
2,GO RESPONSE TO INTERLEUKIN 7,0.00012512,0.22077,0.19732,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.00084609,0.21987,0.18513,1,1
2,GO URONIC ACID METABOLIC PROCESS,0.001986,0.21957,0.161,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.020205,0.21892,0.15312,1,1
2,GO PROTEIN TARGETING TO MITOCHONDRION,0.00025131,0.21733,0.17642,1,1
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.019283,0.21696,0.14742,1,1
2,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0031536,0.21505,0.20453,1,1
2,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.00042998,0.21449,0.21563,1,1
2,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.042857,0.21383,0.28053,1,1
2,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.030383,0.21117,0.15313,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.00012512,0.21083,0.22161,1,1
2,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,2.7343e-05,0.21048,0.31127,1,1
2,GO POSITIVE REGULATION OF MRNA PROCESSING,2.7343e-05,0.20975,0.1878,1,1
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0014738,0.20959,0.21568,1,1
2,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.0021689,0.20851,0.35715,1,1
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.027188,0.20638,0.16504,1,1
2,GO RNA METHYLATION,9.7346e-05,0.20608,0.21429,1,1
2,GO CELLULAR COPPER ION HOMEOSTASIS,0.013798,0.20505,0.17235,1,1
2,GO CELLULAR RESPIRATION,0.00055855,0.20466,0.20082,1,1
2,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0054795,0.2013,0.16895,1,1
2,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00084609,0.20001,0.17039,1,1
2,GO CARDIOLIPIN METABOLIC PROCESS,0.011612,0.19883,0.16015,1,1
2,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.0079323,0.19813,0.17612,1,1
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0085714,0.19781,0.1853,1,1
2,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.042857,0.19738,0.2132,1,1
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.047551,0.19694,0.1282,1,1
2,GO TRNA TRANSPORT,0.00074557,0.19685,0.19311,1,1
2,GO TELOMERIC LOOP DISASSEMBLY,0.0014299,0.1967,0.19765,1,1
2,GO RNA POLYADENYLATION,8.7323e-05,0.19661,0.16335,1,1
2,GO RNA MODIFICATION,9.0551e-05,0.19588,0.20752,1,1
2,GO AMIDE BIOSYNTHETIC PROCESS,0.00055855,0.19512,0.18251,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.00034072,0.19488,0.16853,1,1
2,GO TRANSCRIPTION BY RNA POLYMERASE I,0.00063551,0.1948,0.18255,1,1
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.045624,0.19459,0.10704,1,1
2,GO TRICARBOXYLIC ACID CYCLE,0.00079435,0.19226,0.19157,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO HEAT,7.013e-05,0.191,0.17125,1,1
2,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.00050664,0.19092,0.22242,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.029719,0.1902,0.10359,1,1
2,GO GLUTAMINE METABOLIC PROCESS,0.00024286,0.18877,0.24166,1,1
2,GO PROTEIN NITROSYLATION,0.034637,0.18795,0.16837,1,1
2,GO PIGMENT BIOSYNTHETIC PROCESS,0.00098941,0.18773,0.21328,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.030383,0.18771,0.16601,1,1
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.025414,0.18693,0.14308,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.00013917,0.18592,0.21921,1,1
2,GO CELLULAR RESPONSE TO HEAT,0.00023468,0.18574,0.14786,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00016023,0.18542,0.16356,1,1
2,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.0037331,0.18531,0.30413,1,1
2,GO ALDITOL METABOLIC PROCESS,0.0029794,0.18512,0.20195,1,1
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.0013872,0.1845,0.18435,1,1
2,GO NCRNA EXPORT FROM NUCLEUS,0.001986,0.18321,0.18447,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.001191,0.18259,0.16225,1,1
2,GO L AMINO ACID TRANSPORT,6.7596e-05,0.18257,0.25269,1,1
2,GO HISTONE MRNA METABOLIC PROCESS,8.1192e-05,0.18232,0.1896,1,1
2,GO NUCLEAR PORE ORGANIZATION,0.0034322,0.18041,0.18694,1,1
2,GO DNA REPLICATION INITIATION,0.00044439,0.1803,0.17175,1,1
2,GO NCRNA 3 END PROCESSING,0.0015653,0.1799,0.16386,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION,9.7346e-05,0.17928,0.14631,1,1
2,GO PYRUVATE METABOLIC PROCESS,0.0028141,0.17695,0.12956,1,1
2,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.016734,0.17618,0.12509,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00067758,0.17613,0.17633,1,1
2,GO FEAR RESPONSE,0.040234,0.17401,0.14304,1,1
2,GO PEPTIDE METABOLIC PROCESS,0.0020453,0.17382,0.15312,1,1
2,GO RNA CATABOLIC PROCESS,0.0010528,0.17373,0.18606,1,1
2,GO REGULATION OF SYNAPSE ASSEMBLY,0.021165,0.17307,0.15703,1,1
2,GO PROTEIN TARGETING,0.0014299,0.17188,0.15307,1,1
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0050528,0.1712,0.15105,1,1
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0066042,0.17104,0.11742,1,1
2,GO RRNA 3 END PROCESSING,0.034637,0.17099,0.16181,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.00055855,0.16987,0.16561,1,1
2,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.031748,0.16932,0.12568,1,1
2,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.03939,0.16857,0.12819,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.009256,0.16719,0.14266,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE,0.00010845,0.16676,0.16848,1,1
2,GO HISTONE H3 K9 DEMETHYLATION,0.02068,0.16455,0.17417,1,1
2,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.017137,0.16453,0.16453,1,1
2,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.041093,0.16446,0.12343,1,1
2,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0027346,0.16445,0.13019,1,1
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.0056288,0.16343,0.16223,1,1
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0011199,0.16322,0.15465,1,1
2,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.033166,0.16174,0.13603,1,1
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.036948,0.16164,0.054186,1,1
2,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0027346,0.15925,0.1797,1,1
2,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0015189,0.15639,0.18525,1,1
2,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.0087944,0.15523,0.11227,1,1
2,GO BASE EXCISION REPAIR,0.0025083,0.15485,0.1283,1,1
2,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0059384,0.15353,0.16122,1,1
2,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0049174,0.15252,0.19714,1,1
2,GO REGULATION OF SPINDLE CHECKPOINT,0.0029794,0.15153,0.13355,1,1
2,GO PROTEIN DENEDDYLATION,0.033166,0.1458,0.13333,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0015653,0.14574,0.12856,1,1
2,GO IRON SULFUR CLUSTER ASSEMBLY,0.0057817,0.14571,0.22388,1,1
2,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0066042,0.1451,0.16892,1,1
2,GO BICARBONATE TRANSPORT,0.036948,0.14235,0.095248,1,1
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.011047,0.14122,0.12256,1,1
2,GO CARBOHYDRATE PHOSPHORYLATION,0.03939,0.14046,0.11655,1,1
2,GO REGULATION OF CELL CYCLE ARREST,0.0069616,0.14045,0.09516,1,1
2,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00092958,0.14039,0.15646,1,1
2,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.0050528,0.13944,0.15305,1,1
2,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.027188,0.1394,0.10495,1,1
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0062634,0.13934,0.14105,1,1
2,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.036164,0.13919,0.14094,1,1
2,GO ATP METABOLIC PROCESS,0.00036427,0.13891,0.13733,1,1
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0015653,0.13878,0.12525,1,1
2,GO MODULATION BY HOST OF VIRAL PROCESS,0.0032441,0.13858,0.15865,1,1
2,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.013139,0.13854,0.13794,1,1
2,GO PROTEIN HETEROOLIGOMERIZATION,0.0039469,0.1377,0.15345,1,1
2,GO REGULATION OF MRNA POLYADENYLATION,0.0017123,0.13645,0.12495,1,1
2,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.00021167,0.13509,0.13119,1,1
2,GO MRNA METABOLIC PROCESS,0.00010845,0.13445,0.15089,1,1
2,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.024846,0.13404,0.14161,1,1
2,GO TRNA 5 END PROCESSING,0.0067808,0.13388,0.21578,1,1
2,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.02268,0.13344,0.14731,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.031059,0.13289,0.11038,1,1
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0054795,0.13233,0.10657,1,1
2,GO AMINO ACID TRANSPORT,0.00044439,0.13035,0.15736,1,1
2,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.0075304,0.12987,0.12196,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0040578,0.12982,0.098093,1,1
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.007729,0.12946,0.097881,1,1
2,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.02166,0.12856,0.14164,1,1
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0073363,0.12815,0.10145,1,1
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.029068,0.12728,0.13142,1,1
2,GO RNA 3 END PROCESSING,0.00044439,0.1272,0.12357,1,1
2,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.041093,0.12698,0.1597,1,1
2,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.0050528,0.12566,0.083652,1,1
2,GO REGULATION OF MRNA PROCESSING,0.0032441,0.12523,0.093725,1,1
2,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.0023671,0.12477,0.14432,1,1
2,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.0056288,0.1247,0.13827,1,1
2,GO MRNA 3 END PROCESSING,0.0015189,0.12438,0.10174,1,1
2,GO NUCLEOTIDE PHOSPHORYLATION,0.0047853,0.12371,0.11945,1,1
2,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.015574,0.12358,0.11078,1,1
2,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.011612,0.12247,0.2099,1,1
2,GO RNA CAPPING,0.0051916,0.12224,0.11244,1,1
2,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0067808,0.12224,0.10223,1,1
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00023468,0.12069,0.12789,1,1
2,GO CELLULAR AMIDE METABOLIC PROCESS,0.0059384,0.12048,0.1204,1,1
2,GO CELLULAR RESPONSE TO DRUG,0.0046564,0.11946,0.12898,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.010245,0.11848,0.15949,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.014841,0.11796,0.095721,1,1
2,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.0037331,0.11663,0.14972,1,1
2,GO APOPTOTIC DNA FRAGMENTATION,0.047551,0.11629,0.068816,1,1
2,GO RESPONSE TO HEAT,0.0071468,0.11603,0.094228,1,1
2,GO NCRNA TRANSCRIPTION,0.00021909,0.11512,0.1263,1,1
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.02068,0.1146,0.10974,1,1
2,GO MITOTIC DNA REPLICATION CHECKPOINT,0.027188,0.11392,0.13377,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.010245,0.11382,0.1319,1,1
2,GO PROTEIN TETRAMERIZATION,0.0011199,0.11376,0.12733,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.0034322,0.11335,0.11355,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.011904,0.11264,0.084577,1,1
2,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.042857,0.11171,0.088376,1,1
2,GO RNA PROCESSING,1.8521e-05,0.11065,0.16722,1,1
2,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.014138,0.11022,0.11503,1,1
2,GO TELOMERE ORGANIZATION,0.00032948,0.1101,0.13039,1,1
2,GO PROTEIN HETEROTETRAMERIZATION,0.00353,0.10828,0.13485,1,1
2,GO PEPTIDYL ARGININE MODIFICATION,0.03939,0.10794,0.11053,1,1
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0010206,0.10638,0.11963,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.011326,0.10624,0.099335,1,1
2,GO RNA LOCALIZATION,0.00055855,0.1058,0.14285,1,1
2,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.023205,0.10424,0.082899,1,1
2,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.046579,0.10341,0.079547,1,1
2,GO ERROR FREE TRANSLESION SYNTHESIS,0.019283,0.10313,0.10302,1,1
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0094949,0.1026,0.079982,1,1
2,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.013139,0.10156,0.097536,1,1
2,GO PROTEIN NEDDYLATION,0.02166,0.10136,0.1262,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.0075304,0.10107,0.10394,1,1
2,GO NUCLEAR EXPORT,0.0014299,0.099419,0.10354,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.011612,0.098656,0.094442,1,1
2,GO SNRNA PROCESSING,0.016734,0.098457,0.049846,1,1
2,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.017969,0.098273,0.16477,1,1
2,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.0059384,0.097434,0.10635,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.001191,0.095508,0.096131,1,1
2,GO METHYLATION,0.0019282,0.094303,0.087309,1,1
2,GO NUCLEOTIDE EXCISION REPAIR,0.013139,0.094189,0.076672,1,1
2,GO NUCLEAR TRANSPORT,0.0056288,0.093246,0.073385,1,1
2,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.009256,0.091452,0.093086,1,1
2,GO TRANSCRIPTION BY RNA POLYMERASE III,0.013139,0.090542,0.091484,1,1
2,GO CELLULAR RESPONSE TO UV,0.023741,0.089531,0.083355,1,1
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.00079435,0.08906,0.11576,1,1
2,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.014486,0.088299,0.062428,1,1
2,GO MRNA PROCESSING,0.00054072,0.084613,0.10714,1,1
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0081404,0.084093,0.10753,1,1
2,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.017549,0.083357,0.069036,1,1
2,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0042883,0.081822,0.091204,1,1
2,GO NUCLEOSIDE METABOLIC PROCESS,0.022165,0.079204,0.08034,1,1
2,GO REGULATION OF CELL CYCLE CHECKPOINT,0.02268,0.077697,0.075358,1,1
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.004408,0.07556,0.082134,1,1
2,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.026586,0.075138,0.04598,1,1
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.043763,0.07361,0.049126,1,1
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.0087944,0.073428,0.10102,1,1
2,GO RNA SPLICING,0.001986,0.072933,0.09655,1,1
2,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.010773,0.066106,0.069703,1,1
2,GO SNRNA METABOLIC PROCESS,0.027188,0.063685,0.057015,1,1
2,GO INTERSTRAND CROSS LINK REPAIR,0.0090226,0.063217,0.080227,1,1
2,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.013465,0.06315,0.08346,1,1
2,GO MRNA TRANSPORT,0.011326,0.05716,0.096608,1,1
2,GO MITOCHONDRION ORGANIZATION,0.046579,0.049212,0.052838,1,1
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.036948,0.043057,0.0782,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.00087311,1.8242,1.1555,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00095906,1.3792,0.92946,1,1
3,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,2.7343e-05,1.0841,0.78743,1,1
3,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,7.5427e-07,1.0704,1.1359,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.00081984,1.0456,0.71919,1,1
3,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.0099891,0.99549,0.71391,1,1
3,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,3.0576e-06,0.94768,0.69847,1,1
3,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,4.2876e-06,0.9265,0.75883,1,1
3,GO CYTIDINE TO URIDINE EDITING,1.7118e-05,0.89188,0.77183,1,1
3,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0034322,0.88417,0.6226,1,1
3,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,4.1617e-05,0.84644,0.74388,1,1
3,GO TOLERANCE INDUCTION,0.0013457,0.84255,0.61578,1,1
3,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.00012512,0.82105,0.5537,1,1
3,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,7.9801e-06,0.81941,0.72158,1,1
3,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0014738,0.80247,0.50703,1,1
3,GO GERMINAL CENTER FORMATION,1.3441e-06,0.78625,0.71375,1,1
3,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,2.0829e-07,0.77592,0.75988,1,1
3,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,2.3418e-05,0.76384,0.63678,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00010092,0.76011,0.71256,1,1
3,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,2.0033e-05,0.75826,0.5872,1,1
3,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,1.1776e-06,0.74473,0.65077,1,1
3,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,6.7728e-06,0.73465,0.6467,1,1
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,3.9418e-06,0.72966,0.72603,1,1
3,GO REGULATION OF SUPEROXIDE ANION GENERATION,5.2837e-06,0.71752,0.68755,1,1
3,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,1.2862e-06,0.71602,0.73453,1,1
3,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,3.4421e-05,0.71418,0.54968,1,1
3,GO RESPONSE TO TYPE I INTERFERON,1.2962e-05,0.71352,0.63289,1,1
3,GO REGULATION OF PLASMINOGEN ACTIVATION,0.001662,0.71231,0.47172,1,1
3,GO HISTAMINE SECRETION,2.6322e-07,0.70834,0.7571,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.011326,0.7015,0.48487,1,1
3,GO RENAL ABSORPTION,4.6623e-06,0.70055,0.70954,1,1
3,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0015189,0.69676,0.45614,1,1
3,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00050664,0.69215,0.55451,1,1
3,GO RESPONSE TO INTERFERON BETA,0.00028792,0.6851,0.54941,1,1
3,GO DOPAMINE BIOSYNTHETIC PROCESS,7.0571e-06,0.6838,0.72351,1,1
3,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.001228,0.68132,0.53278,1,1
3,GO MUCUS SECRETION,0.00034072,0.67366,0.60425,1,1
3,GO HISTAMINE TRANSPORT,2.5122e-07,0.6715,0.72999,1,1
3,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,2.6307e-05,0.65948,0.65417,1,1
3,GO PROGESTERONE METABOLIC PROCESS,0.00022676,0.65717,0.89245,1,1
3,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0006154,0.65565,0.53928,1,1
3,GO T CELL MEDIATED CYTOTOXICITY,0.00090094,0.65239,0.44326,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00038934,0.64938,0.46583,1,1
3,GO GLYCOSIDE METABOLIC PROCESS,0.0024367,0.64589,0.78999,1,1
3,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,9.4334e-07,0.64432,0.62932,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,1.104e-05,0.64102,0.53357,1,1
3,GO ACTIN FILAMENT NETWORK FORMATION,0.029719,0.6404,0.28271,1,1
3,GO NEGATIVE REGULATION OF TISSUE REMODELING,2.5122e-07,0.63542,0.66827,1,1
3,GO RETINAL METABOLIC PROCESS,0.00065623,0.6345,0.62113,1,1
3,GO MATURE B CELL DIFFERENTIATION,7.3528e-06,0.62553,0.49547,1,1
3,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.00012512,0.62538,0.55124,1,1
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,1.7118e-05,0.62216,0.58585,1,1
3,GO NEGATIVE REGULATION OF CELL KILLING,0.015953,0.62207,0.41406,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,8.3127e-06,0.61966,0.55454,1,1
3,GO ACTIVATION OF JANUS KINASE ACTIVITY,1.5201e-05,0.61732,0.49039,1,1
3,GO LIPID DROPLET FORMATION,4.8612e-06,0.61646,0.65665,1,1
3,GO NEGATIVE REGULATION OF BONE REMODELING,2.2658e-06,0.6122,0.59343,1,1
3,GO POSITIVE REGULATION OF CELL MATURATION,7.0571e-06,0.60589,0.56953,1,1
3,GO T CELL EXTRAVASATION,0.00037661,0.60292,0.56325,1,1
3,GO GALACTOSE METABOLIC PROCESS,3.0264e-07,0.60248,0.69498,1,1
3,GO RESPONSE TO INTERFERON ALPHA,0.001228,0.60158,0.41097,1,1
3,GO ACTIN FILAMENT SEVERING,0.00012964,0.60069,0.49517,1,1
3,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.0037331,0.60055,0.68532,1,1
3,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,7.2754e-05,0.5878,0.44027,1,1
3,GO DENDRITIC CELL DIFFERENTIATION,0.0028141,0.58699,0.40239,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00013433,0.58091,0.54721,1,1
3,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,9.7801e-06,0.57548,0.51994,1,1
3,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,2.5774e-06,0.57367,0.55037,1,1
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.8251e-06,0.56988,0.55852,1,1
3,GO PLASMINOGEN ACTIVATION,0.00017186,0.56797,0.5171,1,1
3,GO METANEPHRIC GLOMERULUS DEVELOPMENT,8.4205e-05,0.56478,0.43864,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,7.013e-05,0.56344,0.50881,1,1
3,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00013917,0.56147,0.47959,1,1
3,GO REGULATION OF MICROVILLUS ORGANIZATION,0.001228,0.55987,0.45508,1,1
3,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,1.7806e-05,0.55723,0.5795,1,1
3,GO CELLULAR DEFENSE RESPONSE,4.1802e-07,0.55685,0.48696,1,1
3,GO REGULATION OF HORMONE METABOLIC PROCESS,2.4346e-05,0.55608,0.45391,1,1
3,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,9.0179e-06,0.55399,0.49176,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00014935,0.55354,0.47227,1,1
3,GO REGULATION OF TOLERANCE INDUCTION,0.0081404,0.55184,0.46337,1,1
3,GO CYCLOOXYGENASE PATHWAY,0.0012662,0.55032,0.51917,1,1
3,GO TOXIN METABOLIC PROCESS,4.5813e-07,0.55021,0.56649,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00020448,0.54979,0.41384,1,1
3,GO INTESTINAL LIPID ABSORPTION,9.7801e-06,0.54423,0.66274,1,1
3,GO REGULATION OF FIBRINOLYSIS,3.8583e-05,0.54275,0.5135,1,1
3,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.00020448,0.54146,0.46447,1,1
3,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00069957,0.54132,0.50737,1,1
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.00032948,0.54111,0.4283,1,1
3,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00013917,0.5404,0.48665,1,1
3,GO RESPONSE TO PAIN,1.4674e-06,0.5398,0.50108,1,1
3,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,2.8418e-05,0.53864,0.55316,1,1
3,GO REGULATION OF B CELL APOPTOTIC PROCESS,1.5331e-06,0.53709,0.50733,1,1
3,GO RESPONSE TO NITROSATIVE STRESS,7.8282e-05,0.53558,0.4892,1,1
3,GO SUPEROXIDE ANION GENERATION,3.6228e-06,0.53536,0.53683,1,1
3,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00013433,0.53496,0.49447,1,1
3,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.00081984,0.53454,0.3863,1,1
3,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00021167,0.53292,0.42288,1,1
3,GO FRUCTOSE METABOLIC PROCESS,0.0012662,0.52941,0.51924,1,1
3,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0060989,0.52871,0.36959,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.00017186,0.52819,0.48907,1,1
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,7.547e-05,0.52612,0.4334,1,1
3,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,9.0179e-06,0.52562,0.51773,1,1
3,GO ADHESION OF SYMBIONT TO HOST,0.0030654,0.52551,0.38945,1,1
3,GO GLYCOLIPID CATABOLIC PROCESS,4.0073e-05,0.52462,0.50761,1,1
3,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.00092958,0.52434,0.41597,1,1
3,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.00059588,0.5235,0.38943,1,1
3,GO UTERINE SMOOTH MUSCLE CONTRACTION,6.5149e-05,0.5233,0.49496,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,8.4205e-05,0.52109,0.39283,1,1
3,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,4.7955e-07,0.51996,0.51096,1,1
3,GO RESPONSE TO COLD,9.7275e-08,0.51916,0.49583,1,1
3,GO CYSTEINE METABOLIC PROCESS,0.0071468,0.5188,0.44344,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,9.3916e-06,0.51856,0.47634,1,1
3,GO INTESTINAL ABSORPTION,5.9841e-06,0.51834,0.60024,1,1
3,GO SPHINGOMYELIN METABOLIC PROCESS,7.6603e-06,0.51774,0.45603,1,1
3,GO STEROID ESTERIFICATION,1.7474e-06,0.51766,0.70381,1,1
3,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,1.0184e-05,0.51709,0.65755,1,1
3,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,3.1888e-05,0.51562,0.50466,1,1
3,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.00021909,0.51381,0.48535,1,1
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,3.8583e-05,0.51304,0.473,1,1
3,GO DETECTION OF OTHER ORGANISM,0.00028792,0.51251,0.47083,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,9.389e-05,0.51213,0.46548,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,1.9263e-05,0.5114,0.47359,1,1
3,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.7474e-06,0.51081,0.52572,1,1
3,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00052342,0.50934,0.42042,1,1
3,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00010092,0.50824,0.58956,1,1
3,GO RESPONSE TO INTERLEUKIN 18,0.0045306,0.50607,0.43155,1,1
3,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,4.1617e-05,0.50529,0.54607,1,1
3,GO REGULATION OF CHOLESTEROL ESTERIFICATION,3.4728e-06,0.50333,0.75173,1,1
3,GO RESPONSE TO DIETARY EXCESS,5.2837e-06,0.50082,0.50146,1,1
3,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.0032441,0.49731,0.40298,1,1
3,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.0059384,0.49719,0.30776,1,1
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,4.1617e-05,0.49709,0.49809,1,1
3,GO REFLEX,4.8379e-05,0.49432,0.52749,1,1
3,GO RESPONSE TO EPINEPHRINE,0.0023671,0.49377,0.35631,1,1
3,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,3.3287e-06,0.49246,0.61406,1,1
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.0029794,0.49196,0.48289,1,1
3,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0036303,0.49,0.34371,1,1
3,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,8.7323e-05,0.48752,0.42948,1,1
3,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.00044439,0.48537,0.35918,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,7.2111e-07,0.48535,0.50632,1,1
3,GO NEGATIVE REGULATION OF COAGULATION,0.00045924,0.48464,0.39258,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,6.2786e-05,0.48427,0.41426,1,1
3,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.0037331,0.48415,0.32989,1,1
3,GO REGULATION OF INTEGRIN ACTIVATION,3.4772e-07,0.48196,0.53652,1,1
3,GO REGULATION OF ANOIKIS,3.1888e-05,0.47817,0.46637,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,8.1192e-05,0.47648,0.41833,1,1
3,GO BARBED END ACTIN FILAMENT CAPPING,0.0017123,0.47485,0.39222,1,1
3,GO REGULATION OF MYOBLAST FUSION,2.3418e-05,0.47453,0.4118,1,1
3,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00013433,0.47384,0.4517,1,1
3,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.7791e-06,0.47377,0.38034,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,9.8628e-07,0.4733,0.45979,1,1
3,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,1.4609e-05,0.47307,0.40837,1,1
3,GO CORTICOSTEROID HORMONE SECRETION,0.00014935,0.47233,0.43843,1,1
3,GO REGULATION OF NEURON MATURATION,1.5816e-05,0.47152,0.41185,1,1
3,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0023671,0.46924,0.36373,1,1
3,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.035393,0.46886,0.21163,1,1
3,GO VASODILATION,1.1493e-05,0.4682,0.59235,1,1
3,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,2.2524e-05,0.46805,0.45767,1,1
3,GO REGULATION OF BONE REMODELING,6.0198e-07,0.46771,0.48223,1,1
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,4.1617e-05,0.46732,0.41959,1,1
3,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,5.9841e-06,0.46365,0.40481,1,1
3,GO ZYMOGEN ACTIVATION,4.0073e-05,0.46214,0.47229,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00098941,0.46193,0.4952,1,1
3,GO CELL ADHESION MEDIATED BY INTEGRIN,8.6584e-06,0.4586,0.45777,1,1
3,GO SIGNAL PEPTIDE PROCESSING,4.4712e-06,0.45727,0.46685,1,1
3,GO NADP METABOLIC PROCESS,0.00024286,0.45707,0.34617,1,1
3,GO BONE RESORPTION,3.9926e-07,0.45599,0.46505,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.00028792,0.45595,0.49282,1,1
3,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00016023,0.45445,0.38401,1,1
3,GO ACUTE INFLAMMATORY RESPONSE,1.1964e-05,0.45399,0.39267,1,1
3,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,1.4039e-05,0.45388,0.49322,1,1
3,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00063551,0.45386,0.36097,1,1
3,GO PROSTANOID METABOLIC PROCESS,0.00040247,0.4532,0.42374,1,1
3,GO RESPONSE TO ACIDIC PH,8.7323e-05,0.45304,0.3927,1,1
3,GO FOAM CELL DIFFERENTIATION,2.2524e-05,0.45253,0.37941,1,1
3,GO OPTIC NERVE DEVELOPMENT,8.1192e-05,0.4525,0.50253,1,1
3,GO C21 STEROID HORMONE METABOLIC PROCESS,0.001191,0.45056,0.49943,1,1
3,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00035231,0.45025,0.45298,1,1
3,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,2.2524e-05,0.44692,0.39466,1,1
3,GO NEGATIVE REGULATION OF B CELL ACTIVATION,3.8131e-07,0.44622,0.44184,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0056288,0.44609,0.2693,1,1
3,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.1702e-06,0.44507,0.4761,1,1
3,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.00012964,0.44365,0.43077,1,1
3,GO REGULATION OF WATER LOSS VIA SKIN,0.0017641,0.44306,0.37469,1,1
3,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0013054,0.44209,0.37111,1,1
3,GO QUINONE METABOLIC PROCESS,0.00012074,0.44202,0.61914,1,1
3,GO PROTEIN DEGLYCOSYLATION,1.5816e-05,0.44129,0.41173,1,1
3,GO PHAGOLYSOSOME ASSEMBLY,1.8521e-05,0.43968,0.45916,1,1
3,GO LEYDIG CELL DIFFERENTIATION,0.00044439,0.43907,0.48778,1,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00036427,0.43859,0.47729,1,1
3,GO SMOOTH MUSCLE CELL MIGRATION,7.547e-05,0.4382,0.36273,1,1
3,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00029782,0.43715,0.35705,1,1
3,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,2.0833e-05,0.43678,0.4784,1,1
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0033369,0.43535,0.30863,1,1
3,GO NUCLEOTIDE SALVAGE,0.00037661,0.4353,0.36443,1,1
3,GO PROSTANOID BIOSYNTHETIC PROCESS,0.00038934,0.43423,0.33808,1,1
3,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,7.0571e-06,0.4331,0.39447,1,1
3,GO SECONDARY METABOLIC PROCESS,0.00022676,0.43301,0.4134,1,1
3,GO GAP JUNCTION ASSEMBLY,0.0045306,0.43228,0.31773,1,1
3,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00017186,0.4312,0.42831,1,1
3,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00021909,0.43107,0.36161,1,1
3,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.037747,0.4306,0.2276,1,1
3,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,5.8301e-05,0.42986,0.37981,1,1
3,GO MICROVILLUS ORGANIZATION,0.00063551,0.42906,0.36705,1,1
3,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.00063551,0.42905,0.40454,1,1
3,GO PEPTIDYL PROLINE HYDROXYLATION,0.00012964,0.42905,0.44899,1,1
3,GO LIVER MORPHOGENESIS,7.547e-05,0.42898,0.4051,1,1
3,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.00031859,0.42732,0.44656,1,1
3,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,3.3132e-05,0.42701,0.35298,1,1
3,GO RESPONSE TO THYROID HORMONE,0.00029782,0.42573,0.34413,1,1
3,GO ENDOTHELIAL CELL CHEMOTAXIS,5.8301e-05,0.4256,0.38527,1,1
3,GO LIPID DIGESTION,8.1192e-05,0.42387,0.56933,1,1
3,GO REGULATION OF TISSUE REMODELING,7.5427e-07,0.42377,0.4264,1,1
3,GO L PHENYLALANINE METABOLIC PROCESS,0.00012964,0.42376,0.60681,1,1
3,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.010506,0.4232,0.34905,1,1
3,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.001872,0.42291,0.41707,1,1
3,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.00010462,0.42166,0.34212,1,1
3,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,3.5759e-05,0.4207,0.36506,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00037661,0.42061,0.36126,1,1
3,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.0011199,0.4205,0.35637,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,3.3202e-07,0.41907,0.50359,1,1
3,GO B CELL APOPTOTIC PROCESS,2.5774e-06,0.41876,0.46111,1,1
3,GO AMINE BIOSYNTHETIC PROCESS,2.2879e-07,0.41833,0.43985,1,1
3,GO KETONE BIOSYNTHETIC PROCESS,1.7806e-05,0.41796,0.38507,1,1
3,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.0026572,0.41788,0.39184,1,1
3,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0042883,0.41739,0.27,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0010206,0.41626,0.25814,1,1
3,GO REGULATION OF PLATELET ACTIVATION,0.00030804,0.41524,0.35254,1,1
3,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.001662,0.41521,0.36311,1,1
3,GO MITOCHONDRIAL DEPOLARIZATION,2.0033e-05,0.41459,0.37611,1,1
3,GO BASIC AMINO ACID TRANSPORT,0.00079435,0.41453,0.44437,1,1
3,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,3.0689e-05,0.41312,0.42655,1,1
3,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.011047,0.4131,0.2709,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0097392,0.41293,0.2747,1,1
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,1.104e-05,0.41266,0.45935,1,1
3,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,3.0689e-05,0.41216,0.39353,1,1
3,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.014486,0.41046,0.26413,1,1
3,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00047456,0.40992,0.35755,1,1
3,GO NADPH REGENERATION,0.0081404,0.40961,0.25019,1,1
3,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.7118e-05,0.40542,0.46099,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.0036303,0.40492,0.30521,1,1
3,GO CERAMIDE CATABOLIC PROCESS,0.00063551,0.40406,0.38691,1,1
3,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.0184e-05,0.40394,0.3793,1,1
3,GO REGULATION OF STEROID METABOLIC PROCESS,3.3287e-06,0.40337,0.34588,1,1
3,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00017186,0.40318,0.38001,1,1
3,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,1.104e-05,0.40303,0.32825,1,1
3,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,3.3132e-05,0.40243,0.3339,1,1
3,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,4.8379e-05,0.40199,0.37853,1,1
3,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0015653,0.40172,0.44725,1,1
3,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00024286,0.40136,0.38173,1,1
3,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,9.0551e-05,0.40128,0.31159,1,1
3,GO IMMUNOGLOBULIN SECRETION,0.00026903,0.40067,0.33905,1,1
3,GO LIPID DROPLET ORGANIZATION,5.7413e-06,0.40002,0.36225,1,1
3,GO AMMONIUM ION METABOLIC PROCESS,6.0504e-05,0.39978,0.43612,1,1
3,GO RIBONUCLEOSIDE CATABOLIC PROCESS,5.8301e-05,0.3995,0.39399,1,1
3,GO REGULATION OF CELL PROJECTION SIZE,0.0015653,0.39826,0.32351,1,1
3,GO INTEGRIN ACTIVATION,2.5774e-06,0.39662,0.39659,1,1
3,GO ACETYL COA BIOSYNTHETIC PROCESS,1.5201e-05,0.39639,0.37044,1,1
3,GO NATURAL KILLER CELL MEDIATED IMMUNITY,3.1888e-05,0.39626,0.34794,1,1
3,GO RADIAL GLIAL CELL DIFFERENTIATION,0.0028957,0.39519,0.35509,1,1
3,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.00069957,0.39495,0.29671,1,1
3,GO DENDRITIC CELL APOPTOTIC PROCESS,0.0066042,0.3947,0.32608,1,1
3,GO BONE REMODELING,2.8077e-06,0.39431,0.38378,1,1
3,GO PHAGOSOME ACIDIFICATION,8.628e-07,0.39428,0.39598,1,1
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0006154,0.3942,0.43096,1,1
3,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,4.1617e-05,0.39391,0.34574,1,1
3,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,8.1192e-05,0.39246,0.41325,1,1
3,GO PROTEIN DEMANNOSYLATION,2.1663e-05,0.3922,0.40434,1,1
3,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.001228,0.39162,0.33174,1,1
3,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.0006154,0.39153,0.30852,1,1
3,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,2.8418e-05,0.39031,0.33645,1,1
3,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.00010092,0.39018,0.40741,1,1
3,GO STEROID HORMONE SECRETION,5.8301e-05,0.38984,0.39378,1,1
3,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.00012512,0.38936,0.37998,1,1
3,GO TERPENOID BIOSYNTHETIC PROCESS,0.016734,0.38885,0.3296,1,1
3,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.041093,0.38868,0.31389,1,1
3,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0021689,0.38843,0.37676,1,1
3,GO BLOOD VESSEL REMODELING,4.0073e-05,0.38839,0.34919,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,2.8418e-05,0.38766,0.30628,1,1
3,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.0030654,0.38758,0.35578,1,1
3,GO CELLULAR RESPONSE TO FATTY ACID,2.4346e-05,0.38678,0.37067,1,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00044439,0.38479,0.3724,1,1
3,GO ACUTE PHASE RESPONSE,8.4205e-05,0.38449,0.34219,1,1
3,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00026003,0.3843,0.2757,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00036427,0.38385,0.3035,1,1
3,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.02166,0.38317,0.26856,1,1
3,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,3.0689e-05,0.3829,0.38071,1,1
3,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.014486,0.3812,0.22941,1,1
3,GO REGULATION OF PROTEIN COMPLEX STABILITY,5.0226e-05,0.38111,0.36694,1,1
3,GO N GLYCAN PROCESSING,0.00081984,0.38045,0.32066,1,1
3,GO REGULATION OF ORGANIC ACID TRANSPORT,3.3132e-05,0.38008,0.31873,1,1
3,GO INTRACELLULAR STEROL TRANSPORT,0.00029782,0.38006,0.33492,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0014738,0.3799,0.31653,1,1
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00019079,0.37901,0.36114,1,1
3,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.00016023,0.37899,0.3416,1,1
3,GO REGULATION OF LEUKOCYTE DEGRANULATION,5.8301e-05,0.37898,0.31918,1,1
3,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0015189,0.37791,0.25045,1,1
3,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.00041602,0.37767,0.28263,1,1
3,GO DEFENSE RESPONSE TO VIRUS,0.00016595,0.37746,0.26991,1,1
3,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0024367,0.37711,0.37021,1,1
3,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,5.4121e-05,0.37669,0.33384,1,1
3,GO PHOSPHOLIPID EFFLUX,0.00011241,0.37666,0.4075,1,1
3,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00025131,0.37511,0.37166,1,1
3,GO RESPONSE TO INTERLEUKIN 2,0.00032948,0.3739,0.27494,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00011241,0.37352,0.31988,1,1
3,GO REGULATION OF VIRAL GENOME REPLICATION,0.00063551,0.37222,0.27198,1,1
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00012964,0.37179,0.31586,1,1
3,GO THYMOCYTE APOPTOTIC PROCESS,0.001662,0.37179,0.28314,1,1
3,GO REGULATION OF ENDOCRINE PROCESS,1.7806e-05,0.37138,0.30379,1,1
3,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,4.3218e-05,0.37138,0.33764,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00017796,0.37118,0.34984,1,1
3,GO RESPONSE TO XENOBIOTIC STIMULUS,5.8301e-05,0.37101,0.33657,1,1
3,GO POSITIVE REGULATION OF WOUND HEALING,9.7346e-05,0.37064,0.35829,1,1
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00052342,0.37059,0.27448,1,1
3,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.0050528,0.37011,0.3893,1,1
3,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00026003,0.36985,0.32964,1,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00079435,0.36955,0.38994,1,1
3,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,2.6307e-05,0.36925,0.38103,1,1
3,GO TISSUE REMODELING,6.4994e-06,0.36879,0.33439,1,1
3,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.033166,0.36842,0.30694,1,1
3,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,2.5774e-06,0.36775,0.3193,1,1
3,GO RESPONSE TO REDOX STATE,0.0085714,0.36757,0.25442,1,1
3,GO OSTEOBLAST PROLIFERATION,0.00010462,0.36707,0.34573,1,1
3,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0007696,0.367,0.3944,1,1
3,GO CARBOHYDRATE DERIVATIVE TRANSPORT,1.0311e-06,0.36681,0.36737,1,1
3,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,7.547e-05,0.36656,0.38521,1,1
3,GO RESPONSE TO MUSCLE ACTIVITY,0.0025817,0.36634,0.26605,1,1
3,GO ENTRY INTO HOST,0.00072223,0.36551,0.25157,1,1
3,GO ICOSANOID METABOLIC PROCESS,5.0683e-06,0.36543,0.37255,1,1
3,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.0015189,0.36493,0.34785,1,1
3,GO SNARE COMPLEX ASSEMBLY,0.00059588,0.36458,0.27379,1,1
3,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0011549,0.36413,0.35195,1,1
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00023468,0.3639,0.31707,1,1
3,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.00034072,0.36383,0.33357,1,1
3,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00044439,0.36356,0.37907,1,1
3,GO PROTEIN AUTOPROCESSING,1.8521e-05,0.36317,0.40054,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,4.6597e-05,0.36275,0.28576,1,1
3,GO DIGESTION,4.4878e-05,0.36271,0.31021,1,1
3,GO MYOBLAST FUSION,0.00035231,0.36151,0.27797,1,1
3,GO RESPONSE TO DEXAMETHASONE,9.389e-05,0.3613,0.3146,1,1
3,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0045306,0.36125,0.28959,1,1
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.0021062,0.36097,0.35153,1,1
3,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.00020448,0.3606,0.36869,1,1
3,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,3.7145e-05,0.35991,0.41458,1,1
3,GO PROTEIN HYDROXYLATION,0.0016129,0.35935,0.28703,1,1
3,GO LIPOPROTEIN CATABOLIC PROCESS,0.0001165,0.35792,0.30124,1,1
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.00044439,0.35791,0.38814,1,1
3,GO DORSAL AORTA DEVELOPMENT,0.0050528,0.35783,0.25518,1,1
3,GO VASCULAR TRANSPORT,0.0030654,0.3572,0.3419,1,1
3,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.015574,0.35588,0.17796,1,1
3,GO LEUKOCYTE MEDIATED CYTOTOXICITY,9.0551e-05,0.35587,0.28545,1,1
3,GO RESPONSE TO STEROL DEPLETION,6.5149e-05,0.35572,0.44277,1,1
3,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,2.3418e-05,0.3553,0.37956,1,1
3,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,7.8282e-05,0.3551,0.2874,1,1
3,GO POSITIVE REGULATION OF CELL KILLING,0.00042998,0.35504,0.29792,1,1
3,GO REGULATION OF B CELL DIFFERENTIATION,0.00016595,0.35501,0.2955,1,1
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,2.3418e-05,0.35421,0.38863,1,1
3,GO ANTIBACTERIAL HUMORAL RESPONSE,0.00021909,0.35419,0.33016,1,1
3,GO METHIONINE METABOLIC PROCESS,5.0226e-05,0.35395,0.32618,1,1
3,GO RESPONSE TO MINERALOCORTICOID,0.0001547,0.35291,0.29154,1,1
3,GO B CELL MEDIATED IMMUNITY,6.7596e-05,0.35235,0.29828,1,1
3,GO T CELL MEDIATED IMMUNITY,0.0022332,0.35209,0.26736,1,1
3,GO ANOIKIS,1.5201e-05,0.35201,0.33558,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0012662,0.35183,0.22997,1,1
3,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,6.4994e-06,0.35161,0.31709,1,1
3,GO NEGATIVE REGULATION OF WOUND HEALING,0.00021167,0.35124,0.32421,1,1
3,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00074557,0.35106,0.23646,1,1
3,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.00027832,0.35074,0.33735,1,1
3,GO ALPHA BETA T CELL PROLIFERATION,0.00026903,0.35066,0.3321,1,1
3,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00047456,0.35064,0.24863,1,1
3,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.010773,0.35003,0.2531,1,1
3,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00013917,0.34965,0.24458,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00014935,0.34885,0.29062,1,1
3,GO AMINO ACID BETAINE METABOLIC PROCESS,0.00012074,0.34885,0.37263,1,1
3,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.00016023,0.34883,0.29371,1,1
3,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,1.2454e-05,0.34848,0.33901,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00047456,0.34837,0.28323,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.036948,0.34818,0.18286,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,1.2454e-05,0.3477,0.31348,1,1
3,GO RESPONSE TO INTERFERON GAMMA,0.00021167,0.34732,0.33088,1,1
3,GO LYMPHOCYTE MEDIATED IMMUNITY,6.0504e-05,0.34678,0.27649,1,1
3,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00042998,0.34613,0.39094,1,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,1.6455e-05,0.34559,0.34956,1,1
3,GO REGULATION OF LIGASE ACTIVITY,0.0022332,0.34525,0.23354,1,1
3,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00047456,0.34446,0.25608,1,1
3,GO RESPONSE TO LITHIUM ION,3.5759e-05,0.34401,0.42948,1,1
3,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.00019753,0.34348,0.2891,1,1
3,GO STEROL METABOLIC PROCESS,3.7145e-05,0.34335,0.27412,1,1
3,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.00057693,0.34278,0.31263,1,1
3,GO PLATELET DEGRANULATION,0.00023468,0.34277,0.28547,1,1
3,GO DETECTION OF BIOTIC STIMULUS,0.00025131,0.34239,0.35261,1,1
3,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.00010462,0.34188,0.29631,1,1
3,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0029794,0.34181,0.29307,1,1
3,GO POSITIVE REGULATION OF ANION TRANSPORT,1.3441e-06,0.34169,0.38343,1,1
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0011199,0.34141,0.22493,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00040247,0.34129,0.238,1,1
3,GO METHIONINE BIOSYNTHETIC PROCESS,0.0013872,0.34081,0.36832,1,1
3,GO REGULATION OF WOUND HEALING,4.8379e-05,0.34067,0.31079,1,1
3,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,5.4121e-05,0.34063,0.32972,1,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00010092,0.34043,0.30388,1,1
3,GO STEROID BIOSYNTHETIC PROCESS,4.8612e-06,0.33964,0.29786,1,1
3,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.0022332,0.33938,0.29751,1,1
3,GO FATTY ACID CATABOLIC PROCESS,2.2658e-06,0.33907,0.32114,1,1
3,GO RESPONSE TO PROTOZOAN,5.0226e-05,0.33897,0.28254,1,1
3,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00011241,0.33825,0.28476,1,1
3,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.0011199,0.33817,0.32213,1,1
3,GO PROTEIN N LINKED GLYCOSYLATION,1.7118e-05,0.33767,0.28581,1,1
3,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.0036303,0.33748,0.36276,1,1
3,GO LINOLEIC ACID METABOLIC PROCESS,0.0071468,0.33694,0.32583,1,1
3,GO RESPONSE TO INTERLEUKIN 15,0.007729,0.3369,0.25427,1,1
3,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,3.8583e-05,0.33641,0.32876,1,1
3,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00017186,0.33575,0.32219,1,1
3,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0021062,0.33562,0.30247,1,1
3,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.00049035,0.33561,0.3277,1,1
3,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,3.0576e-06,0.33557,0.25654,1,1
3,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,4.6597e-05,0.3352,0.38231,1,1
3,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00074557,0.33493,0.22242,1,1
3,GO STEROID METABOLIC PROCESS,1.7474e-06,0.33486,0.32335,1,1
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.00069957,0.33458,0.28898,1,1
3,GO FUCOSE METABOLIC PROCESS,0.0064317,0.33445,0.31324,1,1
3,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00092958,0.33413,0.35514,1,1
3,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0060989,0.33377,0.28525,1,1
3,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00021909,0.33364,0.26074,1,1
3,GO VACUOLAR ACIDIFICATION,2.0784e-06,0.33349,0.3871,1,1
3,GO LABYRINTHINE LAYER DEVELOPMENT,0.0051916,0.33335,0.23437,1,1
3,GO TRICARBOXYLIC ACID CYCLE,0.0031536,0.33322,0.2583,1,1
3,GO ETHER METABOLIC PROCESS,0.0041716,0.33312,0.23177,1,1
3,GO REGULATION OF GLUCOSE METABOLIC PROCESS,2.8077e-06,0.33282,0.27089,1,1
3,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00095906,0.33271,0.2543,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00013433,0.33249,0.32051,1,1
3,GO POSITIVE REGULATION OF BONE RESORPTION,7.547e-05,0.33197,0.40244,1,1
3,GO VIRAL GENOME REPLICATION,0.0010206,0.33156,0.21755,1,1
3,GO RESPONSE TO ISCHEMIA,9.0179e-06,0.33069,0.29155,1,1
3,GO NUCLEOSIDE CATABOLIC PROCESS,0.00013433,0.33039,0.27657,1,1
3,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0017641,0.33037,0.19872,1,1
3,GO OLIGOPEPTIDE TRANSPORT,0.001228,0.33028,0.35846,1,1
3,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.00013917,0.3297,0.33099,1,1
3,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,8.1192e-05,0.32923,0.30978,1,1
3,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.00027832,0.32889,0.23306,1,1
3,GO SULFUR AMINO ACID METABOLIC PROCESS,0.0021062,0.32869,0.25553,1,1
3,GO MACROPHAGE PROLIFERATION,0.014138,0.3286,0.27795,1,1
3,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,6.2985e-07,0.32832,0.34393,1,1
3,GO REVERSE CHOLESTEROL TRANSPORT,0.00044439,0.32826,0.47116,1,1
3,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,1.4039e-05,0.32825,0.29094,1,1
3,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.02068,0.32822,0.26483,1,1
3,GO FIBRINOLYSIS,0.034637,0.32814,0.29995,1,1
3,GO CARNITINE METABOLIC PROCESS,0.0013872,0.32807,0.27674,1,1
3,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,6.5149e-05,0.32753,0.39315,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.00035231,0.32748,0.29222,1,1
3,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.010506,0.32695,0.2451,1,1
3,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.001986,0.32674,0.25527,1,1
3,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.104e-05,0.32646,0.35442,1,1
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00035231,0.32615,0.24179,1,1
3,GO CELLULAR RESPONSE TO STEROL DEPLETION,6.7596e-05,0.32611,0.37245,1,1
3,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,6.5149e-05,0.32569,0.23939,1,1
3,GO UBIQUINONE METABOLIC PROCESS,4.1112e-06,0.32536,0.33811,1,1
3,GO PEPTIDYL ASPARAGINE MODIFICATION,0.00020448,0.32525,0.29599,1,1
3,GO IMMUNE EFFECTOR PROCESS,3.3132e-05,0.32513,0.25006,1,1
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00057693,0.32503,0.24106,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.7118e-05,0.32489,0.30221,1,1
3,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.0075304,0.32463,0.28742,1,1
3,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0059384,0.32461,0.24472,1,1
3,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00022676,0.32452,0.22071,1,1
3,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00035231,0.32418,0.24215,1,1
3,GO APICAL JUNCTION ASSEMBLY,9.389e-05,0.32402,0.33779,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.034637,0.32402,0.18215,1,1
3,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.0007696,0.32396,0.2666,1,1
3,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.00042998,0.32393,0.28761,1,1
3,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.00020448,0.32393,0.28053,1,1
3,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,1.7118e-05,0.32365,0.26324,1,1
3,GO RETINOL METABOLIC PROCESS,0.00031859,0.32353,0.3996,1,1
3,GO NEUROTRANSMITTER METABOLIC PROCESS,0.00030804,0.32292,0.32868,1,1
3,GO T HELPER 2 CELL DIFFERENTIATION,0.011904,0.32266,0.20148,1,1
3,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0064317,0.32236,0.19397,1,1
3,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.00019079,0.3217,0.24755,1,1
3,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.018836,0.32158,0.32151,1,1
3,GO MUSCLE ATROPHY,0.031059,0.32131,0.21166,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.5774e-06,0.32106,0.36092,1,1
3,GO BILE ACID METABOLIC PROCESS,3.3132e-05,0.3209,0.35851,1,1
3,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.0010528,0.32077,0.38776,1,1
3,GO EPITHELIAL CELL CELL ADHESION,0.0032441,0.32076,0.40207,1,1
3,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,9.0221e-07,0.32056,0.30214,1,1
3,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00034072,0.3198,0.33666,1,1
3,GO PHOSPHOLIPID CATABOLIC PROCESS,0.00022676,0.31935,0.32059,1,1
3,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.00010092,0.31933,0.28476,1,1
3,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0075304,0.31931,0.20645,1,1
3,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.00029782,0.31881,0.33311,1,1
3,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0033369,0.31828,0.22956,1,1
3,GO RESPONSE TO FATTY ACID,6.7596e-05,0.31799,0.26536,1,1
3,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0021689,0.31797,0.38584,1,1
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00069957,0.31762,0.26397,1,1
3,GO BILE ACID BIOSYNTHETIC PROCESS,0.00038934,0.31613,0.28993,1,1
3,GO ALANINE TRANSPORT,0.00059588,0.31608,0.35297,1,1
3,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.00052342,0.31573,0.29701,1,1
3,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.2524e-05,0.31526,0.27807,1,1
3,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,4.4712e-06,0.31519,0.2963,1,1
3,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0017123,0.31507,0.2547,1,1
3,GO LYTIC VACUOLE ORGANIZATION,2.3975e-07,0.31495,0.33823,1,1
3,GO CD40 SIGNALING PATHWAY,0.00095906,0.31478,0.22807,1,1
3,GO LIPID TRANSLOCATION,9.389e-05,0.31441,0.28184,1,1
3,GO GLYCEROL ETHER METABOLIC PROCESS,0.0069616,0.3141,0.18177,1,1
3,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.00098941,0.31392,0.21434,1,1
3,GO MOVEMENT IN HOST ENVIRONMENT,0.00074557,0.31384,0.22551,1,1
3,GO OUTER DYNEIN ARM ASSEMBLY,0.02843,0.31377,0.17546,1,1
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0011199,0.3136,0.28405,1,1
3,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00059588,0.31334,0.22412,1,1
3,GO INNATE IMMUNE RESPONSE,2.3418e-05,0.31309,0.24861,1,1
3,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,1.0184e-05,0.31301,0.28139,1,1
3,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00044439,0.31299,0.22582,1,1
3,GO REGULATION OF RENAL SYSTEM PROCESS,0.0015189,0.31288,0.24967,1,1
3,GO CYTOKINE MEDIATED SIGNALING PATHWAY,1.6455e-05,0.31267,0.26525,1,1
3,GO ETHANOL METABOLIC PROCESS,0.0042883,0.31266,0.2615,1,1
3,GO STEROL TRANSPORT,2.7343e-05,0.31265,0.28893,1,1
3,GO LEUKOCYTE MEDIATED IMMUNITY,2.1663e-05,0.31236,0.26813,1,1
3,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0021062,0.31213,0.26732,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,5.4121e-05,0.312,0.27775,1,1
3,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.0024367,0.31141,0.28574,1,1
3,GO REGULATION OF B CELL ACTIVATION,5.9841e-06,0.31129,0.27219,1,1
3,GO RESPONSE TO CORTICOSTERONE,0.00059588,0.31126,0.3099,1,1
3,GO ICOSANOID BIOSYNTHETIC PROCESS,2.3418e-05,0.31126,0.33389,1,1
3,GO PROTEIN CONTAINING COMPLEX REMODELING,3.1888e-05,0.31125,0.33656,1,1
3,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.0013054,0.31115,0.39369,1,1
3,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.2962e-05,0.31107,0.28686,1,1
3,GO RESPONSE TO INTERLEUKIN 6,0.00010092,0.3106,0.32998,1,1
3,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.0090226,0.31046,0.24347,1,1
3,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00028792,0.3103,0.22858,1,1
3,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00010462,0.31007,0.24602,1,1
3,GO POSITIVE REGULATION OF FERTILIZATION,0.024288,0.31003,0.21447,1,1
3,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,1.9263e-05,0.30999,0.28703,1,1
3,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0032441,0.30946,0.24214,1,1
3,GO ANTIMICROBIAL HUMORAL RESPONSE,7.9801e-06,0.30944,0.28634,1,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.00012512,0.30927,0.29178,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,7.547e-05,0.3092,0.25753,1,1
3,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00026903,0.30907,0.29606,1,1
3,GO DEFENSE RESPONSE TO OTHER ORGANISM,2.1663e-05,0.30869,0.24018,1,1
3,GO REGULATION OF NEUTROPHIL MIGRATION,3.1904e-06,0.30838,0.3528,1,1
3,GO RESPONSE TO INSECTICIDE,0.00098941,0.30798,0.39513,1,1
3,GO ARACHIDONIC ACID METABOLIC PROCESS,3.4421e-05,0.30788,0.33327,1,1
3,GO ENDOCRINE PROCESS,7.8282e-05,0.30753,0.28018,1,1
3,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.00059588,0.30689,0.29356,1,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00026903,0.3068,0.29917,1,1
3,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0039469,0.30673,0.28821,1,1
3,GO TYPE 2 IMMUNE RESPONSE,0.0013457,0.30662,0.27428,1,1
3,GO BEHAVIORAL RESPONSE TO PAIN,0.0033369,0.30651,0.28464,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00013433,0.30624,0.26539,1,1
3,GO INOSITOL METABOLIC PROCESS,5.9841e-06,0.30602,0.33601,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00067758,0.30588,0.25423,1,1
3,GO AUTOPHAGY OF NUCLEUS,0.0045306,0.30576,0.23439,1,1
3,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.00095906,0.30572,0.2501,1,1
3,GO TRANSCYTOSIS,1.2454e-05,0.30568,0.32445,1,1
3,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,4.0073e-05,0.30556,0.26839,1,1
3,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0011549,0.30552,0.20093,1,1
3,GO LIPID LOCALIZATION,7.5427e-07,0.30492,0.29651,1,1
3,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0028141,0.3049,0.28801,1,1
3,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00098941,0.30474,0.28694,1,1
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.00023468,0.30445,0.29424,1,1
3,GO GLUTATHIONE METABOLIC PROCESS,0.0018173,0.30432,0.31967,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,2.0033e-05,0.30411,0.26306,1,1
3,GO HEXOSE CATABOLIC PROCESS,0.00084609,0.30365,0.26476,1,1
3,GO REGULATION OF ICOSANOID SECRETION,0.00020448,0.30353,0.34044,1,1
3,GO RESPONSE TO VIRUS,0.00012074,0.30349,0.23248,1,1
3,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.00072223,0.30332,0.24481,1,1
3,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00036427,0.30299,0.28097,1,1
3,GO INTERLEUKIN 5 PRODUCTION,0.010506,0.3027,0.23418,1,1
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00040247,0.30251,0.27491,1,1
3,GO MAGNESIUM ION TRANSPORT,0.00049035,0.30229,0.27291,1,1
3,GO B CELL HOMEOSTASIS,0.00021167,0.3019,0.26893,1,1
3,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0020453,0.30162,0.3157,1,1
3,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0047853,0.30161,0.21252,1,1
3,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.00021167,0.30158,0.2949,1,1
3,GO POSITIVE REGULATION OF CELL SIZE,2.8418e-05,0.30155,0.35367,1,1
3,GO CELLULAR SODIUM ION HOMEOSTASIS,0.007729,0.30142,0.27355,1,1
3,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.022165,0.30121,0.21818,1,1
3,GO LYMPHOCYTE MIGRATION,4.6597e-05,0.30101,0.2257,1,1
3,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.025994,0.30092,0.24272,1,1
3,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.6307e-05,0.30069,0.26409,1,1
3,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00050664,0.30045,0.35944,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0012662,0.30041,0.30683,1,1
3,GO RESPONSE TO TUMOR NECROSIS FACTOR,1.104e-05,0.30039,0.27976,1,1
3,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00049035,0.30001,0.28576,1,1
3,GO FATTY ACID TRANSMEMBRANE TRANSPORT,6.5149e-05,0.29981,0.30567,1,1
3,GO SYNCYTIUM FORMATION,0.00044439,0.29948,0.21464,1,1
3,GO KERATAN SULFATE METABOLIC PROCESS,0.00038934,0.29919,0.25589,1,1
3,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.0059384,0.29857,0.31647,1,1
3,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.0020453,0.29855,0.32419,1,1
3,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,9.389e-05,0.29847,0.29432,1,1
3,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,2.0833e-05,0.29846,0.24787,1,1
3,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00028792,0.29835,0.34453,1,1
3,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.017137,0.2982,0.2499,1,1
3,GO RESPONSE TO WATER,0.03939,0.29818,0.23004,1,1
3,GO MYELOID LEUKOCYTE ACTIVATION,2.2524e-05,0.2979,0.25851,1,1
3,GO LOCOMOTOR RHYTHM,0.00021167,0.29788,0.29003,1,1
3,GO FUCOSYLATION,0.00095906,0.29784,0.3012,1,1
3,GO REGULATION OF RESPONSE TO WOUNDING,0.00030804,0.2977,0.23958,1,1
3,GO PHOSPHOLIPID HOMEOSTASIS,0.0042883,0.29748,0.26092,1,1
3,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.004408,0.29703,0.24325,1,1
3,GO MONOSACCHARIDE CATABOLIC PROCESS,0.00072223,0.29701,0.24151,1,1
3,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0021062,0.297,0.22733,1,1
3,GO I KAPPAB KINASE NF KAPPAB SIGNALING,2.7343e-05,0.29683,0.24612,1,1
3,GO INTERLEUKIN 8 PRODUCTION,7.8282e-05,0.29592,0.27797,1,1
3,GO DIGESTIVE SYSTEM PROCESS,0.00016595,0.29564,0.26427,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0073363,0.29557,0.24509,1,1
3,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.017137,0.29511,0.23504,1,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.0090226,0.29504,0.25484,1,1
3,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.0041716,0.29493,0.28922,1,1
3,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.3418e-05,0.29489,0.25695,1,1
3,GO AMYLOID BETA CLEARANCE,0.001228,0.29481,0.21044,1,1
3,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.0046564,0.29472,0.35267,1,1
3,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,5.8301e-05,0.29389,0.28822,1,1
3,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,7.547e-05,0.29358,0.23368,1,1
3,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0054795,0.2935,0.23841,1,1
3,GO REGULATION OF AMYLOID BETA CLEARANCE,0.0034322,0.29313,0.27656,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.00012074,0.29309,0.32061,1,1
3,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,2.9532e-05,0.293,0.27849,1,1
3,GO RESPONSE TO PH,0.00031859,0.29284,0.23498,1,1
3,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,8.1192e-05,0.29265,0.25498,1,1
3,GO GOLGI TO ENDOSOME TRANSPORT,0.00095906,0.29201,0.27275,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,9.389e-05,0.29136,0.2376,1,1
3,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.00010092,0.29121,0.31269,1,1
3,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.014486,0.29116,0.20043,1,1
3,GO AMELOGENESIS,0.0017641,0.29099,0.26274,1,1
3,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.033166,0.29062,0.21518,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00025131,0.29032,0.26454,1,1
3,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.00036427,0.2903,0.24988,1,1
3,GO T CELL CYTOKINE PRODUCTION,0.0081404,0.29029,0.21049,1,1
3,GO DEFENSE RESPONSE,1.104e-05,0.29016,0.23751,1,1
3,GO CYTOKINE METABOLIC PROCESS,8.1192e-05,0.29009,0.23936,1,1
3,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,7.8282e-05,0.29002,0.22739,1,1
3,GO REGULATION OF AMINO ACID TRANSPORT,0.0027346,0.28995,0.25265,1,1
3,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,5.0683e-06,0.28994,0.30535,1,1
3,GO GLYCEROLIPID CATABOLIC PROCESS,0.00018427,0.28991,0.2582,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION,0.00059588,0.28982,0.24107,1,1
3,GO MEMBRANE PROTEIN PROTEOLYSIS,0.00049035,0.28963,0.24132,1,1
3,GO DOPAMINE METABOLIC PROCESS,0.00067758,0.28923,0.30545,1,1
3,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,2.6307e-05,0.28895,0.27477,1,1
3,GO REGULATION OF CELLULAR EXTRAVASATION,0.0090226,0.28893,0.22034,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00079435,0.28885,0.22436,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00042998,0.2881,0.21087,1,1
3,GO MIDGUT DEVELOPMENT,0.020205,0.28808,0.25371,1,1
3,GO CELLULAR RESPONSE TO KETONE,0.00092958,0.28806,0.23294,1,1
3,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0069616,0.28765,0.20346,1,1
3,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00029782,0.2876,0.23837,1,1
3,GO RESPONSE TO GONADOTROPIN,6.2786e-05,0.2876,0.29723,1,1
3,GO REGULATION OF EXOSOMAL SECRETION,0.0011549,0.28735,0.24342,1,1
3,GO REGULATION OF ACTIN NUCLEATION,0.0013457,0.28703,0.2766,1,1
3,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.0010859,0.28657,0.31551,1,1
3,GO TETRAPYRROLE METABOLIC PROCESS,0.0007696,0.28647,0.27487,1,1
3,GO INTERLEUKIN 13 PRODUCTION,0.0057817,0.28639,0.23826,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,3.7145e-05,0.28616,0.29813,1,1
3,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0023671,0.28607,0.27562,1,1
3,GO RESPONSE TO PEPTIDOGLYCAN,0.00069957,0.28575,0.25013,1,1
3,GO NEGATIVE REGULATION OF CELL ACTIVATION,7.2754e-05,0.28572,0.22988,1,1
3,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,7.3528e-06,0.2857,0.31063,1,1
3,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00016595,0.28535,0.29788,1,1
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,6.2786e-05,0.2853,0.26905,1,1
3,GO STEROL HOMEOSTASIS,6.2786e-05,0.28523,0.33113,1,1
3,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0017641,0.28508,0.23302,1,1
3,GO RESPONSE TO GROWTH HORMONE,1.1493e-05,0.28466,0.36344,1,1
3,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0033369,0.28462,0.28642,1,1
3,GO INSEMINATION,0.0062634,0.28433,0.25335,1,1
3,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,1.1493e-05,0.28426,0.31119,1,1
3,GO ANIMAL ORGAN REGENERATION,0.0007696,0.28415,0.20479,1,1
3,GO TYPE I INTERFERON PRODUCTION,0.00012074,0.2841,0.23908,1,1
3,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.0067808,0.28403,0.29269,1,1
3,GO XENOBIOTIC TRANSPORT,1.8521e-05,0.28392,0.37132,1,1
3,GO PURINE NUCLEOTIDE TRANSPORT,5.0226e-05,0.28357,0.24554,1,1
3,GO MUSCLE CELL MIGRATION,0.00072223,0.28357,0.24338,1,1
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00025131,0.28357,0.23776,1,1
3,GO OXALATE TRANSPORT,0.00029782,0.28329,0.2611,1,1
3,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,6.2367e-06,0.28309,0.24995,1,1
3,GO REGULATION OF CELL KILLING,0.00024286,0.28259,0.27304,1,1
3,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.001872,0.28249,0.20898,1,1
3,GO VASCULAR WOUND HEALING,0.001662,0.28243,0.37639,1,1
3,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0025083,0.28174,0.26203,1,1
3,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.00044439,0.28171,0.31812,1,1
3,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00022676,0.28162,0.28644,1,1
3,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,4.0073e-05,0.28159,0.2708,1,1
3,GO ORGANIC HYDROXY COMPOUND TRANSPORT,3.1904e-06,0.28156,0.27281,1,1
3,GO FATTY ACID DERIVATIVE TRANSPORT,0.00040247,0.28153,0.26137,1,1
3,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.00029782,0.28148,0.24985,1,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,9.7346e-05,0.28113,0.27207,1,1
3,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0012662,0.28099,0.19956,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.0045306,0.28049,0.24271,1,1
3,GO PH REDUCTION,1.2454e-05,0.28021,0.25705,1,1
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00013917,0.28009,0.23603,1,1
3,GO NAD BIOSYNTHETIC PROCESS,0.015574,0.27985,0.19797,1,1
3,GO RESPONSE TO CORTICOSTEROID,0.00013917,0.27977,0.23734,1,1
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0017641,0.27977,0.25437,1,1
3,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.0099891,0.27973,0.21164,1,1
3,GO AEROBIC RESPIRATION,0.00081984,0.2788,0.24491,1,1
3,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00016595,0.27874,0.26428,1,1
3,GO ER NUCLEUS SIGNALING PATHWAY,0.00045924,0.27868,0.27695,1,1
3,GO CELL KILLING,2.4346e-05,0.27857,0.25496,1,1
3,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,4.8612e-06,0.27852,0.26215,1,1
3,GO CHEMOKINE PRODUCTION,0.00038934,0.27842,0.22728,1,1
3,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.010245,0.27817,0.23816,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0049174,0.27804,0.17704,1,1
3,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0059384,0.27785,0.29542,1,1
3,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.02166,0.27782,0.15857,1,1
3,GO POSITIVE REGULATION OF LIPID STORAGE,8.4205e-05,0.2774,0.28405,1,1
3,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00017796,0.27666,0.22718,1,1
3,GO PHOSPHOLIPID TRANSPORT,3.1904e-06,0.27628,0.25439,1,1
3,GO AMINE METABOLIC PROCESS,1.0311e-06,0.27622,0.29569,1,1
3,GO REGULATION OF CHLORIDE TRANSPORT,0.00098941,0.27578,0.36126,1,1
3,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.00044439,0.27577,0.24562,1,1
3,GO RESPONSE TO ANGIOTENSIN,0.0038387,0.27571,0.24855,1,1
3,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00025131,0.27567,0.23313,1,1
3,GO REGULATION OF CELLULAR RESPIRATION,0.0023671,0.27538,0.26156,1,1
3,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.011904,0.27505,0.2963,1,1
3,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.017137,0.27495,0.18163,1,1
3,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,3.3132e-05,0.27488,0.28382,1,1
3,GO INTRACELLULAR LIPID TRANSPORT,9.0551e-05,0.27473,0.26129,1,1
3,GO MYELOID LEUKOCYTE MIGRATION,3.3132e-05,0.2746,0.22043,1,1
3,GO REGULATION OF ANION TRANSPORT,2.2524e-05,0.27455,0.27493,1,1
3,GO PHAGOSOME MATURATION,6.4994e-06,0.27445,0.31647,1,1
3,GO POSITIVE REGULATION OF TISSUE REMODELING,0.00044439,0.27343,0.30101,1,1
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00069957,0.27341,0.20612,1,1
3,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,1.1964e-05,0.27301,0.30772,1,1
3,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0059384,0.27288,0.24242,1,1
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.017549,0.2727,0.224,1,1
3,GO GLUCOSE METABOLIC PROCESS,6.5896e-07,0.27248,0.26996,1,1
3,GO HORMONE METABOLIC PROCESS,3.3132e-05,0.2723,0.30013,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0056288,0.27226,0.16924,1,1
3,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.00014935,0.27226,0.21641,1,1
3,GO FLUID TRANSPORT,2.1663e-05,0.27208,0.25374,1,1
3,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,5.0683e-06,0.27174,0.24894,1,1
3,GO MACROMOLECULE DEPALMITOYLATION,8.4205e-05,0.27122,0.27948,1,1
3,GO RESPONSE TO FLUID SHEAR STRESS,0.0083534,0.27116,0.19396,1,1
3,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.016734,0.27114,0.19124,1,1
3,GO REGULATION OF PEPTIDASE ACTIVITY,2.2524e-05,0.27087,0.25014,1,1
3,GO POLYSACCHARIDE METABOLIC PROCESS,9.7801e-06,0.27087,0.24018,1,1
3,GO CELLULAR HORMONE METABOLIC PROCESS,0.0006154,0.27083,0.27397,1,1
3,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.6902e-06,0.27077,0.32579,1,1
3,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.026586,0.27064,0.2349,1,1
3,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.00074557,0.2706,0.24084,1,1
3,GO GLYCOSYLATION,9.3916e-06,0.27038,0.26887,1,1
3,GO DEFENSE RESPONSE TO BACTERIUM,2.8077e-06,0.27007,0.26485,1,1
3,GO SEQUESTERING OF TRIGLYCERIDE,0.0037331,0.27005,0.25933,1,1
3,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.010506,0.26999,0.20405,1,1
3,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.013139,0.26989,0.25395,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00019079,0.26988,0.22848,1,1
3,GO ORGANOPHOSPHATE ESTER TRANSPORT,1.1267e-06,0.26973,0.2609,1,1
3,GO ADAPTIVE IMMUNE RESPONSE,9.0551e-05,0.26963,0.26914,1,1
3,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0001165,0.26953,0.24319,1,1
3,GO SPERM CAPACITATION,0.00030804,0.26948,0.25223,1,1
3,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.0046564,0.26942,0.24991,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0025817,0.26939,0.22308,1,1
3,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0018173,0.26925,0.28039,1,1
3,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0050528,0.26903,0.23974,1,1
3,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0038387,0.26889,0.25111,1,1
3,GO CATECHOLAMINE UPTAKE,0.011904,0.26864,0.26325,1,1
3,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00074557,0.26858,0.20988,1,1
3,GO HEMOGLOBIN METABOLIC PROCESS,0.0083534,0.26843,0.22494,1,1
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00023468,0.26808,0.21917,1,1
3,GO HAIR CELL DIFFERENTIATION,0.0017641,0.26776,0.21154,1,1
3,GO DIOL METABOLIC PROCESS,0.0046564,0.26773,0.2671,1,1
3,GO CORNIFICATION,0.00057693,0.2676,0.26809,1,1
3,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0010859,0.26738,0.21405,1,1
3,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00057693,0.26698,0.25647,1,1
3,GO MUSCLE CELL APOPTOTIC PROCESS,7.547e-05,0.2669,0.21697,1,1
3,GO ALPHA BETA T CELL ACTIVATION,9.389e-05,0.26681,0.2372,1,1
3,GO DOPAMINE TRANSPORT,0.00072223,0.26673,0.35335,1,1
3,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0014738,0.26654,0.2409,1,1
3,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.019283,0.26637,0.27822,1,1
3,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.9263e-05,0.26625,0.25599,1,1
3,GO AMYLOID FIBRIL FORMATION,0.013139,0.26625,0.21108,1,1
3,GO AMINO SUGAR CATABOLIC PROCESS,0.00021167,0.26601,0.32856,1,1
3,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00013433,0.26598,0.23267,1,1
3,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,2.0833e-05,0.26572,0.22512,1,1
3,GO REGULATION OF MUSCLE ADAPTATION,0.00065623,0.26558,0.1913,1,1
3,GO ALCOHOL METABOLIC PROCESS,6.7728e-06,0.26523,0.26126,1,1
3,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.012203,0.26448,0.23345,1,1
3,GO FATTY ACID BETA OXIDATION,7.547e-05,0.26396,0.26773,1,1
3,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0050528,0.26355,0.20318,1,1
3,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.0016129,0.26326,0.27397,1,1
3,GO GRANULOCYTE DIFFERENTIATION,0.036164,0.26308,0.17617,1,1
3,GO CHYLOMICRON ASSEMBLY,0.0042883,0.26283,0.30129,1,1
3,GO INFLAMMATORY RESPONSE,1.1964e-05,0.26276,0.23855,1,1
3,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.00069957,0.26272,0.27801,1,1
3,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.00045924,0.2627,0.30175,1,1
3,GO CELLULAR RESPONSE TO STEROL,0.00084609,0.26248,0.28371,1,1
3,GO CELLULAR RESPONSE TO STARVATION,1.104e-05,0.26244,0.24352,1,1
3,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0012662,0.26238,0.1871,1,1
3,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0041716,0.26224,0.21568,1,1
3,GO RENAL SYSTEM PROCESS,5.4121e-05,0.26221,0.23005,1,1
3,GO CELLULAR METABOLIC COMPOUND SALVAGE,1.7806e-05,0.26219,0.29701,1,1
3,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,1.0604e-05,0.26217,0.21835,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0006154,0.26215,0.2156,1,1
3,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,3.8583e-05,0.26213,0.23136,1,1
3,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,8.6584e-06,0.26213,0.28606,1,1
3,GO RESPONSE TO BACTERIUM,5.6174e-05,0.262,0.21522,1,1
3,GO AMYLOID BETA METABOLIC PROCESS,0.00065623,0.26197,0.23083,1,1
3,GO PEROXISOMAL TRANSPORT,0.00013917,0.26186,0.24808,1,1
3,GO NEGATIVE REGULATION OF PROTEOLYSIS,5.6174e-05,0.26168,0.22163,1,1
3,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,1.1776e-06,0.26155,0.25623,1,1
3,GO RESPONSE TO BIOTIC STIMULUS,5.2139e-05,0.26152,0.20757,1,1
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0053338,0.26149,0.19267,1,1
3,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.013465,0.26113,0.17547,1,1
3,GO ARACHIDONIC ACID SECRETION,0.00026003,0.26088,0.25035,1,1
3,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,1.7806e-05,0.26079,0.22575,1,1
3,GO GRANULOCYTE MIGRATION,3.5759e-05,0.26065,0.22698,1,1
3,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0017123,0.26064,0.23707,1,1
3,GO LEUKOCYTE PROLIFERATION,0.0001547,0.26046,0.21123,1,1
3,GO NEUTRAL AMINO ACID TRANSPORT,0.0053338,0.26044,0.28232,1,1
3,GO LIPID OXIDATION,2.4346e-05,0.26008,0.25698,1,1
3,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.0014738,0.25981,0.23375,1,1
3,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0012662,0.25962,0.20886,1,1
3,GO MONOSACCHARIDE METABOLIC PROCESS,2.9301e-06,0.25951,0.27565,1,1
3,GO MACROPHAGE APOPTOTIC PROCESS,0.013798,0.25951,0.21287,1,1
3,GO LIPOPROTEIN METABOLIC PROCESS,1.7806e-05,0.25893,0.23325,1,1
3,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0037331,0.25892,0.22599,1,1
3,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.0050528,0.25884,0.23888,1,1
3,GO REGULATION OF GLIAL CELL PROLIFERATION,0.00353,0.25878,0.21298,1,1
3,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00098941,0.25864,0.18858,1,1
3,GO FIBROBLAST PROLIFERATION,0.0024367,0.25863,0.19558,1,1
3,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00028792,0.25859,0.18847,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0081404,0.25852,0.16561,1,1
3,GO MYELIN MAINTENANCE,0.0073363,0.25807,0.28486,1,1
3,GO KERATINIZATION,0.00055855,0.25781,0.23244,1,1
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0030654,0.25764,0.19277,1,1
3,GO TRANSFERRIN TRANSPORT,2.4692e-06,0.25715,0.3362,1,1
3,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,3.1888e-05,0.25705,0.22655,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00072223,0.25695,0.20674,1,1
3,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.0031536,0.25661,0.22204,1,1
3,GO NEGATIVE REGULATION OF MAPK CASCADE,0.00052342,0.25647,0.1822,1,1
3,GO RESPONSE TO INTERLEUKIN 4,0.00022676,0.25628,0.19619,1,1
3,GO WATER HOMEOSTASIS,0.00067758,0.25618,0.23171,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00017796,0.25587,0.1864,1,1
3,GO ELECTRON TRANSPORT CHAIN,0.00017796,0.2555,0.2517,1,1
3,GO LIPID STORAGE,0.00026003,0.25546,0.25219,1,1
3,GO REGULATION OF LIPID TRANSPORT,8.7323e-05,0.25542,0.24869,1,1
3,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.023741,0.25532,0.21041,1,1
3,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.00079435,0.25501,0.24197,1,1
3,GO REGULATION OF LIPID STORAGE,0.00047456,0.255,0.21743,1,1
3,GO CELL REDOX HOMEOSTASIS,0.00028792,0.2549,0.28901,1,1
3,GO HUMORAL IMMUNE RESPONSE,1.1493e-05,0.25444,0.24782,1,1
3,GO REGULATION OF LIPID LOCALIZATION,6.2786e-05,0.25353,0.23767,1,1
3,GO RESPONSE TO CYTOKINE,4.6597e-05,0.25328,0.21155,1,1
3,GO POSITIVE REGULATION OF CELL ADHESION,0.00035231,0.25311,0.19934,1,1
3,GO CELLULAR KETONE METABOLIC PROCESS,0.00010462,0.2529,0.24725,1,1
3,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00047456,0.25289,0.2321,1,1
3,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00012964,0.25232,0.19423,1,1
3,GO INTERLEUKIN 1 BETA PRODUCTION,0.0010528,0.2522,0.20383,1,1
3,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,8.4205e-05,0.25211,0.22389,1,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0022992,0.25191,0.26264,1,1
3,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,2.5774e-06,0.25174,0.22961,1,1
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.0079323,0.25172,0.21154,1,1
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,6.0504e-05,0.2517,0.22208,1,1
3,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,5.8301e-05,0.25143,0.2641,1,1
3,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,9.0551e-05,0.25115,0.26571,1,1
3,GO MUSCLE HYPERTROPHY,8.7323e-05,0.25109,0.22613,1,1
3,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0015189,0.25092,0.19461,1,1
3,GO INTERLEUKIN 1 PRODUCTION,0.0013054,0.25062,0.19881,1,1
3,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0033369,0.25041,0.19721,1,1
3,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,2.2524e-05,0.25026,0.217,1,1
3,GO TRIGLYCERIDE METABOLIC PROCESS,0.0017123,0.25023,0.18447,1,1
3,GO LIPOSACCHARIDE METABOLIC PROCESS,0.00013433,0.24984,0.23251,1,1
3,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,1.9263e-05,0.24974,0.33765,1,1
3,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.001191,0.24938,0.19431,1,1
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0049174,0.24925,0.27626,1,1
3,GO EXOCYTOSIS,2.0833e-05,0.24921,0.21029,1,1
3,GO POLYSACCHARIDE CATABOLIC PROCESS,0.0015653,0.2492,0.24739,1,1
3,GO RESPONSE TO PROGESTERONE,0.0006154,0.24905,0.2369,1,1
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,1.349e-05,0.24878,0.21784,1,1
3,GO SMOOTH MUSCLE CELL PROLIFERATION,0.00092958,0.2486,0.19903,1,1
3,GO LEUKOCYTE MIGRATION,0.00010462,0.2485,0.21513,1,1
3,GO CYTOKINE PRODUCTION,5.6174e-05,0.24837,0.22037,1,1
3,GO POSITIVE REGULATION OF HAIR CYCLE,0.047551,0.24837,0.22394,1,1
3,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.012203,0.24813,0.18599,1,1
3,GO ADIPOSE TISSUE DEVELOPMENT,0.0015189,0.24803,0.1959,1,1
3,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.044685,0.24802,0.17873,1,1
3,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.00092958,0.2479,0.32137,1,1
3,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00013433,0.24755,0.24749,1,1
3,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00087311,0.24748,0.19721,1,1
3,GO GLYCOPROTEIN METABOLIC PROCESS,0.00010462,0.24746,0.20097,1,1
3,GO ORGANELLE MEMBRANE FUSION,0.00018427,0.24735,0.21517,1,1
3,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,5.2139e-05,0.24734,0.25371,1,1
3,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00054072,0.24719,0.1916,1,1
3,GO COAGULATION,0.00041602,0.24713,0.18554,1,1
3,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.00081984,0.24707,0.26428,1,1
3,GO CERAMIDE TRANSPORT,0.017549,0.24689,0.31926,1,1
3,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.025414,0.24686,0.14706,1,1
3,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.001662,0.24653,0.20666,1,1
3,GO CELL CELL JUNCTION ASSEMBLY,0.00081984,0.24641,0.21514,1,1
3,GO PROSTAGLANDIN TRANSPORT,0.0032441,0.24628,0.30026,1,1
3,GO MACROPHAGE DIFFERENTIATION,0.0079323,0.24609,0.21074,1,1
3,GO ALPHA BETA T CELL DIFFERENTIATION,0.00021167,0.24605,0.21435,1,1
3,GO P38MAPK CASCADE,0.00055855,0.24604,0.23543,1,1
3,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.030383,0.24586,0.21213,1,1
3,GO THIOESTER BIOSYNTHETIC PROCESS,0.00028792,0.24565,0.23998,1,1
3,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0001165,0.2456,0.22889,1,1
3,GO CELLULAR GLUCAN METABOLIC PROCESS,5.8301e-05,0.24538,0.2187,1,1
3,GO LIPID EXPORT FROM CELL,0.00017186,0.24485,0.3204,1,1
3,GO AMINO ACID IMPORT,0.0090226,0.24465,0.20196,1,1
3,GO B CELL ACTIVATION,2.2524e-05,0.24464,0.21056,1,1
3,GO CARBOHYDRATE HOMEOSTASIS,1.0604e-05,0.24457,0.22175,1,1
3,GO ACYLGLYCEROL HOMEOSTASIS,0.021165,0.24445,0.17972,1,1
3,GO NOREPINEPHRINE SECRETION,0.0034322,0.24411,0.25744,1,1
3,GO PROTEIN ACTIVATION CASCADE,0.015953,0.2439,0.27398,1,1
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.023205,0.24379,0.16922,1,1
3,GO REGULATION OF FATTY ACID TRANSPORT,0.00010845,0.24341,0.35488,1,1
3,GO RESPONSE TO NUTRIENT,0.00057693,0.243,0.18993,1,1
3,GO POSITIVE REGULATION OF HEMOPOIESIS,4.8379e-05,0.24299,0.20764,1,1
3,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00016023,0.24288,0.24386,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0053338,0.24276,0.23895,1,1
3,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.036164,0.24193,0.15183,1,1
3,GO REGULATION OF MYOTUBE DIFFERENTIATION,4.0073e-05,0.24188,0.2573,1,1
3,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00059588,0.24156,0.22092,1,1
3,GO REGULATION OF FATTY ACID OXIDATION,0.001228,0.24154,0.23724,1,1
3,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,1.6455e-05,0.24129,0.23915,1,1
3,GO NOREPINEPHRINE TRANSPORT,0.0013457,0.24087,0.24435,1,1
3,GO CAMP BIOSYNTHETIC PROCESS,0.027803,0.24061,0.2181,1,1
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE,2.7343e-05,0.24042,0.22907,1,1
3,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.00037661,0.24034,0.20973,1,1
3,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,8.1192e-05,0.24032,0.2232,1,1
3,GO LIPID IMPORT INTO CELL,0.0081404,0.24018,0.23324,1,1
3,GO CELL CHEMOTAXIS,4.1617e-05,0.23979,0.21882,1,1
3,GO ERK1 AND ERK2 CASCADE,0.00095906,0.23972,0.18284,1,1
3,GO SECRETION BY TISSUE,0.0038387,0.23962,0.20551,1,1
3,GO REGULATION OF INNATE IMMUNE RESPONSE,3.7145e-05,0.23949,0.22977,1,1
3,GO REGULATION OF BODY FLUID LEVELS,0.00027832,0.2394,0.17988,1,1
3,GO NUCLEOTIDE TRANSPORT,8.1192e-05,0.23923,0.23506,1,1
3,GO STEROL BIOSYNTHETIC PROCESS,0.00065623,0.23895,0.23693,1,1
3,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.00019079,0.23879,0.22774,1,1
3,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.029719,0.23869,0.13003,1,1
3,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.013139,0.23861,0.23276,1,1
3,GO MUSCLE ADAPTATION,0.00044439,0.2386,0.18935,1,1
3,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.0042883,0.23857,0.19559,1,1
3,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,2.6307e-05,0.23839,0.27999,1,1
3,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.0013457,0.23809,0.26852,1,1
3,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,3.4421e-05,0.23788,0.19458,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0060989,0.23787,0.15355,1,1
3,GO RESPONSE TO ACTIVITY,0.00054072,0.23783,0.21741,1,1
3,GO HYALURONAN METABOLIC PROCESS,0.0012662,0.23783,0.16523,1,1
3,GO KERATINOCYTE DIFFERENTIATION,0.00074557,0.23737,0.21112,1,1
3,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,4.6597e-05,0.23722,0.18526,1,1
3,GO CAMP METABOLIC PROCESS,0.0039469,0.23715,0.22806,1,1
3,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.00026903,0.23714,0.28605,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00014935,0.23703,0.24694,1,1
3,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.00050664,0.23682,0.22869,1,1
3,GO ANDROGEN METABOLIC PROCESS,5.2139e-05,0.23656,0.41627,1,1
3,GO REGULATION OF DOPAMINE SECRETION,0.02268,0.23638,0.31833,1,1
3,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.030383,0.23615,0.17471,1,1
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.043763,0.236,0.1758,1,1
3,GO CELLULAR RESPONSE TO DSRNA,0.0067808,0.23578,0.18102,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0010528,0.23572,0.23415,1,1
3,GO NEUTRAL LIPID METABOLIC PROCESS,0.00087311,0.23568,0.19402,1,1
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.027188,0.23554,0.23031,1,1
3,GO ER OVERLOAD RESPONSE,0.0018173,0.23538,0.26943,1,1
3,GO CELL ACTIVATION,7.2754e-05,0.23495,0.19527,1,1
3,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0017641,0.2349,0.27255,1,1
3,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.010773,0.2347,0.24704,1,1
3,GO INTERACTION WITH HOST,0.0014299,0.2347,0.17271,1,1
3,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.0049174,0.23437,0.27423,1,1
3,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.0064317,0.23432,0.21253,1,1
3,GO CELLULAR LIPID CATABOLIC PROCESS,9.7801e-06,0.23406,0.27381,1,1
3,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00079435,0.23404,0.22932,1,1
3,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.00074557,0.23365,0.28179,1,1
3,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.00055855,0.23319,0.17546,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,2.7343e-05,0.23298,0.20971,1,1
3,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.026586,0.23282,0.1661,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,6.2786e-05,0.23272,0.22702,1,1
3,GO RENAL SODIUM EXCRETION,0.00059588,0.23257,0.22487,1,1
3,GO PEROXISOME ORGANIZATION,0.00016023,0.23248,0.23128,1,1
3,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.00054072,0.23238,0.20253,1,1
3,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.012508,0.2321,0.16159,1,1
3,GO LEUKOCYTE APOPTOTIC PROCESS,0.00069957,0.23208,0.20153,1,1
3,GO PARTURITION,0.041093,0.23201,0.18349,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0010206,0.23199,0.294,1,1
3,GO RESPONSE TO HYDROGEN PEROXIDE,0.00014418,0.23199,0.19612,1,1
3,GO REGULATION OF IMMUNE RESPONSE,0.00019753,0.23182,0.17801,1,1
3,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.0099891,0.23178,0.205,1,1
3,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.0028957,0.23145,0.25416,1,1
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.001872,0.23137,0.21144,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.001872,0.23116,0.19626,1,1
3,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,8.1192e-05,0.23114,0.25723,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0015653,0.23113,0.21912,1,1
3,GO PEPTIDE SECRETION,6.2367e-06,0.23109,0.21112,1,1
3,GO SODIUM ION HOMEOSTASIS,0.0010528,0.23089,0.20073,1,1
3,GO REGULATION OF FERTILIZATION,0.001191,0.23082,0.29512,1,1
3,GO LIPID HOMEOSTASIS,7.547e-05,0.23082,0.24669,1,1
3,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0081404,0.23082,0.24671,1,1
3,GO B CELL DIFFERENTIATION,1.1964e-05,0.23078,0.22142,1,1
3,GO REGULATION OF INFLAMMATORY RESPONSE,3.3132e-05,0.23047,0.21221,1,1
3,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00022676,0.23046,0.18257,1,1
3,GO MEMBRANE FUSION,5.2139e-05,0.23036,0.2074,1,1
3,GO NEUTROPHIL MIGRATION,1.349e-05,0.23035,0.21762,1,1
3,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,6.2786e-05,0.23029,0.23109,1,1
3,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.00090094,0.2302,0.21301,1,1
3,GO MONOCARBOXYLIC ACID TRANSPORT,2.8418e-05,0.22999,0.23921,1,1
3,GO REGULATION OF PH,5.0683e-06,0.22996,0.22635,1,1
3,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.00065623,0.22994,0.19836,1,1
3,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.00024286,0.22987,0.22775,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00028792,0.22977,0.20773,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0023671,0.22947,0.27756,1,1
3,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.001872,0.22929,0.29044,1,1
3,GO SUPEROXIDE METABOLIC PROCESS,8.1192e-05,0.22909,0.25112,1,1
3,GO CELL CELL JUNCTION ORGANIZATION,0.001872,0.22878,0.19907,1,1
3,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.010773,0.22868,0.21724,1,1
3,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00026003,0.22861,0.19373,1,1
3,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.00098941,0.22852,0.21964,1,1
3,GO REGULATION OF DEFENSE RESPONSE,4.0073e-05,0.22839,0.20411,1,1
3,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.0010206,0.22835,0.22274,1,1
3,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.036164,0.22814,0.26731,1,1
3,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00026903,0.22786,0.18891,1,1
3,GO TISSUE HOMEOSTASIS,0.00026003,0.22779,0.19228,1,1
3,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0013457,0.2277,0.1854,1,1
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0062634,0.22742,0.16396,1,1
3,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0029794,0.2274,0.17904,1,1
3,GO INTERLEUKIN 4 PRODUCTION,0.0085714,0.22721,0.17873,1,1
3,GO CELLULAR RESPONSE TO ALCOHOL,0.0014299,0.2272,0.17151,1,1
3,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,5.0226e-05,0.22705,0.22806,1,1
3,GO POSITIVE REGULATION OF MITOPHAGY,0.001662,0.22701,0.22023,1,1
3,GO STORE OPERATED CALCIUM ENTRY,0.012508,0.22683,0.20663,1,1
3,GO WOUND HEALING,0.0010528,0.22651,0.17422,1,1
3,GO EPIDERMAL CELL DIFFERENTIATION,0.0006154,0.2264,0.20953,1,1
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.014138,0.22635,0.19639,1,1
3,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.02843,0.22606,0.13728,1,1
3,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00019753,0.22601,0.24144,1,1
3,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.00018427,0.22568,0.21659,1,1
3,GO COMPLEMENT ACTIVATION,0.00353,0.2255,0.22615,1,1
3,GO PLATELET MORPHOGENESIS,0.00074557,0.22533,0.24107,1,1
3,GO POSITIVE REGULATION OF CELL AGING,0.0057817,0.22523,0.22335,1,1
3,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00030804,0.22512,0.16835,1,1
3,GO POSITIVE CHEMOTAXIS,0.0039469,0.22497,0.1611,1,1
3,GO PIGMENTATION,0.00021909,0.22479,0.17586,1,1
3,GO SELECTIVE AUTOPHAGY,0.00011241,0.2246,0.22963,1,1
3,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00027832,0.22459,0.28581,1,1
3,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0014299,0.2243,0.22504,1,1
3,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.0033369,0.22358,0.17401,1,1
3,GO CATECHOLAMINE METABOLIC PROCESS,0.0010528,0.22339,0.27564,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00052342,0.22307,0.18368,1,1
3,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.00069957,0.22282,0.31039,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,2.5308e-05,0.2227,0.23526,1,1
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.00031859,0.22259,0.20834,1,1
3,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.00021167,0.22232,0.28903,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0006154,0.22229,0.15877,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.001228,0.22227,0.15974,1,1
3,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.00021909,0.22226,0.21982,1,1
3,GO REGULATION OF ERBB SIGNALING PATHWAY,0.00090094,0.2222,0.20583,1,1
3,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00084609,0.22212,0.14701,1,1
3,GO VESICLE BUDDING FROM MEMBRANE,0.00072223,0.22206,0.20156,1,1
3,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00042998,0.22198,0.18254,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.026586,0.22191,0.18073,1,1
3,GO PROTEIN PROCESSING,1.0184e-05,0.22164,0.26667,1,1
3,GO REGULATION OF PROTEOLYSIS,7.8282e-05,0.22162,0.18448,1,1
3,GO ENDOTHELIAL CELL MIGRATION,0.00074557,0.22152,0.19673,1,1
3,GO REGULATION OF LIPID METABOLIC PROCESS,0.00019753,0.2214,0.18082,1,1
3,GO ORGANIC ACID CATABOLIC PROCESS,0.00014418,0.22129,0.23113,1,1
3,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00081984,0.22115,0.18788,1,1
3,GO REGULATION OF NUCLEASE ACTIVITY,0.0021689,0.22077,0.18488,1,1
3,GO REGULATION OF EXCRETION,0.0069616,0.22068,0.18352,1,1
3,GO REGULATION OF CELL ADHESION,0.00087311,0.2206,0.16737,1,1
3,GO ORGANELLE FUSION,0.00020448,0.22058,0.18899,1,1
3,GO APOPTOTIC SIGNALING PATHWAY,5.4121e-05,0.22052,0.18367,1,1
3,GO SENSORY PERCEPTION OF SMELL,1.7806e-05,0.22047,0.20898,1,1
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00031859,0.22046,0.20752,1,1
3,GO INTERLEUKIN 6 PRODUCTION,0.00079435,0.22038,0.18782,1,1
3,GO PEPTIDYL PROLINE MODIFICATION,0.012508,0.21997,0.15562,1,1
3,GO REGULATION OF CELLULAR PH,5.2837e-06,0.21993,0.2244,1,1
3,GO REGULATION OF TUBE SIZE,8.4205e-05,0.2199,0.22924,1,1
3,GO REGULATION OF CELL MATRIX ADHESION,0.0024367,0.21975,0.19781,1,1
3,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,4.3218e-05,0.2196,0.19543,1,1
3,GO PLATELET AGGREGATION,0.0054795,0.21954,0.17867,1,1
3,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.0011549,0.21932,0.25383,1,1
3,GO T CELL MIGRATION,0.0016129,0.21892,0.19992,1,1
3,GO REGULATION OF CELL CELL ADHESION,0.00067758,0.21881,0.18472,1,1
3,GO RESPONSE TO STARVATION,2.5308e-05,0.21879,0.23202,1,1
3,GO VITAMIN TRANSPORT,0.0069616,0.21861,0.20984,1,1
3,GO ATP BIOSYNTHETIC PROCESS,0.0069616,0.21852,0.19697,1,1
3,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0079323,0.21841,0.30284,1,1
3,GO FATTY ACID BIOSYNTHETIC PROCESS,0.0001165,0.21835,0.23634,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,5.6174e-05,0.21806,0.1969,1,1
3,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.036164,0.21795,0.13642,1,1
3,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.001191,0.21788,0.18142,1,1
3,GO PROTEIN KINASE B SIGNALING,0.00090094,0.21771,0.16122,1,1
3,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.011326,0.21759,0.17581,1,1
3,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.03939,0.21756,0.17994,1,1
3,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.00018427,0.21722,0.21758,1,1
3,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.0040578,0.21712,0.18364,1,1
3,GO REGULATION OF PROTON TRANSPORT,0.040234,0.21695,0.16697,1,1
3,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.0013054,0.21693,0.1757,1,1
3,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00014418,0.21676,0.2368,1,1
3,GO ENGULFMENT OF APOPTOTIC CELL,0.0028957,0.21673,0.20038,1,1
3,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0015653,0.21655,0.19123,1,1
3,GO LONG CHAIN FATTY ACID TRANSPORT,2.8077e-06,0.21645,0.24743,1,1
3,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00013917,0.21644,0.23408,1,1
3,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00026903,0.2164,0.23119,1,1
3,GO ALCOHOL BIOSYNTHETIC PROCESS,9.0551e-05,0.21635,0.22342,1,1
3,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0015189,0.2163,0.2273,1,1
3,GO CHLORIDE ION HOMEOSTASIS,0.0057817,0.2163,0.19738,1,1
3,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00030804,0.21627,0.19407,1,1
3,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0066042,0.21599,0.21346,1,1
3,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.0045306,0.21592,0.15029,1,1
3,GO REGULATION OF PROSTAGLANDIN SECRETION,0.0033369,0.21587,0.28389,1,1
3,GO REGULATION OF MAST CELL ACTIVATION,0.0013457,0.21576,0.2247,1,1
3,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,3.3132e-05,0.21557,0.19535,1,1
3,GO SKIN DEVELOPMENT,0.0036303,0.2152,0.15091,1,1
3,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0001547,0.21504,0.24416,1,1
3,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.0039469,0.21477,0.27499,1,1
3,GO REGULATION OF CELL ACTIVATION,0.00042998,0.21471,0.16322,1,1
3,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.0087944,0.21469,0.16922,1,1
3,GO LEUKOCYTE CELL CELL ADHESION,0.00042998,0.21461,0.18611,1,1
3,GO SPLEEN DEVELOPMENT,0.0021062,0.21429,0.19538,1,1
3,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00035231,0.21412,0.2519,1,1
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00098941,0.21394,0.23564,1,1
3,GO RESPONSE TO CHEMOKINE,3.5759e-05,0.21361,0.21436,1,1
3,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0094949,0.21343,0.19417,1,1
3,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.014841,0.21307,0.25239,1,1
3,GO CARNITINE SHUTTLE,0.001191,0.21282,0.24811,1,1
3,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.00084609,0.21258,0.18163,1,1
3,GO EPIDERMIS DEVELOPMENT,0.001986,0.2125,0.16364,1,1
3,GO CYTOPLASM ORGANIZATION,0.041093,0.21247,0.1833,1,1
3,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0031536,0.21239,0.19542,1,1
3,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0067808,0.21234,0.16838,1,1
3,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.0033369,0.21211,0.16186,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0021062,0.21187,0.17307,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00095906,0.21183,0.16879,1,1
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00016023,0.2117,0.25001,1,1
3,GO FATTY ACID TRANSPORT,2.1663e-05,0.21164,0.23516,1,1
3,GO POLYAMINE BIOSYNTHETIC PROCESS,0.001986,0.21148,0.25703,1,1
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,1.9263e-05,0.21148,0.19116,1,1
3,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.001191,0.21138,0.17147,1,1
3,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.0049174,0.21135,0.20389,1,1
3,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.014138,0.21131,0.17071,1,1
3,GO ANION HOMEOSTASIS,0.0073363,0.21126,0.18307,1,1
3,GO LYMPHOCYTE ACTIVATION,0.00031859,0.21124,0.15536,1,1
3,GO SULFUR COMPOUND TRANSPORT,0.00012512,0.21092,0.21492,1,1
3,GO GOLGI VESICLE BUDDING,7.8282e-05,0.21087,0.22641,1,1
3,GO HORMONE BIOSYNTHETIC PROCESS,0.0016129,0.21069,0.23697,1,1
3,GO ENERGY HOMEOSTASIS,0.0050528,0.21066,0.20392,1,1
3,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.00090094,0.21049,0.19741,1,1
3,GO REGULATION OF HORMONE SECRETION,6.5149e-05,0.21048,0.19425,1,1
3,GO VIRION ASSEMBLY,0.00065623,0.21033,0.16037,1,1
3,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00012074,0.21027,0.20271,1,1
3,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00032948,0.21027,0.16762,1,1
3,GO RESPONSE TO INSULIN,5.2139e-05,0.21012,0.17832,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.104e-05,0.21008,0.20134,1,1
3,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.031059,0.21004,0.13245,1,1
3,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.00034072,0.20991,0.20465,1,1
3,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00072223,0.20976,0.17649,1,1
3,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,8.7323e-05,0.20973,0.17092,1,1
3,GO RESPONSE TO OSMOTIC STRESS,0.0028957,0.20964,0.18951,1,1
3,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00087311,0.20959,0.24289,1,1
3,GO KERATINOCYTE MIGRATION,0.0025083,0.2094,0.18324,1,1
3,GO DEVELOPMENTAL PIGMENTATION,0.0015189,0.20926,0.16169,1,1
3,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,7.547e-05,0.20893,0.17919,1,1
3,GO GLIAL CELL PROLIFERATION,0.02068,0.20877,0.17284,1,1
3,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.0010859,0.20852,0.25597,1,1
3,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0010206,0.2085,0.13726,1,1
3,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.00035231,0.20848,0.20244,1,1
3,GO NECROTIC CELL DEATH,0.00074557,0.2083,0.23749,1,1
3,GO CARBOHYDRATE METABOLIC PROCESS,1.0184e-05,0.20817,0.2166,1,1
3,GO REGULATION OF PEPTIDE SECRETION,1.0604e-05,0.20813,0.20381,1,1
3,GO CELLULAR RESPONSE TO LITHIUM ION,0.0064317,0.20808,0.22395,1,1
3,GO T CELL ACTIVATION,0.00047456,0.20803,0.17587,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0006154,0.20784,0.17817,1,1
3,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0060989,0.20783,0.16539,1,1
3,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,2.2524e-05,0.20766,0.19313,1,1
3,GO T CELL DIFFERENTIATION,0.00016023,0.20746,0.16276,1,1
3,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,5.0683e-06,0.20669,0.21809,1,1
3,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00092958,0.20666,0.15021,1,1
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.015203,0.20644,0.1577,1,1
3,GO REGULATION OF MACROPHAGE ACTIVATION,0.0081404,0.2064,0.16009,1,1
3,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00037661,0.20638,0.19282,1,1
3,GO VIRAL LIFE CYCLE,0.00065623,0.20636,0.16854,1,1
3,GO SENSORY PERCEPTION OF TASTE,0.00074557,0.20608,0.17041,1,1
3,GO CELLULAR RESPIRATION,0.0021689,0.20602,0.19789,1,1
3,GO RESPONSE TO TESTOSTERONE,0.0085714,0.206,0.16192,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0018173,0.20599,0.15983,1,1
3,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0013457,0.20584,0.19724,1,1
3,GO LYMPHOCYTE COSTIMULATION,0.0026572,0.20557,0.16281,1,1
3,GO DRINKING BEHAVIOR,0.0031536,0.20523,0.29001,1,1
3,GO LYMPHOCYTE HOMEOSTASIS,0.0001547,0.20514,0.20411,1,1
3,GO IRON ION TRANSPORT,6.5149e-05,0.20503,0.23605,1,1
3,GO ENDOCYTIC RECYCLING,0.0010206,0.20491,0.15905,1,1
3,GO PROTON TRANSMEMBRANE TRANSPORT,4.4712e-06,0.20469,0.23605,1,1
3,GO CELL CELL ADHESION,0.0031536,0.20465,0.13379,1,1
3,GO RESPONSE TO KETONE,0.00037661,0.20446,0.18457,1,1
3,GO OXIDATION REDUCTION PROCESS,1.2962e-05,0.20394,0.22776,1,1
3,GO MITOPHAGY,0.0049174,0.20385,0.17614,1,1
3,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.026586,0.20362,0.14337,1,1
3,GO FATTY ACID METABOLIC PROCESS,2.0833e-05,0.20344,0.25112,1,1
3,GO POSITIVE REGULATION OF HORMONE SECRETION,0.00024286,0.20342,0.20655,1,1
3,GO REGULATION OF CARDIAC CONDUCTION,0.0006154,0.20341,0.19324,1,1
3,GO NATURAL KILLER CELL ACTIVATION,0.00041602,0.20326,0.18728,1,1
3,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.012203,0.20324,0.16813,1,1
3,GO ACTIN FILAMENT DEPOLYMERIZATION,0.00041602,0.20321,0.19497,1,1
3,GO PSEUDOPODIUM ORGANIZATION,0.045624,0.2023,0.22066,1,1
3,GO CYTOKINE SECRETION,0.00072223,0.20228,0.19295,1,1
3,GO CARBOHYDRATE TRANSPORT,2.5308e-05,0.20216,0.23935,1,1
3,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00023468,0.20205,0.23365,1,1
3,GO RESPONSE TO INTERLEUKIN 1,0.00028792,0.20183,0.17347,1,1
3,GO DENDRITIC CELL MIGRATION,0.014486,0.20167,0.14167,1,1
3,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.00055855,0.20149,0.23563,1,1
3,GO SECRETION,2.0833e-05,0.20146,0.18295,1,1
3,GO POSITIVE REGULATION OF HEART RATE,0.019739,0.20133,0.22608,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.016734,0.20125,0.13452,1,1
3,GO PLASMA MEMBRANE ORGANIZATION,0.00095906,0.20122,0.18062,1,1
3,GO RESPONSE TO STEROL,0.0023671,0.20111,0.22289,1,1
3,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.041967,0.20103,0.18745,1,1
3,GO MITOCHONDRIAL TRANSCRIPTION,0.03939,0.20099,0.16644,1,1
3,GO INSULIN SECRETION,0.00023468,0.2009,0.19018,1,1
3,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0042883,0.20083,0.16705,1,1
3,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0021062,0.20073,0.14635,1,1
3,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.00074557,0.2007,0.16735,1,1
3,GO REGULATION OF VASCULAR PERMEABILITY,0.00031859,0.20068,0.24986,1,1
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.00010092,0.20062,0.19515,1,1
3,GO LIPID BIOSYNTHETIC PROCESS,3.4421e-05,0.20053,0.20288,1,1
3,GO PLATELET ACTIVATION,0.0020453,0.2003,0.1695,1,1
3,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0027346,0.2001,0.2025,1,1
3,GO GPI ANCHOR METABOLIC PROCESS,0.0032441,0.20009,0.19232,1,1
3,GO REGULATION OF GLUCONEOGENESIS,7.013e-05,0.19986,0.2518,1,1
3,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00035231,0.19979,0.17193,1,1
3,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0032441,0.19948,0.27745,1,1
3,GO BICARBONATE TRANSPORT,0.0039469,0.19943,0.20859,1,1
3,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00018427,0.19911,0.22792,1,1
3,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.0032441,0.19894,0.13905,1,1
3,GO T HELPER CELL LINEAGE COMMITMENT,0.019739,0.19877,0.15021,1,1
3,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.00026003,0.19859,0.15963,1,1
3,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0083534,0.19849,0.15253,1,1
3,GO ACETYL COA METABOLIC PROCESS,0.0027346,0.19848,0.19181,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0040578,0.19835,0.17839,1,1
3,GO ORGANIC ANION TRANSPORT,4.2876e-06,0.1982,0.22242,1,1
3,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.00054072,0.19805,0.21669,1,1
3,GO RESPONSE TO WOUNDING,0.0021062,0.19804,0.15279,1,1
3,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.00027832,0.19782,0.17415,1,1
3,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.00353,0.19778,0.14943,1,1
3,GO POSITIVE REGULATION OF SECRETION,2.1663e-05,0.19774,0.19591,1,1
3,GO REGULATION OF ATP METABOLIC PROCESS,0.0017641,0.19768,0.13484,1,1
3,GO LYMPHOCYTE CHEMOTAXIS,0.019739,0.19763,0.1152,1,1
3,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.001986,0.19761,0.15018,1,1
3,GO CELLULAR RESPONSE TO ALKALOID,0.00010462,0.1973,0.21664,1,1
3,GO REGULATION OF MEIOTIC CELL CYCLE,0.00021167,0.19724,0.1779,1,1
3,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,1.104e-05,0.19715,0.21018,1,1
3,GO PROTEIN MATURATION,2.5308e-05,0.19708,0.21717,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.8521e-05,0.197,0.18767,1,1
3,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00018427,0.19687,0.19344,1,1
3,GO GLUTAMATE METABOLIC PROCESS,0.0011199,0.19685,0.19087,1,1
3,GO RESPONSE TO ALCOHOL,0.00026003,0.19679,0.1568,1,1
3,GO CELLULAR RESPONSE TO VIRUS,0.00069957,0.19652,0.18947,1,1
3,GO LEUKOCYTE DIFFERENTIATION,0.00026903,0.19645,0.15508,1,1
3,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.012203,0.19627,0.1881,1,1
3,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0083534,0.19618,0.17028,1,1
3,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.010245,0.19612,0.27948,1,1
3,GO HORMONE TRANSPORT,5.4121e-05,0.196,0.20402,1,1
3,GO LIPID METABOLIC PROCESS,2.5308e-05,0.196,0.20219,1,1
3,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.0039469,0.19559,0.23419,1,1
3,GO REGULATION OF T CELL MIGRATION,0.01282,0.19553,0.16089,1,1
3,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00030804,0.19549,0.20911,1,1
3,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.0028141,0.19541,0.18788,1,1
3,GO TERPENOID METABOLIC PROCESS,0.0059384,0.19523,0.18144,1,1
3,GO REGULATION OF HEART RATE,0.001662,0.19512,0.20099,1,1
3,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.017137,0.19506,0.13391,1,1
3,GO SMALL MOLECULE CATABOLIC PROCESS,2.1663e-05,0.19491,0.22908,1,1
3,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.0027346,0.1949,0.20026,1,1
3,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.9263e-05,0.19444,0.2469,1,1
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.036948,0.19438,0.15583,1,1
3,GO RECEPTOR BIOSYNTHETIC PROCESS,0.020205,0.19403,0.12878,1,1
3,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,1.4609e-05,0.19385,0.24609,1,1
3,GO ISOPRENOID METABOLIC PROCESS,0.0027346,0.19385,0.20412,1,1
3,GO RESPONSE TO STEROID HORMONE,0.00017186,0.19384,0.1822,1,1
3,GO REGULATION OF BLOOD PRESSURE,3.7145e-05,0.19356,0.20509,1,1
3,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00081984,0.19343,0.14877,1,1
3,GO EPITHELIAL CELL DEVELOPMENT,0.010245,0.19332,0.12877,1,1
3,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.00019079,0.19327,0.19847,1,1
3,GO BROWN FAT CELL DIFFERENTIATION,0.0040578,0.19325,0.19215,1,1
3,GO CYTOLYSIS,0.03245,0.19314,0.17764,1,1
3,GO COPII COATED VESICLE BUDDING,0.00026003,0.19304,0.20842,1,1
3,GO POLYAMINE METABOLIC PROCESS,0.001986,0.19295,0.20825,1,1
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0056288,0.19275,0.1781,1,1
3,GO LYMPHOCYTE DIFFERENTIATION,0.00023468,0.19269,0.14274,1,1
3,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00034072,0.19256,0.18527,1,1
3,GO REGULATION OF MITOPHAGY,0.004408,0.19251,0.17472,1,1
3,GO TISSUE MIGRATION,0.001986,0.19242,0.16475,1,1
3,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.0067808,0.19231,0.16246,1,1
3,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,4.8379e-05,0.1922,0.18249,1,1
3,GO REGULATION OF KERATINOCYTE MIGRATION,0.0022332,0.19201,0.19773,1,1
3,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0010859,0.19188,0.18886,1,1
3,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.038561,0.19179,0.21598,1,1
3,GO INORGANIC ANION TRANSPORT,2.5308e-05,0.19169,0.17581,1,1
3,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.00031859,0.19148,0.18188,1,1
3,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00024286,0.19138,0.15638,1,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00072223,0.19123,0.19594,1,1
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.001872,0.19121,0.1463,1,1
3,GO AGING,2.8418e-05,0.19118,0.17088,1,1
3,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,1.1964e-05,0.19115,0.28098,1,1
3,GO INCLUSION BODY ASSEMBLY,0.019283,0.19105,0.24292,1,1
3,GO LYSOSOME LOCALIZATION,0.00026003,0.19079,0.18065,1,1
3,GO CHLORIDE TRANSPORT,8.4205e-05,0.19046,0.17045,1,1
3,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.013465,0.19046,0.23381,1,1
3,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00052342,0.19043,0.16734,1,1
3,GO REGULATION OF HORMONE LEVELS,4.8612e-06,0.19042,0.23667,1,1
3,GO ANION TRANSMEMBRANE TRANSPORT,8.1192e-05,0.19031,0.17646,1,1
3,GO CELLULAR LIPID METABOLIC PROCESS,2.9532e-05,0.19022,0.20467,1,1
3,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.0021689,0.1902,0.18985,1,1
3,GO ADAPTIVE THERMOGENESIS,4.8379e-05,0.19012,0.19476,1,1
3,GO CELLULAR RESPONSE TO IRON ION,0.036948,0.1901,0.1789,1,1
3,GO RESPONSE TO REACTIVE OXYGEN SPECIES,5.8301e-05,0.18982,0.16723,1,1
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.0014738,0.1898,0.17854,1,1
3,GO MONOAMINE TRANSPORT,0.0028141,0.18947,0.26263,1,1
3,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00014418,0.18946,0.16598,1,1
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.026586,0.18934,0.12298,1,1
3,GO REGULATION OF STEROL TRANSPORT,0.0051916,0.18847,0.16637,1,1
3,GO ACTIVATION OF IMMUNE RESPONSE,0.00049035,0.18831,0.16658,1,1
3,GO REGULATION OF VASOCONSTRICTION,0.00021909,0.18808,0.22375,1,1
3,GO STRIATED MUSCLE ADAPTATION,0.0030654,0.18795,0.20138,1,1
3,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0006154,0.18789,0.19423,1,1
3,GO SEQUESTERING OF CALCIUM ION,0.0014738,0.18775,0.16196,1,1
3,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0010528,0.1877,0.1976,1,1
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,9.7346e-05,0.18757,0.18769,1,1
3,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0023671,0.18754,0.18554,1,1
3,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.029068,0.18728,0.11936,1,1
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.034637,0.18727,0.26122,1,1
3,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.035393,0.18709,0.14174,1,1
3,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.0090226,0.18658,0.15679,1,1
3,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.00063551,0.18653,0.14833,1,1
3,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.0075304,0.18638,0.18556,1,1
3,GO VACUOLE ORGANIZATION,3.6228e-06,0.18629,0.23028,1,1
3,GO POLYOL BIOSYNTHETIC PROCESS,0.00021167,0.18625,0.22602,1,1
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.013798,0.18592,0.16833,1,1
3,GO RIG I SIGNALING PATHWAY,0.010245,0.18579,0.12877,1,1
3,GO NIK NF KAPPAB SIGNALING,0.00098941,0.18571,0.14995,1,1
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0062634,0.18541,0.15571,1,1
3,GO NEGATIVE REGULATION OF OSSIFICATION,0.004408,0.18541,0.17281,1,1
3,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,6.7596e-05,0.18537,0.20458,1,1
3,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.031748,0.18514,0.18241,1,1
3,GO RECEPTOR CATABOLIC PROCESS,0.010245,0.1847,0.12854,1,1
3,GO ESTROGEN BIOSYNTHETIC PROCESS,0.0053338,0.18464,0.27144,1,1
3,GO PHOSPHOLIPID METABOLIC PROCESS,5.4121e-05,0.18452,0.16691,1,1
3,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00049035,0.18424,0.15174,1,1
3,GO GOLGI TO VACUOLE TRANSPORT,0.0081404,0.18415,0.1687,1,1
3,GO MANGANESE ION TRANSPORT,0.0046564,0.18384,0.18788,1,1
3,GO IMMUNOGLOBULIN PRODUCTION,0.00010092,0.18381,0.1715,1,1
3,GO REGULATION OF T CELL ACTIVATION,0.0010528,0.1836,0.16152,1,1
3,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0029794,0.18355,0.11872,1,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0021062,0.18346,0.20292,1,1
3,GO CATECHOLAMINE SECRETION,0.0050528,0.18323,0.28412,1,1
3,GO RESPONSE TO MECHANICAL STIMULUS,6.5149e-05,0.18318,0.20258,1,1
3,GO NEUTROPHIL CHEMOTAXIS,0.0001547,0.18307,0.15142,1,1
3,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.019283,0.183,0.21896,1,1
3,GO RESPONSE TO INORGANIC SUBSTANCE,8.7323e-05,0.18299,0.16183,1,1
3,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0090226,0.18269,0.19862,1,1
3,GO ENDOTHELIAL CELL DEVELOPMENT,0.015953,0.18264,0.14452,1,1
3,GO PEPTIDE HORMONE SECRETION,0.00020448,0.1823,0.18285,1,1
3,GO ANION TRANSPORT,5.7413e-06,0.18226,0.20187,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0013872,0.18223,0.14185,1,1
3,GO REGULATION OF VACUOLE ORGANIZATION,0.0013872,0.18214,0.17827,1,1
3,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.0081404,0.18201,0.18281,1,1
3,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.0027346,0.18174,0.19449,1,1
3,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00010462,0.18139,0.22622,1,1
3,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0079323,0.18135,0.24014,1,1
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.00022676,0.18135,0.18973,1,1
3,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0025817,0.18111,0.13471,1,1
3,GO CELLULAR RESPONSE TO LIPID,0.0017641,0.18068,0.1411,1,1
3,GO CHEMICAL HOMEOSTASIS,3.5759e-05,0.18046,0.16747,1,1
3,GO RESPONSE TO LIPID,0.00045924,0.1803,0.15103,1,1
3,GO REGULATION OF T CELL DIFFERENTIATION,0.0016129,0.17997,0.13546,1,1
3,GO REGULATION OF HEMOPOIESIS,0.00059588,0.17996,0.13504,1,1
3,GO LIPID CATABOLIC PROCESS,9.0179e-06,0.17976,0.23783,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.5308e-05,0.17943,0.18265,1,1
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.011047,0.17941,0.15951,1,1
3,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0062634,0.17939,0.16954,1,1
3,GO POSITIVE REGULATION OF PEPTIDE SECRETION,7.8282e-05,0.17886,0.19589,1,1
3,GO CYTOCHROME COMPLEX ASSEMBLY,0.013465,0.17876,0.19619,1,1
3,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00012074,0.17857,0.14709,1,1
3,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0046564,0.17825,0.15105,1,1
3,GO RESPONSE TO ETHER,0.0027346,0.17797,0.1838,1,1
3,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.00031859,0.17786,0.23231,1,1
3,GO RESPONSE TO OXIDATIVE STRESS,0.00014935,0.1776,0.1646,1,1
3,GO RESPONSE TO METAL ION,0.00011241,0.17748,0.18975,1,1
3,GO ENDOSOME ORGANIZATION,0.00065623,0.17737,0.16772,1,1
3,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,7.547e-05,0.17709,0.18452,1,1
3,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.036948,0.17704,0.20996,1,1
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00044439,0.17703,0.17477,1,1
3,GO T CELL APOPTOTIC PROCESS,0.0071468,0.17702,0.16675,1,1
3,GO CELLULAR PIGMENTATION,0.00055855,0.17671,0.18054,1,1
3,GO CHOLESTEROL STORAGE,0.009256,0.17658,0.2078,1,1
3,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.040234,0.17642,0.14319,1,1
3,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0099891,0.17621,0.10392,1,1
3,GO PROTEIN LOCALIZATION TO ENDOSOME,0.046579,0.17608,0.15531,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.00069957,0.17595,0.16867,1,1
3,GO PHAGOCYTOSIS,0.0038387,0.17591,0.13848,1,1
3,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0020453,0.17546,0.17527,1,1
3,GO MYELOID CELL DIFFERENTIATION,0.00079435,0.17517,0.13433,1,1
3,GO SULFUR COMPOUND METABOLIC PROCESS,0.00072223,0.17483,0.18441,1,1
3,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00030804,0.17477,0.17594,1,1
3,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00042998,0.17456,0.13986,1,1
3,GO LYMPH NODE DEVELOPMENT,0.0057817,0.17442,0.21399,1,1
3,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.016734,0.17435,0.14526,1,1
3,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00031859,0.17433,0.17416,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.019739,0.17379,0.12966,1,1
3,GO MULTI ORGANISM CELLULAR PROCESS,0.02166,0.17377,0.13378,1,1
3,GO METAL ION HOMEOSTASIS,0.00025131,0.17373,0.13614,1,1
3,GO MACROPHAGE ACTIVATION,0.00038934,0.17371,0.18149,1,1
3,GO MULTIVESICULAR BODY ORGANIZATION,0.0041716,0.17288,0.13114,1,1
3,GO BASE EXCISION REPAIR AP SITE FORMATION,0.0075304,0.17275,0.16699,1,1
3,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.00036427,0.17247,0.13869,1,1
3,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.0020453,0.17243,0.13763,1,1
3,GO RESPONSE TO ORGANOPHOSPHORUS,0.00025131,0.17234,0.17754,1,1
3,GO INTERFERON GAMMA PRODUCTION,0.0050528,0.17226,0.134,1,1
3,GO RESPONSE TO DRUG,0.00035231,0.17205,0.16548,1,1
3,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0025083,0.17181,0.18559,1,1
3,GO RETINA HOMEOSTASIS,0.013465,0.17181,0.086948,1,1
3,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.0022332,0.17171,0.13521,1,1
3,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.031748,0.1716,0.14079,1,1
3,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.00016023,0.17135,0.16795,1,1
3,GO AMINE TRANSPORT,0.0038387,0.17131,0.24096,1,1
3,GO REGULATION OF SPROUTING ANGIOGENESIS,0.030383,0.17114,0.11081,1,1
3,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.0032441,0.17048,0.38798,1,1
3,GO EXCRETION,0.0001547,0.17046,0.20138,1,1
3,GO REGULATION OF INSULIN SECRETION,0.00074557,0.17038,0.16543,1,1
3,GO REGULATION OF LIPID CATABOLIC PROCESS,0.00037661,0.17026,0.17157,1,1
3,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.027803,0.17025,0.14403,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,5.0226e-05,0.16996,0.16256,1,1
3,GO REGULATION OF LEUKOCYTE MIGRATION,0.0021062,0.16973,0.14715,1,1
3,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.03939,0.16973,0.099159,1,1
3,GO POSITIVE REGULATION OF PROTEOLYSIS,0.00024286,0.16965,0.16252,1,1
3,GO ACID SECRETION,0.0014299,0.1694,0.17985,1,1
3,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.0039469,0.16937,0.16421,1,1
3,GO ATP TRANSPORT,0.02843,0.16918,0.10754,1,1
3,GO REGULATION OF HISTONE DEACETYLATION,0.0023671,0.16906,0.19515,1,1
3,GO ALPHA AMINO ACID METABOLIC PROCESS,0.0071468,0.16887,0.18624,1,1
3,GO BIOLOGICAL ADHESION,0.0067808,0.16867,0.11451,1,1
3,GO POSITIVE REGULATION OF AUTOPHAGY,0.00038934,0.16856,0.17117,1,1
3,GO CARBOHYDRATE CATABOLIC PROCESS,9.7346e-05,0.16848,0.2025,1,1
3,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,8.1192e-05,0.16835,0.15789,1,1
3,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.015953,0.16794,0.12522,1,1
3,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00013433,0.16777,0.20626,1,1
3,GO LACTATE METABOLIC PROCESS,0.045624,0.16776,0.14454,1,1
3,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.0015653,0.16772,0.16897,1,1
3,GO ORGANOPHOSPHATE CATABOLIC PROCESS,4.8612e-06,0.16763,0.18967,1,1
3,GO RESPONSE TO FUNGUS,0.0019282,0.16747,0.14832,1,1
3,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.00095906,0.16743,0.24454,1,1
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.00010462,0.16741,0.16772,1,1
3,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.00090094,0.16738,0.13119,1,1
3,GO REGULATION OF LYMPHOCYTE MIGRATION,0.02068,0.16725,0.12611,1,1
3,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.038561,0.16715,0.22109,1,1
3,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.010773,0.16712,0.14394,1,1
3,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.010506,0.16696,0.10076,1,1
3,GO MAMMARY GLAND DEVELOPMENT,0.0090226,0.16661,0.12002,1,1
3,GO GLYCEROLIPID METABOLIC PROCESS,0.00010092,0.16649,0.16393,1,1
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.00050664,0.16648,0.18991,1,1
3,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.0097392,0.16644,0.15332,1,1
3,GO PIGMENT GRANULE LOCALIZATION,0.0059384,0.16644,0.15019,1,1
3,GO THIOESTER METABOLIC PROCESS,0.00063551,0.16634,0.19394,1,1
3,GO CHOLESTEROL EFFLUX,0.0028141,0.16632,0.19167,1,1
3,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.047551,0.16604,0.24816,1,1
3,GO EPITHELIUM DEVELOPMENT,0.0019282,0.16552,0.11828,1,1
3,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,1.1964e-05,0.16545,0.20319,1,1
3,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00016595,0.16536,0.1652,1,1
3,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.026586,0.16532,0.18374,1,1
3,GO STEROID CATABOLIC PROCESS,0.012508,0.16512,0.24981,1,1
3,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00029782,0.16495,0.19879,1,1
3,GO DEFENSE RESPONSE TO FUNGUS,0.0056288,0.16494,0.14202,1,1
3,GO REGULATION OF SECRETION,9.0551e-05,0.16459,0.1602,1,1
3,GO ORGANELLE DISASSEMBLY,0.00010462,0.16438,0.17945,1,1
3,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.015574,0.16417,0.17187,1,1
3,GO LEUKOCYTE HOMEOSTASIS,0.0026572,0.16413,0.15172,1,1
3,GO WATER TRANSPORT,0.013139,0.16407,0.11373,1,1
3,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0034322,0.16396,0.12592,1,1
3,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.011904,0.16394,0.1181,1,1
3,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.0040578,0.16384,0.17014,1,1
3,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.0045306,0.16375,0.14748,1,1
3,GO PROTEIN DESTABILIZATION,0.0011199,0.16367,0.16062,1,1
3,GO ION HOMEOSTASIS,0.00017796,0.16366,0.14559,1,1
3,GO REGULATION OF MULTI ORGANISM PROCESS,0.019739,0.16357,0.14745,1,1
3,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0062634,0.16351,0.16176,1,1
3,GO NEGATIVE REGULATION OF AUTOPHAGY,0.0046564,0.16348,0.13159,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0022332,0.16345,0.15361,1,1
3,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.035393,0.16279,0.1338,1,1
3,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,5.9841e-06,0.16247,0.2071,1,1
3,GO PYRUVATE METABOLIC PROCESS,0.0046564,0.16229,0.14184,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00072223,0.16209,0.15199,1,1
3,GO T CELL LINEAGE COMMITMENT,0.0010206,0.16204,0.17716,1,1
3,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0012662,0.16199,0.2271,1,1
3,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00025131,0.16187,0.15586,1,1
3,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0036303,0.16186,0.16002,1,1
3,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.042857,0.16183,0.14461,1,1
3,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.011326,0.16142,0.12162,1,1
3,GO POSITIVE REGULATION OF EXOCYTOSIS,0.0010206,0.16121,0.18426,1,1
3,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.00023468,0.16029,0.14325,1,1
3,GO RESPONSE TO EXTRACELLULAR STIMULUS,2.8418e-05,0.16014,0.18809,1,1
3,GO CIRCULATORY SYSTEM PROCESS,0.00032948,0.16,0.14649,1,1
3,GO AUTOPHAGY OF MITOCHONDRION,0.00013433,0.15993,0.19513,1,1
3,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.0046564,0.15983,0.11873,1,1
3,GO RESPONSE TO CALCIUM ION,0.001662,0.15979,0.17514,1,1
3,GO REGULATION OF CELL MATURATION,0.0039469,0.15932,0.16825,1,1
3,GO TEMPERATURE HOMEOSTASIS,0.00026903,0.15927,0.1673,1,1
3,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.0010528,0.15866,0.12412,1,1
3,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0067808,0.15851,0.12759,1,1
3,GO PROTEOLYSIS,5.4121e-05,0.1585,0.15015,1,1
3,GO GLIAL CELL ACTIVATION,0.011904,0.15848,0.14785,1,1
3,GO RUFFLE ORGANIZATION,0.0094949,0.15833,0.16379,1,1
3,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00067758,0.15832,0.17883,1,1
3,GO MACROPHAGE CHEMOTAXIS,0.016339,0.15804,0.12408,1,1
3,GO OXIDATIVE PHOSPHORYLATION,0.0039469,0.15776,0.1863,1,1
3,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.00353,0.15726,0.2007,1,1
3,GO DETECTION OF STIMULUS,3.5759e-05,0.15724,0.13761,1,1
3,GO ION TRANSPORT,0.00010845,0.1572,0.15668,1,1
3,GO AMEBOIDAL TYPE CELL MIGRATION,0.017549,0.15718,0.10354,1,1
3,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00037661,0.15701,0.13644,1,1
3,GO IRON ION TRANSMEMBRANE TRANSPORT,0.025414,0.15668,0.18561,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.0013457,0.15648,0.13052,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.010245,0.15638,0.136,1,1
3,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.016734,0.15637,0.12804,1,1
3,GO RESPONSE TO CARBOHYDRATE,0.00035231,0.1563,0.15023,1,1
3,GO ENDOCRINE HORMONE SECRETION,0.0017123,0.15629,0.19133,1,1
3,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.00020448,0.15615,0.21278,1,1
3,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.033166,0.15615,0.16422,1,1
3,GO CELLULAR ION HOMEOSTASIS,0.00047456,0.15583,0.12991,1,1
3,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.0099891,0.15484,0.10537,1,1
3,GO CARDIAC CELL DEVELOPMENT,0.0064317,0.15449,0.14368,1,1
3,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.00044439,0.15447,0.13774,1,1
3,GO REGULATION OF MAP KINASE ACTIVITY,0.00041602,0.15443,0.16692,1,1
3,GO RESPONSE TO ACID CHEMICAL,0.0021062,0.15407,0.13864,1,1
3,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,8.7323e-05,0.15383,0.15992,1,1
3,GO RESPONSE TO HORMONE,9.389e-05,0.15364,0.16063,1,1
3,GO ENDOCYTOSIS,0.044685,0.15355,0.080213,1,1
3,GO REGULATION OF MITOCHONDRION ORGANIZATION,1.9263e-05,0.15312,0.15816,1,1
3,GO REGULATION OF RESPONSE TO STRESS,0.00041602,0.153,0.13059,1,1
3,GO RESPONSE TO DSRNA,0.0028957,0.15297,0.14707,1,1
3,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0014738,0.15259,0.13363,1,1
3,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.00021167,0.15259,0.17889,1,1
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.02268,0.15212,0.128,1,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00020448,0.15195,0.18083,1,1
3,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0034322,0.15193,0.17,1,1
3,GO ORGANIC ACID METABOLIC PROCESS,0.00018427,0.15184,0.18742,1,1
3,GO VIRAL RNA GENOME REPLICATION,0.038561,0.15184,0.086875,1,1
3,GO VIRAL BUDDING,0.0017641,0.15177,0.1549,1,1
3,GO T CELL RECEPTOR SIGNALING PATHWAY,0.0030654,0.15172,0.13034,1,1
3,GO IMMUNE SYSTEM DEVELOPMENT,0.00084609,0.15151,0.1157,1,1
3,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.019739,0.15149,0.15354,1,1
3,GO MITOCHONDRIAL FISSION,0.0033369,0.15141,0.19675,1,1
3,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00032948,0.15118,0.13761,1,1
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00098941,0.1511,0.14256,1,1
3,GO GOLGI ORGANIZATION,6.5149e-05,0.15093,0.17775,1,1
3,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0021689,0.15086,0.23729,1,1
3,GO ACTIN NUCLEATION,0.010506,0.15073,0.14425,1,1
3,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0010206,0.15064,0.23011,1,1
3,GO HOMEOSTATIC PROCESS,3.8583e-05,0.1506,0.13934,1,1
3,GO ALCOHOL CATABOLIC PROCESS,0.00040247,0.15052,0.19772,1,1
3,GO SYMBIOTIC PROCESS,0.0045306,0.15024,0.10482,1,1
3,GO PEPTIDE CATABOLIC PROCESS,0.0064317,0.14996,0.21672,1,1
3,GO DE NOVO PROTEIN FOLDING,0.0047853,0.14905,0.16517,1,1
3,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0014299,0.14868,0.14023,1,1
3,GO AUTOPHAGOSOME ORGANIZATION,0.00050664,0.14844,0.1846,1,1
3,GO CELLULAR GLUCOSE HOMEOSTASIS,0.00029782,0.14837,0.1681,1,1
3,GO ORGANIC CATION TRANSPORT,0.009256,0.14803,0.19612,1,1
3,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0011549,0.14802,0.17537,1,1
3,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.026586,0.14777,0.10286,1,1
3,GO CELLULAR RESPONSE TO PEPTIDE,0.00055855,0.1475,0.1249,1,1
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.00098941,0.14746,0.14874,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,9.0551e-05,0.1474,0.14773,1,1
3,GO RESPONSE TO MONOSACCHARIDE,0.00034072,0.14737,0.15381,1,1
3,GO ERBB SIGNALING PATHWAY,0.016734,0.14728,0.13408,1,1
3,GO REGULATION OF KIDNEY DEVELOPMENT,0.015203,0.14676,0.13798,1,1
3,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.001228,0.14636,0.16868,1,1
3,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.00027832,0.14632,0.15395,1,1
3,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.001872,0.146,0.13804,1,1
3,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00092958,0.14599,0.12506,1,1
3,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00037661,0.14582,0.12915,1,1
3,GO OOCYTE DIFFERENTIATION,0.0057817,0.14568,0.12435,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.03245,0.1455,0.077319,1,1
3,GO ENERGY RESERVE METABOLIC PROCESS,0.001662,0.14499,0.16726,1,1
3,GO ACTIVATION OF MAPK ACTIVITY,8.1192e-05,0.14485,0.17572,1,1
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.015953,0.14447,0.13577,1,1
3,GO REGULATION OF MAPK CASCADE,0.00095906,0.14446,0.14403,1,1
3,GO REGULATION OF PEPTIDE TRANSPORT,4.4878e-05,0.14383,0.14316,1,1
3,GO CALCIUM ION IMPORT,0.027188,0.1436,0.08806,1,1
3,GO ORGANIC ACID TRANSPORT,1.7806e-05,0.14295,0.21754,1,1
3,GO METAL ION TRANSPORT,0.0032441,0.1428,0.11561,1,1
3,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.013139,0.14253,0.19265,1,1
3,GO MYELOID CELL HOMEOSTASIS,0.0041716,0.1424,0.12463,1,1
3,GO ENDOSOME TO LYSOSOME TRANSPORT,0.00074557,0.14191,0.17351,1,1
3,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00037661,0.14174,0.16411,1,1
3,GO L AMINO ACID TRANSPORT,0.043763,0.14171,0.14766,1,1
3,GO CATION TRANSPORT,0.0010206,0.14165,0.13005,1,1
3,GO RESPONSE TO MISFOLDED PROTEIN,0.0073363,0.14161,0.17521,1,1
3,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.045624,0.14159,0.15794,1,1
3,GO CELL MATURATION,0.00031859,0.14156,0.13955,1,1
3,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00025131,0.14143,0.15004,1,1
3,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00013917,0.14126,0.19505,1,1
3,GO REGULATION OF CHOLESTEROL EFFLUX,0.024846,0.1411,0.11177,1,1
3,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00050664,0.14093,0.14245,1,1
3,GO EXPORT ACROSS PLASMA MEMBRANE,0.0050528,0.14087,0.23093,1,1
3,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.011326,0.14066,0.10093,1,1
3,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.015574,0.14061,0.10469,1,1
3,GO RESPONSE TO ETHANOL,0.004408,0.14034,0.12436,1,1
3,GO IRON ION HOMEOSTASIS,0.014841,0.14023,0.1502,1,1
3,GO PROTEIN FOLDING,0.010245,0.14015,0.12903,1,1
3,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00010845,0.14002,0.14011,1,1
3,GO RESPONSE TO PEPTIDE HORMONE,0.00017796,0.13992,0.13991,1,1
3,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.00095906,0.13972,0.13768,1,1
3,GO REGULATION OF PROTEIN BINDING,0.0015189,0.13966,0.13723,1,1
3,GO OVARIAN FOLLICLE DEVELOPMENT,0.0079323,0.13966,0.14782,1,1
3,GO ION TRANSMEMBRANE TRANSPORT,0.00045924,0.1396,0.13493,1,1
3,GO CALCIUM ION REGULATED EXOCYTOSIS,0.013139,0.13917,0.23001,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.025994,0.13913,0.10143,1,1
3,GO RESPONSE TO TEMPERATURE STIMULUS,0.00031859,0.13911,0.144,1,1
3,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.015953,0.13906,0.14229,1,1
3,GO IMPORT ACROSS PLASMA MEMBRANE,0.0069616,0.13905,0.15731,1,1
3,GO TRANSMEMBRANE TRANSPORT,9.7346e-05,0.13897,0.15161,1,1
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.012508,0.13896,0.083426,1,1
3,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.0013872,0.13896,0.10778,1,1
3,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0025083,0.13896,0.12599,1,1
3,GO VITAMIN METABOLIC PROCESS,0.016339,0.1389,0.17036,1,1
3,GO METANEPHRIC NEPHRON DEVELOPMENT,0.018398,0.13879,0.1523,1,1
3,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0083534,0.13866,0.15587,1,1
3,GO CELL MOTILITY,0.0067808,0.13849,0.10115,1,1
3,GO ESTROGEN METABOLIC PROCESS,0.024846,0.13839,0.15452,1,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.023741,0.13823,0.14518,1,1
3,GO PROSTAGLANDIN SECRETION,0.02068,0.13818,0.21051,1,1
3,GO POSITIVE REGULATION OF MAPK CASCADE,0.00044439,0.138,0.15384,1,1
3,GO REGENERATION,0.042857,0.13796,0.079295,1,1
3,GO IRON SULFUR CLUSTER ASSEMBLY,0.020205,0.13794,0.18651,1,1
3,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.00021909,0.13776,0.13387,1,1
3,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0011549,0.13766,0.1485,1,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.025994,0.13742,0.11357,1,1
3,GO MAINTENANCE OF LOCATION,0.0017641,0.13737,0.12469,1,1
3,GO RESPONSE TO NITROGEN COMPOUND,0.00030804,0.13736,0.11902,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00074557,0.13703,0.13405,1,1
3,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0033369,0.13679,0.10624,1,1
3,GO MEMBRANE ORGANIZATION,0.001986,0.13672,0.10831,1,1
3,GO SULFUR COMPOUND CATABOLIC PROCESS,0.045624,0.13671,0.12091,1,1
3,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.036948,0.13669,0.15346,1,1
3,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.014138,0.13669,0.10327,1,1
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.011612,0.1365,0.11114,1,1
3,GO REGULATION OF PROTEIN DEACETYLATION,0.0097392,0.13596,0.14432,1,1
3,GO REGULATION OF REPRODUCTIVE PROCESS,0.0037331,0.13579,0.11032,1,1
3,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0030654,0.13574,0.11759,1,1
3,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0085714,0.13476,0.10531,1,1
3,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0013457,0.13475,0.14378,1,1
3,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.0020453,0.13467,0.17488,1,1
3,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.00045924,0.13464,0.13861,1,1
3,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.041093,0.13438,0.1456,1,1
3,GO RESPONSE TO ESTRADIOL,0.0094949,0.13419,0.1016,1,1
3,GO REGULATION OF HYDROLASE ACTIVITY,0.0025083,0.1336,0.10795,1,1
3,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.00017186,0.13356,0.12058,1,1
3,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00026903,0.13347,0.16791,1,1
3,GO GOLGI RIBBON FORMATION,0.038561,0.13309,0.14623,1,1
3,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.00067758,0.13307,0.13768,1,1
3,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0010528,0.13305,0.11564,1,1
3,GO INTERMEDIATE FILAMENT BASED PROCESS,0.035393,0.13279,0.13255,1,1
3,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0054795,0.13245,0.11892,1,1
3,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00087311,0.13243,0.14595,1,1
3,GO REGULATION OF GLUCOSE IMPORT,0.016734,0.13243,0.13399,1,1
3,GO T CELL SELECTION,0.0037331,0.13242,0.1237,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.046579,0.13241,0.14001,1,1
3,GO APOPTOTIC CELL CLEARANCE,0.036948,0.1323,0.096204,1,1
3,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.009256,0.13229,0.14325,1,1
3,GO REGULATION OF CELL DEATH,0.00081984,0.13223,0.11313,1,1
3,GO FEEDING BEHAVIOR,0.00353,0.13201,0.14579,1,1
3,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0011549,0.13191,0.14057,1,1
3,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.010245,0.13149,0.13396,1,1
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0054795,0.13144,0.24752,1,1
3,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.0017123,0.13138,0.13585,1,1
3,GO COENZYME A BIOSYNTHETIC PROCESS,0.013465,0.13097,0.17227,1,1
3,GO RESPONSE TO OXYGEN LEVELS,0.0014299,0.1309,0.13965,1,1
3,GO MITOCHONDRIAL TRANSPORT,0.0021689,0.13084,0.10266,1,1
3,GO MUSCLE CELL PROLIFERATION,0.014486,0.13072,0.099487,1,1
3,GO POSITIVE REGULATION OF T CELL MIGRATION,0.033166,0.13032,0.10693,1,1
3,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0022992,0.13026,0.11273,1,1
3,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.019739,0.1302,0.096602,1,1
3,GO REGULATION OF PROTEIN STABILITY,0.00022676,0.12998,0.13126,1,1
3,GO PROTEIN AUTOUBIQUITINATION,0.0013457,0.12989,0.11636,1,1
3,GO INTERMEMBRANE LIPID TRANSFER,0.010506,0.12943,0.14332,1,1
3,GO T CELL HOMEOSTASIS,0.033166,0.12911,0.12164,1,1
3,GO ERYTHROCYTE HOMEOSTASIS,0.0011549,0.12893,0.1398,1,1
3,GO TRANSITION METAL ION TRANSPORT,0.00016023,0.12873,0.20969,1,1
3,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0079323,0.12811,0.10664,1,1
3,GO APOPTOTIC PROCESS,0.00063551,0.12757,0.11538,1,1
3,GO PIGMENT METABOLIC PROCESS,0.015953,0.1275,0.16857,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION,0.00079435,0.12745,0.10418,1,1
3,GO SECOND MESSENGER MEDIATED SIGNALING,0.001191,0.1273,0.11837,1,1
3,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.0041716,0.12726,0.11484,1,1
3,GO CATION TRANSMEMBRANE TRANSPORT,0.0031536,0.12704,0.11691,1,1
3,GO POSITIVE REGULATION OF CELL DEATH,0.0045306,0.12691,0.10325,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00019753,0.12687,0.12616,1,1
3,GO GLUCOSE IMPORT,0.015574,0.12674,0.14241,1,1
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.015574,0.12661,0.091353,1,1
3,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0013054,0.12643,0.10869,1,1
3,GO POTASSIUM ION HOMEOSTASIS,0.031748,0.12598,0.13742,1,1
3,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.0030654,0.1259,0.12764,1,1
3,GO REGULATION OF MACROPHAGE MIGRATION,0.015953,0.12552,0.13508,1,1
3,GO RESPONSE TO PEPTIDE,0.00049035,0.12547,0.12189,1,1
3,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0015653,0.12491,0.12205,1,1
3,GO RESPONSE TO ALKALOID,0.02268,0.12484,0.099488,1,1
3,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.014841,0.12481,0.17109,1,1
3,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0067808,0.12464,0.10278,1,1
3,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.0030654,0.12443,0.13023,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.013465,0.12426,0.13163,1,1
3,GO CALCIUM MEDIATED SIGNALING,0.0007696,0.12426,0.10579,1,1
3,GO RESPONSE TO CAMP,0.0051916,0.12426,0.16414,1,1
3,GO MAINTENANCE OF LOCATION IN CELL,0.001662,0.12413,0.12323,1,1
3,GO CRISTAE FORMATION,0.037747,0.124,0.14198,1,1
3,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0054795,0.12358,0.11137,1,1
3,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0050528,0.12331,0.13914,1,1
3,GO RESPONSE TO ENDOGENOUS STIMULUS,0.00050664,0.12297,0.11625,1,1
3,GO POSITIVE REGULATION OF SIGNALING,0.00034072,0.1229,0.11882,1,1
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.011904,0.1227,0.10255,1,1
3,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00026903,0.12221,0.12797,1,1
3,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.00029782,0.12181,0.12784,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.041967,0.12179,0.12855,1,1
3,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.0047853,0.12142,0.15432,1,1
3,GO REGULATION OF VASCULATURE DEVELOPMENT,0.0037331,0.12071,0.14043,1,1
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0010206,0.12069,0.11079,1,1
3,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.035393,0.12013,0.10853,1,1
3,GO SINGLE FERTILIZATION,0.016734,0.12011,0.086543,1,1
3,GO PEPTIDYL TYROSINE MODIFICATION,0.0066042,0.11954,0.12515,1,1
3,GO NEGATIVE REGULATION OF CELL DEATH,0.001872,0.11936,0.11171,1,1
3,GO ATP METABOLIC PROCESS,0.0010206,0.11909,0.14845,1,1
3,GO EXOCYTIC PROCESS,0.0049174,0.11885,0.18523,1,1
3,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0029794,0.11876,0.10602,1,1
3,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0039469,0.11847,0.12749,1,1
3,GO ACTIVATION OF GTPASE ACTIVITY,0.025994,0.11835,0.071045,1,1
3,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.013798,0.11764,0.09719,1,1
3,GO KILLING OF CELLS OF OTHER ORGANISM,0.00067758,0.11755,0.1735,1,1
3,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.015574,0.11754,0.075905,1,1
3,GO POSITIVE REGULATION OF TRANSPORT,0.0016129,0.11733,0.10911,1,1
3,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0018173,0.1171,0.11354,1,1
3,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0057817,0.11693,0.098962,1,1
3,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0018173,0.1169,0.10701,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.0062634,0.11678,0.096386,1,1
3,GO CELLULAR HOMEOSTASIS,0.00044439,0.11641,0.12605,1,1
3,GO CELL CELL RECOGNITION,0.033894,0.11621,0.12261,1,1
3,GO RESPONSE TO ABIOTIC STIMULUS,0.00084609,0.1162,0.10632,1,1
3,GO POSITIVE REGULATION OF CELL GROWTH,0.031748,0.11598,0.076566,1,1
3,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.041967,0.11528,0.11281,1,1
3,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.023741,0.11503,0.093759,1,1
3,GO POLYOL METABOLIC PROCESS,0.0081404,0.11444,0.11935,1,1
3,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.00012512,0.11425,0.15386,1,1
3,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.02268,0.11405,0.085538,1,1
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.0049174,0.11389,0.11733,1,1
3,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0024367,0.11363,0.11439,1,1
3,GO NUCLEOTIDE PHOSPHORYLATION,0.026586,0.11357,0.1078,1,1
3,GO INTRA S DNA DAMAGE CHECKPOINT,0.010773,0.1133,0.11074,1,1
3,GO NEGATIVE REGULATION OF SECRETION,0.013139,0.11286,0.093521,1,1
3,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.0083534,0.11276,0.11401,1,1
3,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.022165,0.11249,0.10725,1,1
3,GO DNA CATABOLIC PROCESS,0.0011549,0.11206,0.11775,1,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.029719,0.11187,0.15578,1,1
3,GO REGULATION OF ENDOCYTOSIS,0.047551,0.11185,0.076576,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.012508,0.11155,0.11848,1,1
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.021165,0.1111,0.079663,1,1
3,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.036948,0.11047,0.095369,1,1
3,GO PROTEIN CATABOLIC PROCESS,0.00095906,0.11031,0.1017,1,1
3,GO SULFATE TRANSPORT,0.041967,0.10961,0.098514,1,1
3,GO CELLULAR EXTRAVASATION,0.035393,0.10945,0.095393,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.024288,0.10933,0.10348,1,1
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.013798,0.10877,0.097109,1,1
3,GO PROTEIN STABILIZATION,0.0042883,0.10866,0.10474,1,1
3,GO MEGAKARYOCYTE DIFFERENTIATION,0.010245,0.10742,0.092244,1,1
3,GO FATTY ACYL COA METABOLIC PROCESS,0.038561,0.10735,0.16869,1,1
3,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.038561,0.10686,0.07668,1,1
3,GO MITOTIC CELL CYCLE ARREST,0.019283,0.10681,0.2095,1,1
3,GO ENDOSOMAL TRANSPORT,0.00063551,0.10628,0.10097,1,1
3,GO BODY FLUID SECRETION,0.033894,0.10578,0.088495,1,1
3,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.0053338,0.10565,0.12128,1,1
3,GO REGULATION OF AUTOPHAGY,0.00063551,0.10482,0.12275,1,1
3,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0042883,0.10473,0.10603,1,1
3,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.00092958,0.10374,0.12619,1,1
3,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.016339,0.10369,0.13457,1,1
3,GO TOR SIGNALING,0.0021689,0.10335,0.079563,1,1
3,GO MITOCHONDRION ORGANIZATION,0.0013054,0.10297,0.11795,1,1
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.012508,0.10295,0.079663,1,1
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.0099891,0.10174,0.076872,1,1
3,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.047551,0.10167,0.085428,1,1
3,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.012203,0.10081,0.13462,1,1
3,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0073363,0.1008,0.10078,1,1
3,GO SPERM EGG RECOGNITION,0.017549,0.10027,0.11391,1,1
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.036948,0.099053,0.10912,1,1
3,GO POLYOL CATABOLIC PROCESS,0.025994,0.098919,0.12829,1,1
3,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.0030654,0.098172,0.10898,1,1
3,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.00019753,0.097897,0.13378,1,1
3,GO SENSORY PERCEPTION,0.0097392,0.097559,0.077317,1,1
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.010506,0.097559,0.083434,1,1
3,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.011326,0.097204,0.10387,1,1
3,GO REGULATION OF PHOSPHORYLATION,0.001662,0.096503,0.1056,1,1
3,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.0038387,0.096089,0.092123,1,1
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.023205,0.095849,0.068794,1,1
3,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.033894,0.0955,0.069219,1,1
3,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.02268,0.094033,0.11424,1,1
3,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0066042,0.093762,0.086178,1,1
3,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0064317,0.093305,0.10357,1,1
3,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.004408,0.09329,0.091001,1,1
3,GO CYTOSOLIC TRANSPORT,0.0022992,0.093116,0.1106,1,1
3,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.045624,0.092832,0.07248,1,1
3,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.02843,0.091519,0.12818,1,1
3,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0056288,0.091238,0.091747,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.042857,0.089532,0.066687,1,1
3,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.00079435,0.088711,0.10063,1,1
3,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.041093,0.088208,0.086236,1,1
3,GO PROTEIN K63 LINKED UBIQUITINATION,0.0075304,0.088158,0.10702,1,1
3,GO CELLULAR AMIDE METABOLIC PROCESS,0.036164,0.087774,0.091734,1,1
3,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.0049174,0.087366,0.087844,1,1
3,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.011904,0.086289,0.083812,1,1
3,GO CELLULAR COMPONENT DISASSEMBLY,0.018398,0.08526,0.080843,1,1
3,GO MACROMOLECULE CATABOLIC PROCESS,0.014138,0.085064,0.066766,1,1
3,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.023741,0.084707,0.1072,1,1
3,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0060989,0.08436,0.1096,1,1
3,GO NEGATIVE REGULATION OF TRANSPORT,0.015953,0.081303,0.088573,1,1
3,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.041967,0.080741,0.079288,1,1
3,GO MULTI ORGANISM PROCESS,0.036948,0.080565,0.054671,1,1
3,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.031748,0.079115,0.096146,1,1
3,GO MACROMOLECULE DEACYLATION,0.042857,0.077897,0.055569,1,1
3,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0039469,0.077731,0.092103,1,1
3,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0030654,0.077458,0.089511,1,1
3,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.044685,0.077405,0.055436,1,1
3,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.017549,0.075011,0.08168,1,1
3,GO NEGATIVE REGULATION OF SIGNALING,0.035393,0.072754,0.069531,1,1
3,GO REGULATION OF CATABOLIC PROCESS,0.0071468,0.072058,0.078354,1,1
3,GO AMINO ACID TRANSPORT,0.025994,0.071734,0.14242,1,1
3,GO REGULATION OF TRANSFERASE ACTIVITY,0.009256,0.071681,0.081989,1,1
3,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0073363,0.070556,0.086879,1,1
3,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.0087944,0.069805,0.093798,1,1
3,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.0081404,0.069789,0.090124,1,1
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.035393,0.069646,0.071608,1,1
3,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.034637,0.069564,0.050357,1,1
3,GO REGULATION OF CALCIUM ION TRANSPORT,0.019283,0.068846,0.10657,1,1
3,GO VESICLE LOCALIZATION,0.019739,0.06884,0.095849,1,1
3,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.021165,0.056497,0.071559,1,1
3,GO INTRACELLULAR PROTEIN TRANSPORT,0.022165,0.054812,0.054694,1,1
3,GO INTRACELLULAR TRANSPORT,0.0053338,0.054562,0.070655,1,1
3,GO MACROAUTOPHAGY,0.0020453,0.05403,0.11991,1,1
3,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.046579,0.053363,0.13732,1,1
3,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.010245,0.046732,0.068925,1,1
3,GO CELLULAR MACROMOLECULE LOCALIZATION,0.031059,0.046347,0.05028,1,1
3,GO REGULATION OF MACROAUTOPHAGY,0.026586,0.030058,0.091305,1,1
4,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.2876e-06,0.93086,0.8835,1,1
4,GO FOREBRAIN NEURON FATE COMMITMENT,0.00010092,0.67655,0.86206,1,1
4,GO CARDIOBLAST PROLIFERATION,0.00013433,0.67562,0.69151,1,1
4,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,1.4039e-05,0.61808,0.63723,1,1
4,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.00024286,0.60299,0.55258,1,1
4,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,4.3218e-05,0.58596,0.60783,1,1
4,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.00031859,0.56255,0.57167,1,1
4,GO ATRIAL SEPTUM MORPHOGENESIS,0.00012074,0.55205,0.50705,1,1
4,GO CARDIAC CELL FATE COMMITMENT,0.00012964,0.53353,0.56691,1,1
4,GO SOMATIC STEM CELL DIVISION,0.0036303,0.51072,0.40392,1,1
4,GO NEURON FATE COMMITMENT,2.2658e-06,0.50808,0.52615,1,1
4,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,9.0551e-05,0.49839,0.43105,1,1
4,GO ECTODERMAL PLACODE DEVELOPMENT,4.6597e-05,0.49751,0.5871,1,1
4,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0042883,0.49113,0.45631,1,1
4,GO NEURON FATE SPECIFICATION,5.8301e-05,0.48688,0.56503,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,3.8583e-05,0.47708,0.43939,1,1
4,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.00020448,0.47526,0.38478,1,1
4,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,4.4878e-05,0.4627,0.47456,1,1
4,GO GANGLION DEVELOPMENT,0.00042998,0.44535,0.5137,1,1
4,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.0007696,0.44523,0.44036,1,1
4,GO RETINAL ROD CELL DIFFERENTIATION,0.00054072,0.44056,0.39595,1,1
4,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00037661,0.43729,0.42475,1,1
4,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0033369,0.4281,0.40121,1,1
4,GO MYOBLAST MIGRATION,0.00021167,0.42339,0.47432,1,1
4,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,2.3418e-05,0.42322,0.50676,1,1
4,GO LATERAL MESODERM DEVELOPMENT,0.004408,0.41936,0.30387,1,1
4,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.0090226,0.41606,0.40783,1,1
4,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.00087311,0.41326,0.42362,1,1
4,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,1.6455e-05,0.40686,0.37512,1,1
4,GO ATRIAL SEPTUM DEVELOPMENT,0.00353,0.38066,0.32462,1,1
4,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00031859,0.37921,0.40648,1,1
4,GO NEURAL CREST FORMATION,0.0033369,0.37264,0.28512,1,1
4,GO FORELIMB MORPHOGENESIS,0.00029782,0.37048,0.34467,1,1
4,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00084609,0.37003,0.47362,1,1
4,GO THALAMUS DEVELOPMENT,0.00022676,0.36958,0.36151,1,1
4,GO FAT CELL PROLIFERATION,0.0015189,0.36809,0.31388,1,1
4,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.0038387,0.36552,0.31963,1,1
4,GO DENDRITE SELF AVOIDANCE,2.0033e-05,0.36494,0.35579,1,1
4,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0033369,0.36309,0.30385,1,1
4,GO CELL DIFFERENTIATION IN SPINAL CORD,1.5331e-06,0.36288,0.35041,1,1
4,GO CARDIOBLAST DIFFERENTIATION,0.00035231,0.36054,0.37474,1,1
4,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.0011199,0.36032,0.43034,1,1
4,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,4.4878e-05,0.35976,0.39388,1,1
4,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,6.5149e-05,0.35604,0.36344,1,1
4,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,5.6174e-05,0.35264,0.40219,1,1
4,GO ESTROUS CYCLE,0.0019282,0.35244,0.26626,1,1
4,GO LEFT RIGHT AXIS SPECIFICATION,0.023205,0.3454,0.21169,1,1
4,GO MALE SEX DETERMINATION,0.0027346,0.34154,0.28373,1,1
4,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.01282,0.33772,0.23924,1,1
4,GO V D J RECOMBINATION,0.00095906,0.33616,0.27179,1,1
4,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,1.1493e-05,0.33048,0.30375,1,1
4,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0023671,0.32784,0.32581,1,1
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0054795,0.32436,0.24608,1,1
4,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.045624,0.31796,0.23819,1,1
4,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.007729,0.31437,0.28216,1,1
4,GO POSITIVE REGULATION OF BEHAVIOR,0.001986,0.3132,0.30363,1,1
4,GO DECIDUALIZATION,0.01282,0.31062,0.20901,1,1
4,GO SPINAL CORD PATTERNING,0.00029782,0.30655,0.40139,1,1
4,GO HINDLIMB MORPHOGENESIS,0.020205,0.30184,0.22565,1,1
4,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0054795,0.2945,0.29943,1,1
4,GO TONGUE DEVELOPMENT,0.0025083,0.29444,0.29462,1,1
4,GO VENTRAL SPINAL CORD DEVELOPMENT,0.00028792,0.28554,0.27171,1,1
4,GO PROSTATE GLAND MORPHOGENESIS,0.035393,0.28171,0.3457,1,1
4,GO CARTILAGE MORPHOGENESIS,0.009256,0.28121,0.37864,1,1
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00019079,0.27983,0.25416,1,1
4,GO CELL FATE SPECIFICATION,5.0226e-05,0.27723,0.31206,1,1
4,GO HISTONE H3 K9 METHYLATION,8.3127e-06,0.27692,0.24013,1,1
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.014841,0.27569,0.23487,1,1
4,GO TONGUE MORPHOGENESIS,0.0053338,0.27528,0.38094,1,1
4,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0011199,0.2705,0.28035,1,1
4,GO PITUITARY GLAND DEVELOPMENT,0.012203,0.26896,0.25074,1,1
4,GO POST ANAL TAIL MORPHOGENESIS,0.00047456,0.26859,0.22976,1,1
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0094949,0.26806,0.20152,1,1
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0057817,0.267,0.26827,1,1
4,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,2.6307e-05,0.26418,0.33212,1,1
4,GO SINGLE STRAND BREAK REPAIR,0.0017123,0.26162,0.1716,1,1
4,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.0011199,0.25922,0.27752,1,1
4,GO APICAL PROTEIN LOCALIZATION,6.2786e-05,0.25853,0.31685,1,1
4,GO CELLULAR RESPONSE TO VITAMIN D,0.013139,0.25823,0.2819,1,1
4,GO CELLULAR RESPONSE TO X RAY,0.0024367,0.25811,0.18244,1,1
4,GO FOREBRAIN REGIONALIZATION,0.0026572,0.25369,0.24714,1,1
4,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.021165,0.25281,0.21951,1,1
4,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.025994,0.24932,0.24028,1,1
4,GO CARDIAC ATRIUM MORPHOGENESIS,0.0029794,0.24885,0.23261,1,1
4,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0014299,0.24875,0.23027,1,1
4,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.001228,0.24734,0.29506,1,1
4,GO DIENCEPHALON DEVELOPMENT,0.012508,0.2464,0.20631,1,1
4,GO HEMATOPOIETIC STEM CELL PROLIFERATION,1.2962e-05,0.24304,0.28999,1,1
4,GO POSITIVE REGULATION OF BONE RESORPTION,0.010245,0.2429,0.18964,1,1
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0014738,0.24226,0.22882,1,1
4,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.00021909,0.2415,0.25417,1,1
4,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.042857,0.23955,0.21306,1,1
4,GO HISTONE H3 K9 MODIFICATION,3.3132e-05,0.23942,0.20841,1,1
4,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.0047853,0.23603,0.26519,1,1
4,GO TRACHEA DEVELOPMENT,0.033166,0.2347,0.21599,1,1
4,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.004408,0.23408,0.19835,1,1
4,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.0017641,0.23294,0.25965,1,1
4,GO REGULATION OF SISTER CHROMATID COHESION,0.00012074,0.23154,0.22616,1,1
4,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.018398,0.23008,0.21036,1,1
4,GO REGULATION OF STEM CELL PROLIFERATION,0.00079435,0.22787,0.21304,1,1
4,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.0042883,0.22584,0.21313,1,1
4,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00019079,0.22556,0.19652,1,1
4,GO MATERNAL PLACENTA DEVELOPMENT,0.0032441,0.2245,0.22467,1,1
4,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.00016595,0.22391,0.2019,1,1
4,GO CHONDROCYTE DEVELOPMENT,0.025414,0.22329,0.19859,1,1
4,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.03939,0.22285,0.18658,1,1
4,GO RESPONSE TO VITAMIN D,0.029068,0.22156,0.237,1,1
4,GO LIMB BUD FORMATION,0.013465,0.22058,0.37467,1,1
4,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.007729,0.21962,0.25567,1,1
4,GO AXIS ELONGATION,0.046579,0.21812,0.24709,1,1
4,GO NEURAL TUBE PATTERNING,0.0014738,0.21553,0.22945,1,1
4,GO PARTURITION,0.035393,0.21489,0.17559,1,1
4,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.004408,0.21443,0.20105,1,1
4,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.012203,0.21335,0.19955,1,1
4,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.0066042,0.21177,0.23357,1,1
4,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0097392,0.21093,0.21905,1,1
4,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.0042883,0.21043,0.19571,1,1
4,GO SPERMATID NUCLEUS DIFFERENTIATION,0.00052342,0.20876,0.20343,1,1
4,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.03245,0.20874,0.19575,1,1
4,GO GAMMA DELTA T CELL ACTIVATION,0.03939,0.20862,0.21212,1,1
4,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0010528,0.20848,0.19473,1,1
4,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.0014299,0.20678,0.21793,1,1
4,GO HISTONE H3 K9 TRIMETHYLATION,0.00023468,0.20671,0.21365,1,1
4,GO KINETOCHORE ORGANIZATION,0.00087311,0.20638,0.22633,1,1
4,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.017549,0.20592,0.21653,1,1
4,GO REPLACEMENT OSSIFICATION,0.036164,0.20566,0.20219,1,1
4,GO VIRAL LATENCY,0.009256,0.20533,0.16637,1,1
4,GO DORSAL VENTRAL PATTERN FORMATION,0.00019753,0.20511,0.22383,1,1
4,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.014841,0.20437,0.16204,1,1
4,GO HISTONE H4 K5 ACETYLATION,5.0226e-05,0.20353,0.23906,1,1
4,GO ESCRT COMPLEX DISASSEMBLY,0.011612,0.20064,0.16271,1,1
4,GO HISTONE H4 K16 ACETYLATION,3.8583e-05,0.1995,0.22283,1,1
4,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.010506,0.19827,0.20179,1,1
4,GO MRNA SPLICE SITE SELECTION,0.0021689,0.19808,0.19724,1,1
4,GO NATURAL KILLER CELL DIFFERENTIATION,0.0026572,0.19805,0.1815,1,1
4,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.0017641,0.1977,0.18484,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.015574,0.19703,0.16133,1,1
4,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.026586,0.19578,0.21611,1,1
4,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.046579,0.19547,0.20421,1,1
4,GO MIDDLE EAR MORPHOGENESIS,0.012203,0.19524,0.27511,1,1
4,GO NEGATIVE REGULATION OF DNA RECOMBINATION,9.7346e-05,0.1952,0.18472,1,1
4,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.004408,0.19432,0.15947,1,1
4,GO CELLULAR RESPONSE TO LITHIUM ION,0.0083534,0.19414,0.20655,1,1
4,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.036948,0.19402,0.20862,1,1
4,GO NEGATIVE REGULATION OF DNA BINDING,0.0053338,0.19386,0.1579,1,1
4,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.025414,0.19354,0.21411,1,1
4,GO KINETOCHORE ASSEMBLY,0.0047853,0.19216,0.17593,1,1
4,GO SPINAL CORD DEVELOPMENT,0.0001165,0.19208,0.24725,1,1
4,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0060989,0.19198,0.15261,1,1
4,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.0085714,0.19133,0.21226,1,1
4,GO EMBRYONIC DIGIT MORPHOGENESIS,0.030383,0.19131,0.1544,1,1
4,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.0025817,0.19058,0.21634,1,1
4,GO REGULATION OF NEURON PROJECTION REGENERATION,0.018836,0.18839,0.18102,1,1
4,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.00081984,0.18524,0.21843,1,1
4,GO MITOTIC DNA REPLICATION,0.024288,0.18516,0.13541,1,1
4,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0024367,0.18393,0.16737,1,1
4,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.0011549,0.18337,0.20355,1,1
4,GO MITOTIC SISTER CHROMATID COHESION,0.0013054,0.17986,0.19976,1,1
4,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.0056288,0.17879,0.1646,1,1
4,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.010506,0.17734,0.23565,1,1
4,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.045624,0.17702,0.1162,1,1
4,GO CARDIAC ATRIUM DEVELOPMENT,0.02268,0.17479,0.18009,1,1
4,GO HISTONE H3 K27 METHYLATION,0.021165,0.17192,0.12949,1,1
4,GO DNA DOUBLE STRAND BREAK PROCESSING,0.015953,0.16941,0.11857,1,1
4,GO DIGESTIVE TRACT MORPHOGENESIS,0.0059384,0.16913,0.20038,1,1
4,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0030654,0.16779,0.17737,1,1
4,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00038934,0.16766,0.16892,1,1
4,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.015203,0.16459,0.15113,1,1
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.011047,0.16395,0.15112,1,1
4,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0045306,0.16293,0.21063,1,1
4,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.034637,0.16108,0.11716,1,1
4,GO PROTEIN LOCALIZATION TO CHROMATIN,0.0015189,0.16092,0.13622,1,1
4,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.0047853,0.16048,0.16069,1,1
4,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.014841,0.16005,0.15245,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0020453,0.15926,0.17788,1,1
4,GO CELL CELL JUNCTION MAINTENANCE,0.041967,0.15884,0.21158,1,1
4,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0028141,0.15837,0.16366,1,1
4,GO APPENDAGE MORPHOGENESIS,0.0034322,0.15795,0.21193,1,1
4,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.041967,0.15733,0.1208,1,1
4,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.025414,0.15479,0.1803,1,1
4,GO CENTROSOME DUPLICATION,0.00026003,0.15447,0.15554,1,1
4,GO SULFATION,0.047551,0.15407,0.11531,1,1
4,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.018398,0.1532,0.23916,1,1
4,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.024846,0.15065,0.11967,1,1
4,GO REGULATION OF CENTRIOLE REPLICATION,0.013139,0.14985,0.11175,1,1
4,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.026586,0.14965,0.18065,1,1
4,GO POSITIVE REGULATION OF DNA REPAIR,6.0504e-05,0.14878,0.15086,1,1
4,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.0022992,0.14773,0.17542,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0015653,0.14595,0.16459,1,1
4,GO REGULATION OF CELL FATE SPECIFICATION,0.019283,0.14514,0.30884,1,1
4,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0013872,0.14438,0.12402,1,1
4,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.035393,0.14309,0.14656,1,1
4,GO ROOF OF MOUTH DEVELOPMENT,0.0069616,0.14262,0.1626,1,1
4,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.021165,0.14219,0.12956,1,1
4,GO THYMUS DEVELOPMENT,0.037747,0.13923,0.11839,1,1
4,GO MAINTENANCE OF CELL NUMBER,0.036948,0.13819,0.12181,1,1
4,GO SMOOTHENED SIGNALING PATHWAY,0.0081404,0.13743,0.12913,1,1
4,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.00044439,0.13635,0.13496,1,1
4,GO PEPTIDYL LYSINE TRIMETHYLATION,0.00092958,0.13627,0.12227,1,1
4,GO ATP DEPENDENT CHROMATIN REMODELING,0.00035231,0.13522,0.15823,1,1
4,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.0062634,0.13491,0.14165,1,1
4,GO MESENCHYMAL CELL PROLIFERATION,0.019739,0.13375,0.21325,1,1
4,GO HETEROCHROMATIN ORGANIZATION,0.00031859,0.13346,0.11801,1,1
4,GO REGULATION OF HELICASE ACTIVITY,0.041093,0.13343,0.14231,1,1
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.0015653,0.13298,0.15049,1,1
4,GO MITOTIC CHROMOSOME CONDENSATION,0.00092958,0.13284,0.16972,1,1
4,GO HISTONE H3 K4 TRIMETHYLATION,0.0042883,0.12959,0.12569,1,1
4,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.00063551,0.12935,0.15497,1,1
4,GO POST EMBRYONIC DEVELOPMENT,0.010773,0.12836,0.12687,1,1
4,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.019739,0.12682,0.17048,1,1
4,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.00057693,0.12664,0.11728,1,1
4,GO ECTODERM DEVELOPMENT,0.017137,0.12648,0.13209,1,1
4,GO STEM CELL PROLIFERATION,0.0023671,0.12568,0.16896,1,1
4,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.011612,0.12536,0.13448,1,1
4,GO CENTRIOLE ASSEMBLY,0.011612,0.12422,0.10311,1,1
4,GO CENTROMERE COMPLEX ASSEMBLY,0.00084609,0.12197,0.18325,1,1
4,GO REGULATION OF MYELINATION,0.034637,0.12184,0.11022,1,1
4,GO POSITIVE T CELL SELECTION,0.017137,0.12077,0.10177,1,1
4,GO REGULATION OF CENTROSOME DUPLICATION,0.0079323,0.11901,0.11226,1,1
4,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.00028792,0.11867,0.11445,1,1
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.034637,0.11762,0.082675,1,1
4,GO REGULATION OF HISTONE METHYLATION,0.00074557,0.11693,0.11785,1,1
4,GO CHROMOSOME LOCALIZATION,0.0039469,0.11532,0.10187,1,1
4,GO RDNA HETEROCHROMATIN ASSEMBLY,0.019739,0.11514,0.12903,1,1
4,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0025083,0.11362,0.11258,1,1
4,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.047551,0.11314,0.098042,1,1
4,GO HISTONE UBIQUITINATION,0.0062634,0.11293,0.084748,1,1
4,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.0079323,0.11085,0.14038,1,1
4,GO NEURAL PRECURSOR CELL PROLIFERATION,0.0051916,0.11067,0.1362,1,1
4,GO PEPTIDYL LYSINE METHYLATION,0.00026003,0.11058,0.10938,1,1
4,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.02166,0.11054,0.10452,1,1
4,GO REGULATION OF DNA REPAIR,0.001986,0.10976,0.096699,1,1
4,GO REGULATION OF CENTROSOME CYCLE,0.00098941,0.10899,0.12143,1,1
4,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.046579,0.1085,0.21906,1,1
4,GO HISTONE MONOUBIQUITINATION,0.0071468,0.10836,0.097072,1,1
4,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.029719,0.10706,0.10318,1,1
4,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.017137,0.10658,0.1016,1,1
4,GO NUCLEOSOME ORGANIZATION,0.00035231,0.10629,0.11424,1,1
4,GO ERYTHROCYTE DEVELOPMENT,0.0085714,0.10563,0.10299,1,1
4,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.027803,0.10474,0.098675,1,1
4,GO HISTONE H3 K4 METHYLATION,0.0013457,0.10317,0.13533,1,1
4,GO SOMITE DEVELOPMENT,0.0039469,0.10295,0.15161,1,1
4,GO CENTROSOME SEPARATION,0.030383,0.10267,0.13325,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.012508,0.10261,0.16571,1,1
4,GO NUCLEOSOME ASSEMBLY,0.0024367,0.10233,0.13221,1,1
4,GO MITOTIC METAPHASE PLATE CONGRESSION,0.02166,0.1014,0.095906,1,1
4,GO T CELL SELECTION,0.015203,0.099531,0.09478,1,1
4,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.00023468,0.098024,0.11137,1,1
4,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.0028141,0.096341,0.12218,1,1
4,GO CELL FATE COMMITMENT,0.0041716,0.095836,0.14757,1,1
4,GO DNA INTEGRITY CHECKPOINT,0.0062634,0.095388,0.066991,1,1
4,GO HISTONE H4 ACETYLATION,0.0021062,0.095012,0.10052,1,1
4,GO PEPTIDYL LYSINE ACETYLATION,8.7323e-05,0.094134,0.10888,1,1
4,GO CHROMATIN REMODELING,0.00024286,0.093236,0.11745,1,1
4,GO CHROMATIN REMODELING AT CENTROMERE,0.0085714,0.092893,0.16228,1,1
4,GO POSITIVE THYMIC T CELL SELECTION,0.027188,0.092651,0.12372,1,1
4,GO HISTONE H3 K9 DEMETHYLATION,0.025994,0.091848,0.16121,1,1
4,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.0075304,0.091545,0.15046,1,1
4,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.025994,0.09152,0.079043,1,1
4,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.0014738,0.089212,0.119,1,1
4,GO MITOTIC CELL CYCLE CHECKPOINT,0.0057817,0.088526,0.071584,1,1
4,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.031059,0.08763,0.1107,1,1
4,GO CELL CYCLE CHECKPOINT,0.0023671,0.087136,0.075364,1,1
4,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.0057817,0.08581,0.097999,1,1
4,GO CELL CYCLE DNA REPLICATION,0.03245,0.085602,0.076866,1,1
4,GO REGULATION OF DNA BINDING,0.014841,0.084919,0.097291,1,1
4,GO DNA PACKAGING,0.0011549,0.084302,0.095798,1,1
4,GO CHROMATIN ORGANIZATION,0.00027832,0.082632,0.079317,1,1
4,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.015953,0.08251,0.059072,1,1
4,GO RECOMBINATIONAL REPAIR,0.01282,0.081921,0.069341,1,1
4,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.026586,0.081684,0.10779,1,1
4,GO METAPHASE PLATE CONGRESSION,0.0079323,0.081581,0.09766,1,1
4,GO CHROMATIN SILENCING,0.027188,0.08146,0.082165,1,1
4,GO HISTONE METHYLATION,0.001986,0.079774,0.079316,1,1
4,GO SISTER CHROMATID SEGREGATION,0.0042883,0.07908,0.087216,1,1
4,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0099891,0.077811,0.081789,1,1
4,GO CHROMOSOME SEGREGATION,0.011612,0.076511,0.065156,1,1
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.024288,0.076418,0.081445,1,1
4,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.01282,0.076243,0.11627,1,1
4,GO DNA CONFORMATION CHANGE,0.0062634,0.076173,0.072796,1,1
4,GO REPLICATION FORK PROCESSING,0.038561,0.075776,0.081698,1,1
4,GO PEPTIDYL LYSINE MODIFICATION,0.0030654,0.075762,0.061023,1,1
4,GO MITOTIC SISTER CHROMATID SEGREGATION,0.015574,0.07508,0.083613,1,1
4,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0054795,0.071996,0.064286,1,1
4,GO HISTONE EXCHANGE,0.014486,0.071902,0.11151,1,1
4,GO PROTEIN ACETYLATION,0.0059384,0.07048,0.074004,1,1
4,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.017137,0.069767,0.068226,1,1
4,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.013465,0.065599,0.084132,1,1
4,GO PROTEIN METHYLATION,0.0060989,0.06345,0.064215,1,1
4,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.0024367,0.06314,0.069257,1,1
4,GO HISTONE H3 ACETYLATION,0.047551,0.062328,0.063063,1,1
4,GO COVALENT CHROMATIN MODIFICATION,0.0030654,0.061231,0.067113,1,1
4,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.02166,0.059927,0.074199,1,1
4,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.014486,0.059197,0.087596,1,1
4,GO NUCLEAR CHROMOSOME SEGREGATION,0.022165,0.058686,0.056323,1,1
4,GO CHROMOSOME ORGANIZATION,0.0064317,0.051776,0.049927,1,1
4,GO REGULATION OF RNA SPLICING,0.015203,0.049972,0.066448,1,1
4,GO REGULATION OF CHROMOSOME SEGREGATION,0.038561,0.043834,0.075848,1,1
4,GO REGULATION OF CHROMOSOME ORGANIZATION,0.034637,0.039878,0.045885,1,1
4,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.02843,0.03155,0.069958,1,1
